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Abstract 
 
Evidence for nutritional interventions to address protein-energy malnutrition in 
the care home setting is lacking. To define outcomes and optimise the design for an 
adequately powered randomised controlled trial to compare the efficacy of 
established nutrition support interventions, a cluster randomised feasibility trial was 
undertaken. Ninety-three care home residents at risk of malnutrition were identified 
across six UK care home sites. Homes were cluster randomised to receive food-
based intervention, oral nutritional supplement intervention, or standard care, for six 
months. Key outcomes were trial feasibility and acceptability of design, allocated 
interventions and outcome assessments. The trial design was feasible to undertake. 
Recruitment and retention targets for care homes and residents were met and the 
interventions were acceptable to residents and staff. Weight, body mass index (BMI) 
and mid-arm circumference were feasible and acceptable measurements to 
undertake, but measurement of function and patient-centred outcomes was 
hampered by dementia and immobility. A definitive trial comparing the efficacy of 
nutrition support interventions in increasing weight and BMI in malnourished care 
home residents can be conducted. However, this feasibility trial has highlighted a 
current lack of clinically relevant outcome measures, which are feasible to undertake 
in this setting. 
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CHAPTER ONE: INTRODUCTION 
MALNUTRITION IN THE OLDER ADULT POPULATION 
AND ITS NUTRITIONAL MANAGEMENT 
 
This thesis considers the feasibility and acceptability of running an adequately 
powered definitive trial, evaluating nutritional interventions for malnutrition within care 
homes for older adults (over 65 years). This chapter will describe the condition of 
protein energy malnutrition (PEM) and its current nutritional management, and will 
relate this to the UK care home setting. 
 
1.1 Protein- Energy Malnutrition in the UK 
There is no universally accepted definition of malnutrition, but one of the most 
widely accepted, describes it as a ‘state of nutrition in which a deficiency or excess 
(or imbalance) of energy, protein, and other nutrients causes measurable adverse 
effects on tissue/body form (shape, size and composition) and function, and clinical 
outcome’ (Elia, 2003, p8). Within the scope of this thesis, the term malnutrition will 
be used to refer to under nutrition and involuntary weight loss. The recent literature 
suggests that involuntary weight loss can be categorised into three primary 
aetiologies; starvation, sarcopenia and cachexia (Thomas, 2007; Chapman, 2011; 
Yaxley and Miller, 2011). In clinical practice, differentiation is infrequent and there 
are no universally shared criteria for diagnosis. It is generally accepted however, that 
starvation, synonymous with protein-energy malnutrition (PEM), results in the loss of 
fat and fat-free mass due to protein-energy deficiency (Thomas, 2007), whilst 
sarcopenia is characterised by the loss of skeletal muscle mass and strength 
associated with ageing (Burton and Sumukadas, 2010). Cachexia is a multifactorial 
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metabolic syndrome, driven by inflammation and characterised by severe wasting of 
fat free mass, with or without fat mass (Muscaritoli et al., 2010). This thesis will focus 
largely on the condition of PEM (Stratton et al., 2003). 
Often under-recognised and under-treated, PEM develops when energy 
intake and/or protein intake, chronically fail to meet the body’s nutritional 
requirements (Hoffer, 1999). It can affect virtually every function and organ system of 
the human body (Correia and Waitzberg, 2003), predisposing individuals to disease 
and delaying recovery from illness (McWilliams, 2008).  Those at risk are admitted to 
hospital more frequently, experience a reduced quality of life and have an increased 
risk of mortality (Gaskill et al., 2008; Heismayr et al., 2009; Brotherton, Simmonds 
and Stroud, 2010). In the UK, more than 1 million people over the age of 65 are 
malnourished, or at risk of PEM and the vast majority (93%) are resident in the 
community setting (Elia and Russell, 2009), where increased risk is associated with 
frailty and reduced physical independence (Stratton et al., 2003).  
In 2007, the health and social care costs associated with malnutrition were 
estimated to exceed £13 billion annually, more than 10% of the public expenditure 
on health care (Elia and Russell, 2009). Characteristically, older adults deteriorate to 
a state of PEM more quickly than younger people and are known to be especially 
vulnerable to the associated adverse outcomes (Kubrak and Jensen, 2007). With the 
UK over 65 population (11.1 million in 2013) projected to increase by nearly 50% in 
the next 20 years (Office for National Statistics, 2013; Age UK, 2013), the prevalence 
of PEM and the cost to society and the individual is likely to increase significantly. 
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1.2 Recommendations for the nutritional management of 
PEM 
There is no internationally agreed protocol for the nutritional treatment of PEM 
in older adults (Baldwin and Weekes, 2011). Widely used techniques to enhance oral 
dietary intake include food-based (FB) intervention (fortification to increase energy 
and/or protein density, provision of nourishing snacks and/or drinks) and/or the use 
of prescribed oral nutritional supplements (ONS) (NICE, 2006), ‘dietary foods for 
special medical purposes’ (FSMPs) (Commission Directive, 1999). The ‘standard’ 
ready-to-drink ONS contains 1 to 2.4kcal/ml and is composed of a combination of 
macronutrients and micronutrients (National Prescribing Centre, 2012).  The British 
Dietetic Association (BDA) and The National Prescribing Centre (NPC) advocate, 
improving dietary intake first using fortification of conventional food and secondly by 
prescribed means (Prickett, 2007; NPC, 2012). However, few trials have evaluated 
the food-based approach and it remains unclear whether this intervention is able to 
improve clinical outcomes for malnourished individuals (Odlund Olin et al., 2003; 
Smoliner et al., 2008; Baldwin and Weekes, 2011). 
Food-based intervention is considered more economical to the National 
Health Service (NHS) in England than prescribed ONS. In 2011, ONS incurred an 
annual spend of £105 million, a 10% increase from 2010 (NHS Business Services 
Authority, 2011). Many General Practitioner (GP) practices identified significant and 
increasing spends on ONS at this time, often accompanied by prolonged and 
inappropriate prescribing. Medicines Management teams subsequently imposed 
stricter prescribing guidance and encouraged greater use of food-based intervention 
(Hobday, 2010). However, the development of initiatives to reduce ONS usage has 
since prompted concerns about delayed appropriate prescribing (Brotherton et al., 
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2010). Whilst there may be potential to improve oral dietary intake in a variety of 
ways, it is important to establish the effectiveness of both food-based and ONS 
interventions, to ensure that the most appropriate nutrition support is initiated 
promptly for vulnerable individuals, to minimise further deterioration in nutritional 
status. 
1.3 The UK care home
1
 setting 
Care home residents are a distinct group of over 400,000 people (including 17% 
of those aged over 85) (Government Statistical Service, 2006), with very different 
mortality (Nimmo et al., 2006), health status, and health and care needs (Petty et al., 
1998; Sinclair et al., 2001) from those of individuals, of the same age, residing in 
their own homes. Differences are often so pronounced, that research outcomes 
established for older people living within their own homes cannot be considered valid 
for care home residents and cannot therefore be used to guide best care practice 
(Bugeja et al., 1997; Bayer and Todd, 2000). 
1.3.1 PEM in UK care homes  
Care homes are arguably home to one of the UK’s most vulnerable 
populations (Quince, 2013), 30% to 42% of whom are estimated to be at risk of 
malnutrition (Russell and Elia, 2010). PEM significantly impacts upon the physical 
and emotional well-being of residents and has been linked to, increased vulnerability 
to infection and pressure ulcers, clinical complications, depression and decreased 
quality of life (Cowan et al., 2004; Arvanitakis et al., 2009; Meijers et al., 2012). In 
2012, The Care Quality Commission’s (CQC) Dignity and Nutrition Inspections, 
                                                          
1
 In this thesis, the term care home is used to refer to all residential long-term care settings providing group living alongside 
personal and/or nursing care for older people and other adults 
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revealed that one in six UK care homes were failing to meet the nutritional needs of 
their residents (CQC, 2012), whilst data obtained from the Office for National 
Statistics, revealed that from 2003 to 2012, 1,158 care home residents suffered 
dehydration-related deaths, 318 residents died from starvation or severe malnutrition 
and 2,815 deaths were related to pressure sores (Office for National Statistics, 
2012). Significant changes to culture and practice within the care home setting are 
required to improve nutritional care, and food and eating practices.   
There is a tendency to avoid research in care homes, because of the 
methodological issues involved (Maas et al., 2002). Many studies specifically 
exclude care home residents on the basis that their inclusion would present the 
research team with ethical and practical difficulties (Watts, 2012) and a recent review 
revealed that the majority of epidemiological studies, either exclude care home 
residents at the outset, or fail to follow-up participants when they move into 
institutional care (Collingridge Moore and Hanratty, 2013). With an ageing population 
set to increase, care homes will play an increasingly vital role in supporting and 
caring for older people. The lack of evidence to support best practice has led to 
recommendations for more studies to be conducted in this setting (The Royal 
College of Physicians, 2000) and provides an opportunity to bring new ideas to the 
field.  
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CHAPTER TWO: LITERATURE REVIEW 
 NUTRITION SUPPORT INTERVENTIONS FOR 
PROTEIN ENERGY MALNUTRITION IN THE CARE 
HOME POPULATION 
 
 An initial broad scoping search into the use of nutritional interventions for 
PEM revealed that the majority of studies have used ONS as the intervention 
strategy, comparing effectiveness with placebo or standard care, predominantly 
within the acute setting. One Cochrane review was identified, which assessed the 
impact of food-based intervention on PEM within a variety of settings, but there was 
a lack of published evidence reviewing the impact of either intervention in the care 
home population. This chapter provides an overview of current evidence for the 
management of PEM using prescribed ONS and using food-based intervention, with 
a focus on the older community-based population, followed by a detailed analysis of 
research evaluating nutritional interventions within the care home setting. 
2.1 The nutritional management of PEM in older adults using 
prescribed ONS: A broad overview of current evidence 
Systematic reviews of nutritional interventions for PEM (Stratton et al., 2003; 
Milne et al., 2005; Koretz, 2007; Milne et al., 2009), have tended to focus on the 
effectiveness of ONS compared with placebo or standard care. In 2006, the National 
Institute for Clinical Excellence (NICE) conducted a systematic synthesis of best 
evidence, which has formed the basis of UK national policy on the management of 
malnutrition by oral, enteral and parenteral means (NICE, 2006). Study design was 
limited to published, systematic reviews, meta-analyses of randomised controlled 
trials (RCTs), and RCTs. Within the review of oral interventions, 40 RCTs were 
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identified, which assessed the effectiveness of ONS alone or alongside dietary 
advice, compared to standard care. The trials were small, with considerable clinical 
heterogeneity of patients and outcomes, but the results suggested significant weight 
gain with 1 to 3 ONS daily (300-900kcal) (n=22)  and a meta-analysis indicated 
statistically significant reductions in complications (n=9) (post-surgical infective 
complications (n=6), fracture healing complications (n=1), pressure ulcers (n=2))  
and mortality rate (n=25). The search strategies were not confined to specific patient 
groups, but there was a predominance of evidence from the acute setting and just 3 
RCTs examined the effectiveness of ONS in malnourished older adults in the 
community. These trials suggested an increase in weight with ONS, but did not 
support the net mortality benefit identified within the meta-analysis.  
In 2009, a Cochrane meta-analysis of 62 RCTs evaluated the effectiveness of 
ONS in undernourished adults over 65 years (Milne et al., 2009). Whilst the review 
reported a small, but consistent weight gain with ONS, the inclusion of primary 
outcomes of relevance to patients, such as functional measures and quality of life 
were lacking. The risk of bias (assessed in accordance with the Cochrane handbook, 
1997) was rated highest with regards to allocation concealment, ‘intention to treat’ 
(ITT) analysis and blinding of outcome assessors, all of which may have affected the 
internal validity of the included trials. Severely malnourished individuals were 
frequently excluded for ethical reasons and the length of intervention was often short 
(less than 35 days for 17 trials), which may have affected the external validity of the 
findings. The authors rated the overall quality of the trials as poor. 
Preserving physical independence, preventing functional disability and 
improving quality of life are important outcomes within the clinical care of older adults 
(Neelemaat et al., 2012). A recently published clinical trial, involving over 200 older 
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adults, was the first to demonstrate significant improvements in functional limitations, 
on comparing a multi-component nutritional intervention (energy and protein 
enriched diet, 2 ONS servings (600kcal), a calcium-vitamin D supplement and 
telephone counselling with a dietitian, for 3-months post hospital), with standard care 
(Neelemaat et al., 2012). It is unclear though, whether the observed improvement 
was due to the effects of ONS, another component, or a combined effect of the plan. 
With respect to quality of life, this trial, like others (Edington et al. 2004; McMurdo et 
al. 2009), found no significant difference between groups, after 8 to 12 weeks. 
On consideration of the Grading of Recommendations Assessment, 
Development and Evaluation (GRADE) system (Balshem et al., 2011), the current 
evidence for ONS intervention in the older adult community-based population is low 
quality. Whilst the systematic review by NICE included only RCTs (associated with 
low risk of bias), the results were indirect in relation to the population of interest. The 
majority of trials were conducted in the acute setting in patients with various disease 
states. Milne et al (2009) focused on RCTs conducted with older adults, however the 
risk of bias was high and 42 of the 62 trials had less than 100 participants, reducing 
precision of results. To determine whether ONS intervention improves clinical and 
functional outcomes for older malnourished individuals in a community setting, 
adequately powered trials, with low risk of bias and sufficient length of follow-up are 
required.  
2.2 The impact of dietary advice and/or food based 
intervention in the treatment of PEM in older adults: An 
overview of the evidence 
A Cochrane systematic review and meta-analysis was the first to evaluate the 
impact of dietary advice and/or food-based intervention on PEM (Baldwin and 
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Weekes, 2007; 2011). Studies of patients with, or at risk of malnutrition, in any 
setting were included and 45 published RCTs and quasi-RCTs (n=3186) were 
identified, examining:  
 
 
 
 
 
 
 
 
Primary outcomes were mortality, morbidity and measures of nutritional status; 
although mortality and morbidity did not differ significantly between any of the 
groups. Results from the first 3 comparisons are considered most relevant to this 
review (Table 1).  
 
 
 
 
 
 
 
 
 
 
 
 
1. Dietary advice/intervention versus no advice/intervention (12 trials)  
2. Dietary advice/intervention versus prescribed ONS (8 trials)  
3. Dietary advice/intervention versus dietary advice/intervention plus ONS         
(16 trials) 
4. Dietary advice/intervention plus ONS versus no advice/intervention and no 
ONS (14 trials) 
Figure 1: Comparison groups in the Cochrane Systematic review (2011) 
*Three of the 45 identified trials included two of the above comparisons, and one trial included three of 
the above comparisons. 
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Table 1: Summary of findings from three of the comparison groups in the Cochrane 
Systematic review (2011) 
 
Comparison: Findings related to measures of nutritional status: 
 
1. Dietary advice/ 
intervention 
compared to no 
dietary advice/ 
intervention 
Significant improvements in body weight were seen with: 
 Interventions longer than 12 months (Mean Difference (MD) of 3.75kg, 95% 
Confidence Interval (CI) 0.97 to 6.53kg, p= 0.0081; 1 trial, n = 92) 
 Interventions of up to 12 months duration (MD = 1.47kg, 95% CI 0.32 to 
2.61kg, p = 0.012; 9 trials, n = 733).  
*Heterogeneity between trials was high (I
2 
= 90%; P< 0.00001) and the 
reported effect size was influenced by 1 quasi-RCT with high risk of bias.  
Significant increases in mid arm muscle circumference (MAMC) were 
seen with: 
3 2 trials (n = 130). A mean difference of 0.81cm was observed (95% CI 0.31 
to 1.31cm, p = 0.0015), *although moderate heterogeneity existed between 
the 2 included trials (I
2
 = 54%; P = 0.14). 
Significant increases in energy intake were seen with: 
4 7 trials (n= 981), with a mean difference of 257.78 kcal/day (95% CI -0.74 to 
516.30, P = 0.05). *Heterogeneity between trials was again high (I
2 
= 98%; P 
< 0.00001). 
2. Dietary advice/ 
intervention 
compared with 
ONS 
 
No significant differences between groups for primary or secondary 
outcomes when dietary advice/intervention was compared with ONS. 
3. Dietary advice 
/intervention 
compared with 
dietary advice/ 
intervention plus 
ONS 
 
Significant increases MAMC were seen with:  
 
5 3 trials (n = 492), with a mean difference of 0.89cm (95% CI 0.43 to 1.35cm, 
p= 0.00016) in favour of dietary advice/intervention and ONS. 
 
Significant increases in handgrip strength were seen with: 
6 4 trials (n = 364). Handgrip strength was greater in those who received 
dietary advice/intervention and ONS (MD -1.67kg, 95% CI -2.96 to -0.37, p = 
0.01). *The effect was determined to be moderately heterogeneous (I
2
 = 
50%, p = 0.11). 
 
ONS = Oral Nutritional Supplements 
*In each comparison, the authors have examined the differences between the results of the studies using the I
2
 statistic, which 
describes the percentage of total variation that is the result of heterogeneity rather than chance (Higgins, 2003). Heterogeneity 
was categorised as low (I
2 
of less than 33%), moderate (I
2
 of 34 to 66%) or high (I
2
 of 67% or more) (Baldwin and Weekes, 
2011).   
One trial (n = 96), which contributed data to the analysis for weight change 
and energy intake (comparison 1) was conducted with malnourished older adults 
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(Rydwik, 2008, cited in Baldwin and Weekes, 2011). No trials, which contributed data 
to the analysis in comparisons 2 or 3, specifically included older adults.  
2.2.1 The evidence from the Cochrane review 
 This review suggests that dietary advice and intervention for PEM may 
improve weight and indicators of muscle mass, with or without ONS, but the findings 
are not specific to the older adult population and the evidence is low quality (in 
accordance with the GRADE guidelines, Balshem et al., 2011). The majority of 
included trials were affected by limitations in design and implementation. Most were 
not adequately blinded and descriptions of allocation concealment and sequence 
generation were lacking (assessed by the authors using the Cochrane Handbook, 
Higgins, 2011). Findings on weight change were attained from 1 quasi-RCT (Macia, 
1991), with high risk of attrition and selection bias, and should therefore be 
interpreted with caution. Most trials provided information on intervention duration, 
however there was minimal information on the intensity or content, presenting a risk 
of indirectness of evidence in relation to interventions actually used in practice. The 
majority of trials were conducted in the outpatient setting, which limits transferability 
to other care settings and highlights the need for adequately powered, low risk of 
bias trials to assess the effectiveness of food-based intervention in the population of 
interest. 
2.3 Malnutrition interventions within the care home setting: a 
systematic review  
 
2.3.1 Systematic review method  
 
A systematic review is a summary of primary research that attempts to 
identify, select, synthesise and appraise all high quality evidence relevant to a 
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specific research question, to be able to answer it (Cochrane, 1999).  Such a review 
is usually based on RCTs that have met rigorous standards of quality and have low 
risk of bias. However, since data from RCTs may be insufficient to fully answer a 
research question, non-randomised study designs are sometimes considered (Norris 
et al., 2010).  
Neither the Cochrane review, which addressed the use of ONS in older adults 
(Milne et al., 2009), or the Cochrane review, which assessed the evidence for food-
based intervention (Baldwin and Weekes, 2011) made any specific conclusions 
regarding the treatment of PEM in care home residents. The preliminary scoping 
search of the literature identified a small number of RCT’s investigating the 
effectiveness of nutritional interventions in care homes and highlighted a complete 
lack of observational studies or qualitative research. Given the absence of any 
relevant qualitative literature, a systematic review method was chosen and RCT 
study designs were considered.  
 
2.3.2 Literature Search 
 The primary search strategy was a database search of: CINAHL, PubMed, 
Embase and Web of Science. PubMed contains more than 23 million citations for 
biomedical literature from MEDLINE, life sciences journals and online books and it 
was felt that relevant and peer-reviewed articles could be identified here 
(http://www.ncbi.nlm.nih.gov/pubmed). Bibliographies of the included articles and 
previously published systematic reviews were checked for other relevant literature, 
including books and book chapters. Titles, abstracts, and potential full-text articles 
were assessed for inclusion. The PICOS framework (Patients, Intervention, 
Comparison, Outcomes, Study Design) was used to facilitate the search (Table 2): 
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Table 2: PICOS (Participants, Interventions, Comparisons, Outcomes, Study Design) 
for meta-analysis and review. 
 
Patients Care home residents, with, or at risk of malnutrition 
Interventions 
Oral nutritional supplements (ONS), home-made milk based fortified drinks; 
fortification of normal food sources and dietary advice 
Comparison 
Standard/Usual care; or ONS compared to food-based strategies 
Outcomes 
Primary outcomes: Mortality, Morbidity (assessed by risk of hospital admission 
or readmission and length of hospital stay), measures of nutritional status 
(including change in weight, mid-arm muscle circumference (MAC), tricep 
skinfold thickness (TSF), hand grip strength) 
Secondary outcomes: Nutritional intake pre and post intervention, Measures 
of clinical function (immune function, cardiac function, respiratory function), 
Quality of life (QoL) or health state, and cost 
Study Design 
Randomised controlled trials (RCTs)  
Confounding factors such as compliance and adverse events were also observed. 
 
Inclusion criteria were applied (Table 3) and searches were limited to English 
as resources were not available to have articles translated. Due to time constraints, it 
was not realistic to contact the authors of any articles for further data or for 
clarification. The searches were conducted in March 2014. All articles published 
before 21st March 2014 were included. 
Table 3: Search terms and inclusion criteria 
Search Terms Inclusion criteria 
Malnutrition/Protein energy malnutrition  
AND 
Oral nutritional interventions/food 
fortification/oral nutritional 
supplements/nutritional treatment 
AND 
Nursing home/care home, residents/patients 
1. English language 
2. Up to March 2014 
3. Adults >65 years 
4. Conducted in the care home setting 
5. Randomised Controlled Trials  
 
 
 
The number of articles searched through each stage is described diagrammatically 
(Figure 2). 
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Records retrieved 
(n = 120) 
Id
e
n
ti
fi
ca
ti
o
n
 
Records after duplicates 
removed 
(n = 89) 
S
cr
e
e
n
in
g
 
Titles of records 
screened 
(n = 89) 
Records excluded  
(n =58) 
Excluded if irrelevant to the 
research question (that is, 
where nutrition support was 
discussed in terms of enteral 
or parenteral feeding (n=9), 
malnutrition screening (n=16), 
prevalence of malnutrition 
(n=18), or specific 
micronutrient deficiencies 
(n=15)). 
 
Full text articles 
assessed for eligibility 
(n =31) 
E
lig
ib
ili
ty
 
Full text articles 
excluded  
(n =20) 
Some described multi-
component interventions 
(nutritional interventions 
combined with exercise (n=8) 
or behavioural interventions 
(n=3)). Others included 
participants from both, care 
homes and from community 
care (n=9) and made no 
specific conclusions regarding 
the care home setting. 
 
Articles remaining 
 (n =11) 
In
cl
u
d
e
d
 
Total included studies 
(n = 15) 
Extra articles identified 
from search of reference 
lists 
(n =4) 
Figure 2: Flow chart for the selection of studies for the review (adapted from The Preferred 
Reporting Items for Reviews and Meta Analysis; PRISMA flow chart, Moher et al., 2009) 
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Fifteen original RCTs were identified. The trials examined 3 bodies of 
evidence; food-based intervention versus standard care (n=7), ONS intervention 
versus standard care or placebo (n=6) and food-based intervention versus ONS 
(n=2). The Cochrane Risk of Bias Tool was used to assess risk of bias for each trial 
(Higgins et al., 2011) (Table 7)2, the GRADE system was used to rate the quality of 
each body of evidence (Balshem et al., 2011) (Table 8) and the PRISMA statement 
was used to guide evidence reporting (Moher et al., 2009). 
2.3.3 A review of the findings 
 
2.3.3.1 Food-based (FB) intervention for malnutrition in the care home 
setting 
 Seven original studies; 4 RCTs, 2 cluster RCTs and 1 cluster feasibility RCT 
examined the effect of FB interventions on clinical outcomes for care home 
residents. Interventions included diet supplementation with milk powder (n=1); two 
additional servings of dairy food daily (n=1); dietary modification to increase energy 
content (n=2); food fortification (n=1); increasing meal frequency (n=1) and provision 
of a homemade liquid supplement (n=1). The trials examined outcome measures 
meeting the inclusion criteria, including change in weight (n=3), body mass index 
(BMI) (n=3) or mid upper arm circumference (MAC) (n=1), physical function 
(handgrip strength, activities of daily living (ADL) score) (n=3), change in nutrient 
intake (n=5) and quality of life (n=1). Mortality and cost were not included as primary 
or secondary outcomes within any identified trials. All trials used a control of 
standard care, described as ‘usual, care home meal provision’ and follow-up varied 
from 4 to 15 weeks. A summary of the evidence is described (Table 4).
                                                          
2
 Table 7 and Table 8 are located at the end of Section 2.3, pp. 27-31 
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Table 4: Summary of evidence for food-based interventions: methodological characteristics and major outcomes of included studies 
Source: Sample 
size 
Population: Design: Food-based 
intervention 
Resident 
compliance 
Outcomes: Intervention vs. Control 
Kwok, 
2001 
 
 
 
n = 47 
 
Nursing home 
residents with poor 
intake in China.  
Mean age 81 ± 10 in 
IG and 80 ± 10 in CG. 
Mean BMI IG: 19.1, 
CG: 20.1 
RCT, CG 
received 
same foods 
as IG 
 
25g low lactose 
milk powder twice 
daily 
 
 
+175kcal 
98.5% 
compliance 
Weight change (kg): IG increased from 42.94 
to 44.39, CG decreased from 46.73 to 46.39, 
NSD 
Grip strength, mental function, disability 
measures, NSD 
 
 
Beck, 2002 
 
n = 66 
 
Undernourished 
nursing home 
residents in Denmark, 
mean age 84, mild to 
moderate cognitive 
impairment 
RCT 
 
Home-made oral 
supplement,  
 
 
+384kcal 
Mean intake 
of: 
 
 
380kcal 
Weight change (kg): CG 1.2 (-1.0-3.0) vs. IG 
1.5 (-2.3-9.0), NSD 
 
Odlund, 
2003 
 
 
n = 35 Nursing home 
residents in Sweden, 
median age 83 years, 
median BMI of 23.1 
 
RCT -Meals fortified 
with natural 
ingredients 
(cream, oil, butter) 
-Desserts fortified 
with cream, sour 
cream, 
hydrolysed starch. 
+500kcal 
Not reported IG: Energy intake increased from 23.5kcal/kg 
body weight to 31.9 kcal/kg body weight 
(P<0.001), 
ADL function was unchanged 
CG: No change in energy intake, ADL 
decreased significantly (P<0.001).  
 
5 deaths (12.5%) 
Taylor, 
2006 
 
n = 37 Residents of an 
extended-care facility, 
>65 years, receiving a 
texture-modified diet, 
Mean BMI: 20.4 
Crossover 
design with 
random 
assignment 
and two 4-
day study 
periods. 
Provision of five 
daily meals 
 
Energy content 
the same as for 
3 meals 
Consumed a 
mean of 
80% of 
energy 
served 
Average energy intakes similar between the 
three- and five meal patterns (1,325±207 
kcal/day vs. 1,342±177 kcal/day, 
respectively; P=0.6) 
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Smoliner, 
2008 
n = 65 Nursing home 
residents with, or at 
risk of malnutrition, 19 
men and 46 women 
with a median age of 
85.2 years 
Mean BMI IG: 21.6, 
CG: 22.5 
Excluded residents 
with severe cognitive 
impairment 
RCT -Protein and 
energy-enriched 
soups and sauces  
-Two additional 
snacks high in 
protein and 
energy between 
meals. 
 
+kcal unclear 
Not reported Higher protein intake in the IG (62.6 ± 11.5 
versus 74.3±18.3g/d, P = 0.007). Energy 
intake was similar in both groups 
Handgrip strength, fat free mass, Barthel 
Index and SF-36 NSD 
 
 
Leslie, 
2012 
 
n = 41 Residential care home 
residents, BMI 
<18.5kg/m
2 
Without acute disease. 
Mean age 91 ± 7 
Mean BMI IG: 17.1, 
CG: 17.3 
 
 
Cluster RCT 
across 21 
residential 
care homes 
 
 
-Double cream 
(50 ml) added to 
foodstuffs 
-Butter (8 g) 
added to 
potatoes.  
-250-ml fortified 
malted milk drink 
x 1 daily 
 
Maximum of + 
400kcal 
Not reported Weight change (kg): IG: 1.3kg, p = 0.03, CG: 
-0.2 NSD, between group differences not 
significant 
Energy intake, NSD 
 
Attrition rate of 25%, including 7 deaths 
(17%) 
 
 
Iuliano, 
2013 
 
n = 130 Care home residents 
from four care facilities 
in Melbourne, Australia 
78% female mean age 
86.5±5.6 years. 
Mean BMI IG: 23.7, 
CG: 25.4 
Prospective 
feasibility 
RCT 
Two additional 
servings of dairy 
foods daily 
 
+kcal unclear 
 
Not reported IG: Mean energy intake (+900kJ, P<0.001), 
protein intake (+25g, P<0.0001), proportion 
of estimated energy requirements (EER) 
(+18%, P<0.0001)  
CG: Mean energy intake remained below the 
EER, protein intake remained unchanged.  
BMI= Body Mass Index; RCT= Randomised Controlled Trial; ADL= Activities of Daily Living; EER= Estimated Energy Requirements; IG= Intervention group; CG= Control group, NSD = 
no significant difference
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Four trials, using interventions involving either enrichment of existing diet, or 
drink and/or snack swaps, found evidence for increased energy and/or protein intake 
in the intervention group (Beck et al., 2002; Odlund et al., 2003; Iuliano et al., 2013; 
Smoliner et al., 2013). One trial, which used an intervention of more frequent meal 
patterns, reported no difference in nutrient intake (Taylor and Barr, 2006). Two trials 
reported weight gain with FB intervention (Kwok et al., 2001; Leslie et al., 2012), but 
this was only significant in the energy-enriching approach (Leslie et al., 2012) and no 
evidence for any functional benefit was found (Kwok et al., 2001; Smoliner et al., 
2013). This may be due to short intervention and follow-up, or may suggest that 
functional frailty in this population is influenced more by age-related morbidity and 
immobilisation than by nutritional intake. The trial, which attempted to assess quality 
of life (Leslie et al., 2012), found that residents were unable to fully comprehend the 
questionnaire, a barrier that has been reported previously (Hickson and Frost, 2004). 
Intervention compliance was reported in 3 trials, but only 1 (Beck et al., 2002) gave 
an indication of average intervention intake as energy consumed (380kcal). 
 
Assessment of the risk of bias within food-based intervention trials (Table 7, pp. 27)  
 
The risk of bias for each trial was assessed (Table 7 (Higgins, 2011)). Only 1 
trial adequately described the method of randomisation sequence generation and 
allocation concealment and was assessed as low risk of selection bias (Leslie et al., 
2012). Three trials described allocation of intervention at the cluster level (Odlund et 
al., 2003; Smoliner et al., 2008; Iuliano et al., 2013), but did not make any reference 
to a clustered trial design.  No included trials were blinded to participants or 
personnel and blinding of outcome assessors was often unclear. It is acknowledged 
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that the challenge associated with designing a trial with adequate placebo for FB 
intervention is significant and whilst it might be possible to undertake blinded 
outcome assessment, this was not the case in many of the included trials, perhaps 
due to lack of funding. No trials included an intention to treat (ITT) analysis, and 2 
were rated as being at high risk of attrition bias, where loss-to-follow up was 
described as high (20% and 25% respectively), but was not accounted for within the 
analysis. All trials reported on the pre-specified outcomes and were rated as low risk 
of reporting bias. 
 
Overall rating of quality for the food-based body of literature (Table 8, pp.31) 
 
 The GRADE system (Balshem et al., 2011) was used to rate the quality of the 
body of evidence for FB intervention (Table 8). In the context of this review, quality 
reflects confidence that the findings of the included trials are correct. The overall 
rating was ‘very low’, due to limitations in the design and implementation of the 
included trials (Table 7) and identified indirectness of the evidence. Three of the 7 
trials, did not specifically recruit residents with, or at risk of malnutrition, therefore the 
evidence may be indirect in relation to the clinical population of interest. The nature 
of the intervention was broadly defined within all trials, but the type, content and 
delivery method varied and was often poorly described, affecting external validity 
and making the trials hard to replicate. Although several trials indicated 
improvements in nutritional parameters, the potential benefit to functional and clinical 
outcomes is unclear, whilst patient-centred outcomes require further investigation. 
More adequately powered, low risk of bias trials are required to draw any definite 
conclusions.  
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2.3.3.2 ONS intervention for malnutrition in the care home setting 
Six original RCTs, examined the effect of ONS in care home residents. The 
trials examined a number of outcomes meeting the criteria, including, change in 
weight (n=6), BMI (n=6) or MAC (n=2), physical function (handgrip strength, ADL 
score) (n=3) and change in dietary intake (n=2). One trial included quality of life 
(QoL) as a secondary outcome measure (Stange et al., 2012) and another included 
a 1-year follow up to observe mortality (Lee et al., 2013). Three included trials 
analysed fasting biochemistry pre-and post-intervention (Wouters-Wesseling et al., 
2002; Manders et al., 2009; Lee et al., 2013). All 6 trials utilised a parallel design, but 
3 compared ONS with a placebo supplement drink and 3 compared with standard 
care. Follow-up ranged from 60 days to 24 weeks. A summary of the evidence is 
described (Table 5).
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Table 5: Summary of evidence for ONS interventions: methodological characteristics and major outcomes of included studies 
Source: Sample 
size 
Population: Design: ONS 
intervention 
Resident 
compliance 
Outcomes: Intervention vs Control 
Fiatarone, 
2000 
n = 50 
 
Frail nursing 
home residents, 
mean age 88 
RCT 
 
This study 
was a 
subgroup 
analysis of 
the larger 
FISCIT trial 
Multinutrient liquid 
supplement 
(240ml) versus a 
non-nutritive 
(4kcal) placebo 
drink (240ml) 
 
+360kcal 
99% 
compliance 
with ONS 
(360kcal) 
but decrease 
in habitual 
dietary intake  
Significant decrease in habitual dietary intake, 
Gain in weight NSD. 
No effect on physical activity levels, muscle 
strength, depressive symptoms or cognitive 
function 
 
 
Lauque, 
2000 
n =88 Elderly nursing 
home residents 
in Toulouse.  
Mean age 84±8 
to 80±4 
Semi-
randomised 
Concurrent 
controls 
Liquid 
supplements 
4 different 
supplements 
offered: soup, 
fruit, dessert or a 
liquid 
 
+300-500kcal 
Mean intake 
of: 
 
393±23kcal in 
the at risk 
group 
 
430±20kcal in 
the 
malnourished 
group 
Malnourished group: weight gain of 1.5 ± 0.4kg, 
p<0.05. 
At risk group, weight gain of 1.4±0.5kg, NSD 
CG: no change in weight, BMI, grip strength, 
NSD 
Wouters-
Wesseling, 
2002 
n = 42 Psycho-geriatric 
nursing home 
residents in the 
Netherlands 
with low BMI. 
Mean age IG: 
85±8 and CG: 
79±9 
RCT, 
placebo 
controlled 
Complete 
micronutrient-
enriched liquid 
ONS (125 ml) or 
Placebo (125 ml) 
twice daily 
between meals. 
+270kcal 
Mean intake 
of: 
 
91%/246kcal 
Weight change: 1.4±2.4 kg vs. -0.08 ±3.0kg,  
p = 0.02  
 
Resident drop out: 17% 
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Manders, 
2009 
n = 176 Residents from 
three homes for 
the elderly, 
three nursing 
homes and 
three ‘mixed’ 
homes in the 
Netherlands. 
Mean age: 83 
Mean BMI 25.3 
(IG), 25.0 (CG) 
Double-
blind RCT, 
placebo-
controlled, 
intervention 
trial 
125ml nutrient 
enriched dairy 
drink x 2 vs. a 
placebo 
+500kcal 
Median intake 
of  
 
 
78%/390kcal 
 
<50% 
compliance in 
1/5
th
 of 
population 
Intake of energy, macronutrients, vitamins and 
minerals increased in IG and decreased or 
remained stable in the CG (P=0.001), 
Energy intake from normal foods decreased in 
both groups. 
Body weight increased by 1.4 kg in the IG and 
decreased by 0.6 kg in CG, NSD 
Resident drop-out: 33% 
Lee, 2013 n = 92 Undernourished 
geriatric nursing 
home residents 
in Taiwan. Mean 
age in CG: 
80.2±7.8, IG: 
78.9±8.4. mean 
BMI CG: 20.31, 
IG: 20.43 
 
Excluded 
residents not 
cognitively able 
to answer the 
questionnaire 
Double-
blind RCT 
50 g/day soy-
protein-based 
nutritional 
supplement 
containing all 
essential micro-
nutrients 
 
+250kcal, 9.5g 
protein 
Not reported Intervention significantly improved (or minimized 
decline of): body weight (IG +0.08±2.72; CG       
-0.33±1.51), BMI, MAC, calf circumference and 
serum albumin and cholesterol concentrations 
(all p < 0.05)  
No significant effect on hemoglobin, hematocrit 
and lymphocyte count status. 
 
Stange, 
2013 
 
n = 87 Nursing home 
residents with or 
at risk of 
malnutrition, in 
Germany, 
90.9% female 
Mean age 87±6 
years.  
RCT 2 x125 ml ONS 
per day vs. 
routine care 
+600kcal, 24g 
protein 
Median ONS 
intake:  
 
73%/438kcal  
Body weight, BMI, and arm and calf 
circumferences increased in the IG and did not 
change in the CG (P<0.05). 
Assessment of function was hampered by 
dementia and immobility, 
FISCIT= Frailty and Injuries in Later Life; ONS= Oral Nutritional Supplements; RCT= Randomised Controlled Trial; BMI= Body Mass Index; MAC= Mid Upper Arm Circumference; IG= 
Intervention group; CG= Control group, NSD = no significant difference 
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 Five trials examining weight or BMI found evidence for improvements with 
ONS, which was significant in all but 1 (Manders et al., 2009). Two trials showed 
improvements in MAC and Calf Circumference (CC) (Lee et al., 2013; Stange et al., 
2013) and 1 trial found evidence for a significant increase in overall energy, vitamin, 
and mineral intake (Manders et al., 2009), although energy intake from normal food 
was reduced. No evidence for any functional benefit was found, which may be due to 
short intervention and follow-up, or may illustrate the difficulty achieving functional 
improvements in this population. Assessment of function by Stange et al (2013) was 
reportedly hampered by dementia and immobility, which limited significance of the 
results. Intervention compliance was reported in 5 trials as mean or median energy 
intake (246 to 438kcal/day).  
 
Assessment of the risk of bias within ONS intervention trials (Table 7, pp. 27)  
 
 Two trials adequately described the method of random allocation (Lee et al., 
2013; Stange et al., 2013), but allocation concealment was not clearly described, or 
was not used in any included trials. Three trials (Wouters-Wesseling et al., 2002; 
Manders et al., 2009; Lee et al., 2013) were double-blinded to participants and 
personnel, but it was unclear if any of the included trials used blinded outcome 
assessment, placing them at unclear or high risk of detection bias. Losses to follow-
up were accounted for in all trials, but ITT analysis was used in only 1 (Stange et al., 
2013). The majority of included trials reported on pre-specified outcome measures, 
although the description of primary outcomes was unclear in 1 trial (Lauque et al., 
2000) and although mortality was described as an outcome in another (Lee et al., 
2013), it was not reported in results or discussion. 
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Overall rating of quality for the ONS body of literature (Table 8, pp. 31)  
 
The quality of this body of literature was assessed as ‘low’ using the GRADE 
approach (Table 8). The quality level decreased due to limitations in the design and 
implementation of the included trials (Table 7) and due to identified indirectness of 
the evidence in relation to the population of interest. Two trials (Lauque et al., 2000; 
Manders et al., 2009) were conducted with residents that were not undernourished 
and 1 trial had numerous exclusion criteria, which meant that the study population 
was relatively healthy (Fiatarone et al., 2000). The 6 trials varied with respect to 
design, conduct and intervention energy content (270kcal to 600kcal/day) and it was 
difficult to directly compare findings, because 3 compared ONS to placebo, whilst 3 
compared ONS to standard care. Standard care varied significantly and in 1 trial, 
even included provision of homemade snacks or ONS prescribed by a GP (Stange et 
al., 2013). Some evidence for a positive effect of ONS intervention on weight, 
anthropometry and nutrient intake was identified; however, more adequately 
powered, low risk of bias trials are required to determine whether the improvement in 
nutritional parameters can translate into improvements of functionality and patient-
reported outcomes. 
2.3.3.3 ONS intervention versus food-based (FB) intervention for 
malnutrition in the care home setting 
 Two RCTs compared FB intervention with ONS intervention in the care home 
setting. Both examined change in nutrient intake as the primary outcome measure 
and utilised a parallel design. The follow-up period was 6-weeks (Turic et al., 1998) 
and 12-weeks (Parsons et al., 2011) respectively. A summary of the evidence is 
described (Table 6).
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Table 6: Summary of evidence for ONS intervention vs. food-based intervention: methodological characteristics and major outcomes 
of included studies 
Source: Sample 
size 
Population: Design: Interventions Resident 
compliance 
Outcomes: Intervention vs. Control 
Turic, 
1998 
n = 68 Care home residents 
at risk of malnutrition, 
from 4 Long term 
care facilities. 
Mean age ONS: 
84±7.6, FB: 85 ±10. 
Mean BMI, ONS: 
20±3.42 and FB: 
20.6± 3.18  
RCT Daily food snacks 
x 3 vs. 3 x 8oz 
servings of ONS 
(711ml total) 
 
+900kcal with 
ONS 
Snacks unclear 
Mean intake 
of: 
 
611kcal 
ONS had significantly higher intake of energy 
and all nutrients p<0.001 
Parsons, 
2011 
n = 104 Care home residents, 
at risk of malnutrition. 
Mean age: 
88.3±7.7y, mean BMI 
19.1±2.7kg/m2, 86% 
female 
RCT Two servings of 
ONS vs. written 
or verbal dietary 
advice 
 
+600kcal with 
ONS 
Mean intake 
of: 
 
333kcal±237 
Total energy intake:  ONS: 1655±502kcal vs. 
FB: 1253±469kcal, p=0.001;  
Protein intake: ONS: 62.1±18.4g vs. FB: 
49.6±19.9g, p=0.004,  
Appetite sensations, NSD 
 
Resident drop-out: 27% 
RCT= Randomised Controlled Trial; BMI= Body Mass Index; ONS= Oral Nutritional Supplement group; FB= Food-based intervention group; NSD = no significant difference
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One trial compared 3 energy-dense snacks daily to 3 servings of ONS daily 
(900kcal) and demonstrated an increased energy intake of 26-30% with snacks and 
46-50% with ONS (Turic et al., 1998). The second trial compared ONS intervention 
with dietary advice (cognitive intervention) and showed increased energy and protein 
intakes that were 32% and 25% higher respectively in the ONS group (Parsons et 
al., 2011). Mean intakes of ONS intervention were 56% (Turic et al., 1998) and 68% 
(Parsons et al., 2011), but compliance with dietary advice or FB intervention was not 
reported.  
There is a lack of published research that has compared the effectiveness of 
nutritional interventions in the care home population. The 2 identified trials were 
rated high risk of performance bias (Table 7), because of a lack of blinding and both 
had unclear risk of selection bias, due to an absence of discussion of allocation 
concealment during intervention assignment.  The 2 trials differed greatly with 
respect to design, interventions and control and an overall rating of low quality was 
assigned, following assessment using GRADE (Table 8). The quality level was 
decreased due to identified limitations in the trial designs and implementation (Table 
7) and because of indirectness of the evidence. One trial compared ONS to food-
based snacks, but provided no information on whether the nutrient composition of 
the interventions was comparable, whilst the other compared ONS to written advice. 
To enable the efficacy of FB and ONS interventions to be compared in the care 
home setting, adequately powered, low risk of bias trials comparing interventions of 
equivalent nutrient content are required. 
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Table 7: Risk of bias in RCTs (assessed using the Cochrane risk of bias tool (Higgins et al., 2011)) 
 
 Selection Bias Performance 
Bias 
Detection 
Bias 
Attrition 
Bias 
Reporting 
Bias 
Other bias Overall risk of 
bias 
 Random 
sequence 
generation 
Allocation 
Concealment 
Blinding of 
participants 
and 
personnel 
Blinding of 
outcome 
assessment 
Incomplete 
outcome 
data 
Selective 
reporting 
 
Food-based intervention vs. 
standard care  
  
Kwok, 2001 High risk 
 
Quasi-random 
allocation 
High risk 
 
Allocation 
concealment 
not carried out 
High risk 
 
Open-label 
Unclear risk  
 
No information 
given regarding 
whether 
outcome 
assessors were 
blinded 
Unclear risk 
 
Losses to 
follow- up 
disclosed, but 
ITT analysis 
not described 
Low Risk 
 
All pre-specified 
outcomes were 
reported 
 High 
Beck, 2002 High risk 
 
Semi-randomised 
approach described 
High risk 
 
Allocation 
concealment 
not carried out 
High risk 
 
Open-label 
Unclear risk  
 
No information 
given regarding 
whether 
outcome 
assessors were 
blinded 
Unclear risk 
 
Losses to 
follow- up 
disclosed, but 
ITT analysis 
not described 
Low Risk 
 
All pre-specified 
outcomes were 
reported 
 High 
Odlund, 2003 High risk 
 
Residents in one ward 
given intervention, 
residents in the other 
ward remained on 
regular diet. 
No information given 
on method of random 
allocation 
High risk 
 
Allocation 
concealment 
not carried out 
High risk 
 
Open-label 
High risk 
 
Open-label 
Unclear risk 
 
Losses to 
follow-up 
disclosed, but 
ITT analysis 
not described 
Low risk 
 
All pre-specified 
outcomes were 
reported 
Unclear risk 
 
Examples of energy-
enriched diet given, 
but unclear if the 
same level of 
enrichment provided 
daily and no 
information on 
assessment of 
compliance. Could 
result in performance 
bias. 
High 
Taylor, 2006 High risk 
 
‘Participants were 
randomly assigned to 
one of the two groups’ 
High Risk 
 
No description 
of allocation 
concealment 
High risk 
 
Open-label 
Unclear risk  
 
No information 
given regarding 
whether 
Low risk 
 
No loss to 
follow up 
Low risk 
 
All pre-specified 
outcomes were 
reported 
Unclear risk 
 
Implemented in a ‘real 
life’ setting, this limited 
ability to provide 
Medium 
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No information given 
on method of random 
allocation 
 
outcome 
assessors were 
blinded 
complete control. May 
lead to performance 
bias, but provide 
information on 
effectiveness in a 
typical setting. 
Smoliner, 2008 High risk 
 
‘Randomisation was 
done according to 
ward’ No information 
given on method of 
random allocation 
High Risk 
 
No description 
of allocation 
concealment 
High risk 
 
Open-label 
Unclear risk  
 
No information 
given regarding 
whether 
outcome 
assessors were 
blinded 
High risk 
 
Losses to 
follow-up 
disclosed, but 
ITT analysis 
not described, 
despite 
attrition rate of 
20% 
Low risk 
 
All pre-specified 
outcomes were 
reported 
Unclear risk 
 
FB interventions 
described 
inadequately- unclear 
how often energy 
enriched food was 
offered and in what 
quantities. Snacks not 
described. May lead 
to performance bias 
High 
Leslie, 2012 Low risk 
 
Cluster randomisation 
using a random 
permuted block 
design. 
 
All residents within the 
homes invited to 
participate 
Low risk 
 
Carried out by 
a statistician 
with no 
contact with 
the homes 
High risk 
 
No blinding of 
residents, staff 
or research team 
Unclear risk  
 
No information 
given regarding 
whether 
outcome 
assessors were 
blinded 
High risk 
 
Losses to 
follow-up 
disclosed, but 
ITT analysis 
not described, 
despite 
attrition rate of 
25% 
Low Risk 
 
All pre-specified 
outcomes were 
reported 
Unclear risk 
 
Unclear information 
given on the 
intervention provided 
in terms of energy 
added for all residents 
(only maximum 
amount reported). No 
clear information on 
compliance. This 
could lead to 
performance bias 
Medium 
Iuliano, 2013 High Risk 
 
‘Two facilities were 
randomly selected for 
intervention’ 
No information given 
on method of random 
allocation 
‘Probably not done’ 
High Risk 
 
No description 
of allocation 
concealment 
High risk 
 
Open-label 
High risk 
 
Open-label 
Unclear risk 
 
No information 
given on 
losses to 
follow-up 
Low risk 
 
All pre-specified 
outcomes were 
reported 
Unclear risk 
 
Content of the 
interventions unclear. 
Method of determining 
whether residents 
were able to take 2 
additional daily 
servings not 
described. May lead 
to performance bias 
High 
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ONS intervention vs. 
standard care 
  
Fiatarone, 2000 Unclear risk 
 
Described as 
randomised placebo 
controlled but no 
information on method 
of random allocation 
Unclear risk 
 
Not clear if 
allocation 
concealment 
used 
Unclear risk 
 
The larger 
FISCIT trial was 
double-blinded 
Unclear risk  
 
No information 
given 
regarding 
whether 
outcome 
assessors 
were blinded 
Unclear risk 
 
Losses 
accounted for, 
but  not clear if 
ITT analysis 
used 
Low risk 
 
All pre-specified 
outcomes were 
reported 
 Medium- High 
Lauque, 2000 High risk 
 
Semi-randomised trial. 
No information given 
on method of random 
allocation for group B 
High risk 
 
Allocation 
concealment 
not used 
High risk 
 
Open-label 
Unclear risk  
 
No information 
given 
regarding 
whether 
outcome 
assessors 
were blinded 
Unclear risk 
 
Losses 
accounted for, 
but ITT analysis 
not used 
Unclear risk 
 
Outcomes 
reported, but 
description of 
primary unclear 
Stated that the 
baseline groups 
differed significantly, 
likely due to 
assignment based on 
MNA score and semi-
randomised design 
High 
Wouters-Wesseling, 2002 Unclear risk 
 
Described as 
randomised, but 
method not stated 
Unclear risk 
 
Unclear if 
method of 
allocation 
concealment 
used 
Low risk 
 
Double-blinded 
placebo 
controlled 
Unclear risk 
 
Not mentioned 
if outcome 
assessors 
blinded 
Unclear risk 
 
Losses to follow 
up accounted 
for, but ITT 
analysis was not 
possible 
Low risk 
 
All pre-specified 
outcomes were 
reported 
Patients in the 
intervention group 
were significantly 
older 
Low-Medium 
Manders, 2009 Unclear risk 
 
Described as 
randomised, placebo-
controlled, but no 
information on method 
of random allocation. 
Unequal distribution 
used on basis of 
perceived ONS benefit 
vs. placebo. 
Dietary intakes 
assessed in a non-
randomly selected 
subsample. 
Unclear risk 
 
Potential 
confounding 
factors 
accounted for 
in allocation to 
treatment 
described, but 
method of 
allocation 
concealment 
not clear 
Low risk 
 
Double-blinded 
trial to 
participants and 
personnel 
Unclear risk 
 
No information 
given 
regarding 
whether 
outcome 
assessors 
were blinded 
Unclear risk 
 
Losses to follow-
up accounted 
for. Unclear if 
ITT analysis 
used. Noted 
differences 
between drop-
outs and 
compliers may 
have resulted in 
bias. 
Low risk 
 
All pre-specified 
outcomes were 
reported 
 Medium 
Lee, 2013 Low risk 
 
Subjects were 
‘randomly assigned to 
Unclear risk 
 
Unclear if 
allocation 
Low risk 
 
Double-blinded 
trial 
Unclear risk  
 
No information 
given 
Unclear risk 
 
Losses 
accounted for, 
Unclear risk 
 
Trial mentioned a 
one year follow up 
 Medium 
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either the control or the 
experimental group by 
drawing pieces of 
folded paper from a 
bag 
concealment 
used 
regarding 
whether 
outcome 
assessors 
were blinded 
but ITT analysis 
not used. No 
information on 
whether drop-
outs differed 
significantly from 
compliers 
to observe 
mortality within 
methods, but this 
was not discussed 
again in results or 
discussion 
Stange, 2013 Low Risk 
 
‘Randomisation was 
performed in blocks of 
6 to 10 subjects per 
ward, to balance 
differences between 
the wards, by closed 
envelopes’ 
Unclear risk 
 
Not made 
clear if the 
allocation 
sequence was 
concealed 
from those 
assigning 
interventions 
High risk 
 
Open-label 
High risk 
 
Open-label 
Low risk 
 
Losses to follow-
up accounted for 
and ITT analysis 
used 
Low risk 
 
All pre-specified 
outcomes were 
reported 
The CG received 
usual care, but this 
included snacks and 
ONS when provided 
by family or a GP.  
Medium 
FB intervention vs. ONS 
intervention 
  
Turic, 1998 Low risk 
 
A randomisation 
schedule was created 
using a statistical 
analysis system, which 
used a pseudo-random 
variate 
Unclear risk 
 
Not made 
clear if the 
allocation 
sequence was 
concealed 
from those 
assigning 
interventions 
High risk 
 
Open-label- 
necessary due 
to the nature of 
the interventions 
Unclear risk 
 
Not mentioned 
if outcome 
assessors 
blinded 
Unclear risk 
 
Losses to follow 
up accounted 
for, but ITT 
analysis was not 
used 
Low risk 
 
All pre-specified 
outcomes were 
reported 
The FB group 
received 3 food-based 
snacks but these were 
not described, making 
the trial difficult to 
replicate 
Medium 
Parsons, 2011 Unclear risk 
 
Described as 
randomised, but 
method not stated 
Unclear risk 
 
Unclear if 
method of 
allocation 
concealment 
used 
High risk 
 
Open-label- 
necessary due 
to the nature of 
the interventions 
Unclear risk 
 
Not mentioned 
if outcome 
assessors 
blinded 
Low risk 
 
Losses to follow-
up accounted for 
and ITT analysis 
used 
Low risk 
 
All pre-specified 
outcomes were 
reported 
Compared a physical 
intervention with a 
cognitive intervention 
Medium 
ONS= Oral Nutritional Supplements; ITT= Intention to Treat; FISCIT= Frailty and Injuries in Later Life; MNA= Mini Nutritional Assessment; CG= Control Group 
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Table 8: Assessment of the quality of the evidence (Using the GRADE system (Balshem et al., 2011)) 
 
Body of evidence Study 
Design and 
Initial 
quality  
Factors that decrease the quality Factors that increase the quality Quality of the 
body of 
evidence 
Risk of Bias 
(Table 5) 
Inconsistency 
of results 
Indirectness of 
evidence 
Imprecision of 
results 
Risk of 
publication 
bias 
Large effect Dose-
response 
gradient 
Plausible biases 
underestimating 
intervention effect 
Food-based 
intervention vs. 
standard care 
 
RCTs- HIGH 
(+4) 
 
 
 
 
 
 
Very 
serious 
(-2) 
 
 
 
 
 
 
Most show 
similar 
results 
(0) 
 
 
 
 
 
One type noted 
(-1) 
 
Three trials (Odlund et 
al., 2003; Taylor, 
2006; Iuliano et al., 
2013) not undertaken 
with undernourished 
residents 
Unclear 
(0) 
 
Few trials reported 
confidence 
intervals. 
Few participants 
(<100 in all but 1 
trial), but 
insufficient 
information to 
downgrade. 
Unclear 
(0) 
 
 
 
 
(0) 
 
 
Not 
applicable- 
effect sizes 
were small 
and often 
non-
significant 
(0) 
 
 
Dose-
response 
gradient not 
reported 
(0) 
 
 
Risk of bias was 
high for most trials, 
but no evidence that 
this worked to 
underestimate the 
intervention effect 
 
+, very low 
ONS intervention vs. 
standard care or 
placebo 
RCTs- HIGH 
(+4) 
 
Serious 
(-1) 
 
Consistent 
(0) 
 
Considered 
estimates of 
effect for 
Weight gain 
and BMI (most 
widely reported 
outcome) 
Two types noted 
(-1) 
 
1. Two trials (Lauque 
et al., 2000; Manders 
et al., 2009) not 
undertaken with 
undernourished 
residents. 
2.Three trials 
compared ONS to 
placebo, the other 3 
compared to SC 
Unclear 
(0) 
 
Few trials reported 
confidence 
intervals. 
Few participants 
(<100 in all but 1 
trial), but 
insufficient 
information to 
downgrade. 
Unclear 
(0) 
 
(0) 
 
 
Not 
applicable- 
effect sizes 
were small 
and often 
non-
significant 
(0) 
 
 
Dose-
response 
gradient not 
reported  
(0) 
 
 
Risk of bias was 
unclear or high for 
most trials across 
the criteria, but no 
evidence that this 
worked to 
underestimate the 
intervention effect 
 
++, Low 
Food-based 
intervention vs. ONS 
intervention 
RCTs- HIGH 
(+4) 
 
Serious 
(-1) 
 
Showed 
similar 
results 
(0) 
One type noted 
(-1) 
 
One trial compared 
ONS to snacks, the 
other compared ONS 
to advice 
Unclear 
(0) 
 
Unclear 
(0) 
 
(0) 
 
 
Not 
applicable- 
effect sizes 
were small 
(0) 
 
 
Dose-
response 
gradient not 
reported  
(0) 
 
 
Not observed 
 
++, Low 
BMI= Body Mass Index; ONS= Oral Nutritional Supplements; SC= Standard Care
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2.4 The challenges of conducting primary research in the care 
home setting 
Several trials within the systematic review highlighted the challenges of 
conducting research with the frail, dependent care home population (Leslie et al., 
2012; Stange et al., 2013). The complexities involved have been discussed within 
several published articles and include, recruitment difficulties due to physical and/or 
cognitive impairments (Maas et al., 2002), the consent process (Maas et al., 2002; 
Hall et al., 2009), and the high attrition rates of older people from research (Maas et 
al., 2002; Ridda et al., 2008). Difficulties with receipt of consent was highlighted 
within a number of the included trials (Taylor and Barr, 2006; Smoliner et al., 2008; 
Stange et al., 2012), whilst drop-out rates of 25% to 33% were reported in others 
(Manders et al., 2009; Parsons et al., 2011; Leslie et al., 2012).  
Individuals who drop out tend to be different from those that complete a trial 
(Estellat et al., 2009), which can result in attrition bias, although drop-out rates of up 
to 20% are generally considered acceptable (Schulz and Grimes, 2002). One reason 
for high attrition rates in care homes, is high mortality, which has been reported in 
published work from various countries (Raines and Wight, 2002; Van Dijk et al., 
2005; Lee et al., 2009). A recent UK cohort study, which described 1-year mortality 
in care home residents compared with community-dwelling residents, found that 
2,558 (26.2%) of care home residents died within 1 year, compared to 11,602 (3.3%) 
community residents (Shah et al., 2012). High mortality can considerably reduce the 
number of residents available for analysis at the trial end-point and has led to 
recommendations for expected mortality to be accounted for in sample size 
calculations (Zermansky, 2007).  
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The challenges inherent in care home research has led to malnutrition 
intervention trials including advanced dementia and immobility within the exclusion 
criteria (Fiatarone et al., 2000; Smoliner et al., 2008; Manders et al., 2009; Lee et al., 
2013), despite these being well-established risk factors for malnutrition. As a result, 
knowledge of the actual effectiveness of nutritional intervention in this vulnerable 
population is limited and the clinical applicability of findings to those residents most 
at risk is often questionable. 
 
2.4.1 Summary 
 
To enable the efficacy of nutritional interventions to be compared within the 
care home population, an adequately powered RCT is required, using interventions 
that are homogeneous in nutrient composition, alongside a comparative standard 
care arm. Given the complexities involved in care home research, a feasibility trial 
was proposed prior to the initiation of a definitive RCT. 
 
2.5 Research Question 
 
 Is it feasible and acceptable to run a definitive trial in the care home setting, 
comparing and evaluating FB intervention, ONS intervention and the standard care 
home diet for malnutrition?  
 
2.6 Research Aim 
 
To explore trial design, staff, and resident acceptability of the interventions 
and outcome measures and to provide data to estimate the parameters (sample size 
and intra-cluster correlation coefficient) required to design a definitive RCT.   
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CHAPTER THREE: METHODOLOGY 
 
3.1 Research Design 
3.1.1 Choice of methodology:  A Prospective cluster randomised       
feasibility trial 
A number of individual components make up complex healthcare 
interventions such as nutritional support in the care home setting, making it difficult 
to specify the ‘active ingredient’ of the intervention and to compare intervention 
variations (Medical Research Council, 2000). The RCT is the optimal study design to 
minimise selection bias (Kunz et al., 2007), to demonstrate potential causative effect 
(Ho et al., 2008) and to provide the most accurate estimate of an intervention’s 
benefits (Medical Research Council, 2000). However, prior to evaluation in a 
definitive RCT, The Medical Research Council (MRC) framework (2008) 
recommends that complex interventions be investigated using preliminary studies, to 
optimise trial design, define outcomes and ensure feasibility.  In light of the lack of 
adequately powered, low risk of bias trials evaluating nutritional interventions within 
the care home setting, a feasibility trial for a definitive cluster RCT was designed.  
The feasibility trial assessed 3 arms; FB intervention, ONS intervention, and 
the standard care (SC) home diet for malnutrition, with 6-month intervention duration. 
A cluster design was chosen primarily to avoid contamination (Torgerson, 2001), 
because the care home staff at each site could not be expected to treat participating 
residents differently, but was also used for practical reasons. The aim of the trial was 
to assess the feasibility and acceptability of delivering and monitoring nutritional 
interventions in the care home setting, and hence the home was the unit of 
randomisation. Six care home sites were randomised into the 3 trial arms. 
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3.1.2 Trial Objectives 
 The trial objectives are outlined below (Table 9). 
 
Table 9: The primary and secondary objectives of the trial 
 
Primary Objectives Secondary Objectives 
 
1. 1. To assess how many care homes for the 
elderly accept the invitation to participate in a 
nutritional intervention feasibility  trial 
 
2. 2. To determine whether the eligibility criteria for 
malnourished care home residents are too open 
or too restrictive, by estimating feasible eligibility 
and recruitment rate 
 
3. 3. To assess retention of care homes and 
residents, by estimating 3- and 6-month follow up 
rates 
 
4. 4. To investigate the acceptability of nutrition 
support interventions to malnourished care home 
residents, in terms of compliance, and to care 
home staff in terms of adherence to the 
intervention schedule 
 
 
5. 5. To assess the acceptability and feasibility (and 
factors influencing this) of the different outcome 
measures as methods to measure efficacy of 
nutritional interventions within a definitive trial 
 
1. 1. To investigate the completion and accuracy of 
nutritional screening and questionnaire 
completion by care home staff 
 
2. 2. To determine how many malnourished 
residents are able to participate in Participant 
Reported Outcome Measures (PROMs) and to 
complete the questionnaires. 
 
3. 3. To pilot a Healthcare Resource Usage (HCRU) 
questionnaire 
 
 
4. 4. To measure key outcome domains (for 
completion rates, missing data, estimates, 
variances and 95% confidence intervals for the 
difference between the intervention arms) for 
malnourished care home residents including 
physical outcome measures and PROMs 
 
5. 5. To collect and synthesise data, from which the 
Intracluster Correlation Coefficient (ICC) and 
sample size of a definitive cluster RCT (CRCT) 
could be estimated 
 
 
3.2 Ethical approval 
All UK clinical trials are governed by ‘The Research Governance Framework 
(RGF) for Health and Social Care’ (Department of Health, 2005a). To meet the 
framework requirements, trial approval was required from a Research Ethics 
Committee (REC) (Appendix 1) and the Research and Development (R&D) 
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Department of the NHS trust sponsoring the research (Appendix 2), prior to 
commencement. The REC approved the consent, randomisation and intervention 
taking place at the care home level. However, the committee felt that the inclusion of 
residents lacking capacity in the collection of Participant Reported Outcome 
Measures (PROMs) could not be justified in accordance with the Mental Capacity 
Act (Department of Health, 2005b). They requested that those residents having 
capacity to complete PROMs, provide individual consent for this part. The trial was 
conducted in accordance with the Declaration of Helsinki of the World Medical 
Association (WMA, 2000) and the International Conference on Harmonisation Good 
Clinical Practice (ICHGCP) guidelines (European Medicines Agency, 2002). 
 
3.3 Participants 
 
3.3.1 Setting and population 
 
The feasibility trial was conducted within the borough of Solihull, West 
Midlands, in England. Prior to trial commencement, 17 care homes providing 
accommodation for older adults (over 65 years), were receiving regular dietetic input 
to improve the identification and first-line management of malnutrition. Six, privately 
owned care homes, selected by purposive sampling to obtain a diverse sample 
based on type of care provided (residential or nursing/nursing and residential) were 
invited to take part in the trial. This enabled the evaluation of feasibility and 
acceptability across a range of care home settings.  
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3.3.2 Care homes (Clusters) 
 
Prospective care homes were provided with a full explanation of the trial by 
the Primary researcher, a registered dietitian with a history of clinical input in all 6 
homes. An invitation letter (Appendix 3) and an information sheet (Appendix 4) were 
sent to the Manager, followed by a face-to-face visit to enable discussion. Each care 
home was given 1 week to consider participating, after which, the manager was 
asked to sign a consent form (Appendix 5). The GP for each care home was 
informed in writing of their involvement (with the care home’s consent to do so). 
 
3.3.3 Care home residents 
The process of resident screening, identification and consent (for those 
participating in PROMs) is outlined below (Figure 3). 
 
 
 
Receipt of Care Home 
consent 
Malnutrition Screening 
using 'MUST'*, identifying 
those with or at risk of 
malnutrition 
Care home staff assess 
resident eligibility to receive 
nutritional intervention  
Review of care records by staff to 
ensure that each resident meets all 
eligibility criteria 
Care staff assign each 
resident a number. 
Assessment of capacity by 
trained care home staff or 
care home GP 
Residents lacking capacity to be 
included for outcomes measured 
within usual monitoring only 
Receipt of consent for residents 
with capacity, to take part in 
participant- reported outcomes 
Randomisation of the care 
homes into the 3 
intervention arms 
Training of assigned care 
home staff in accordance 
with allocated plan 
Figure 3: The recruitment and consent process: Eligible residents were identified 
using routine malnutrition screening, a review of care home records and consultation with 
staff 
*‘MUST’= Malnutrition Universal Screening Tool 
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All residents at risk of malnutrition, without a dietetic-led plan in place, were 
considered for eligibility within participating care homes (Care home screening log, 
Appendix 6). Care home staff with responsibility for conducting monthly nutritional 
screening (Nurses or Senior Carers), used the Malnutrition Universal Screening Tool 
(‘MUST’) (Appendix 7) to identify those at risk of malnutrition. ‘MUST’ classifies risk 
as low, medium or high based on body mass index (BMI), history of unintentional 
weight loss (%) and acute illness effect (Elia, 2003; NICE, 2006). ‘MUST’ has been 
validated for use in adults, has very good-to-excellent inter-observer reliability in care 
homes (kappa 0.8-1.0) and is acceptable to participants and healthcare workers 
(Elia, 2003).  
The REC requested that assessment of eligibility be carried out by non-
research staff. Care home staff therefore reviewed the records of those residents 
identified as medium or high risk of malnutrition, against the eligibility criteria (Table 
10) consulting with the dietetic service and the GP, as required. Each resident 
eligible to receive an intervention was assigned a unique trial number (Trial Protocol, 
Appendix 8, p151-152). 
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Table 10: Eligibility criteria for residents to receive an intervention within the 
participating care homes 
 
Inclusion criteria Exclusion criteria 
 A score of ‘1’ or higher on the Malnutrition 
Universal Screening tool (‘MUST’; Elia, 2003) 
 Able to eat and drink 
 Registered with a Solihull GP and 
subsequently eligible for the provision of 
healthcare services provided  by the Heart of 
England NHS foundation Trust (HEFT) 
 
 Receiving (or likely to receive in the next 6 
months) tube or parenteral nutrition  
 Receiving nutrition support in the form of 
individualised dietetic advice or prescribed 
ONS.  
 Have a known eating disorder or illness, 
which requires a therapeutic diet 
incompatible with fortification and/or 
supplementation. This may include but is not 
limited to, Galactosemia or known lactose 
intolerance, chronic renal disease requiring 
dialysis, poorly controlled diabetes, in receipt 
of active cancer treatment, or liver failure.   
 On an end-of-life care pathway 
Exclusion criteria for Participant reported 
outcome measures (PROMs) 
 
 Non-native English speaking 
 Lacking the capacity to consent 
 
An estimated 80% of care home residents have Dementia or severe memory 
problems (Quince, 2013) and it was anticipated that the eligible residents, would 
include individuals lacking the capacity to consent. In accordance with the 
requirements of the approving REC (section 3.2), these residents were excluded 
from taking part in PROMs. The decision to exclude non-native English speaking 
residents, with or without capacity, was based on the primary researcher’s existing 
knowledge and experience of the population group and consideration of the finances 
available to run the trial. The primary researcher estimated that less than 5% of the 
resident and staff population would be non-native English speaking. This trial was 
conducted as part of a student Masters project and as such, had no additional 
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funding attached to it. This prohibited translation of information leaflets into different 
languages and the hire of an interpreter (Appendix 8, p150).  
3.3.3.1 Individual resident consent for PROMs  
 
Within the care home setting, capacity is assessed by trained care home staff, 
or the GP in accordance with the Mental Capacity Act (Department of Health, 
2005b). Written consent was sought on an individual basis from eligible residents 
assessed as having functional capacity.  Residents were provided with a full 
explanation of their required participation (Appendix 8, p153-154) alongside a 
Participant Information Sheet (Appendix 9). They were given 1 week to ask 
questions and decide whether they would like to provide information on quality of life, 
health state and dietary satisfaction. Each resident was asked to sign a consent form 
(Appendix 10).  
3.4 Nutritional interventions 
 
3.4.1 Food-based (FB) intervention in addition to standard care 
(3.4.3) 
 The content of the FB intervention was based on local nutrition support 
guidelines (Heart of England NHS Foundation Trust, 2012) and national guidance for 
best practice (NICE, 2006; PrescQIPP Nutrition Toolkit, 2012; Malnutrition pathway, 
2012). Care staff and catering teams within the 2 homes randomised to FB 
intervention, received face-to-face instruction by the primary researcher to increase 
participating resident’s daily nutritional intake by approximately 600kcal and 20-25g 
of protein. The interventions used included homemade enriched drinks, and/or 
between-meal fortified snacks (Table 11) (Appendix 11). The combination agreed by 
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the primary researcher and the staff was documented for each resident, at baseline 
and at three-months (Appendix 12) and intervention recipes were provided. Staff 
recorded intervention intake on the daily food record chart (FRC) as a proportion 
taken (All; ¾; ½; ¼; refused) 
Table 11: Food-based intervention composition 
Fortified drink and snack 
options 
Volume per 
serving (ml) 
Energy content 
(kcal) per serving 
Protein content 
(g) per serving 
Fruit fool  200 275 7.9 
Chocolate mousse  150 410 10.95 
Milkshake  200 306 9.8 
Fruit smoothie  200 306 10 
Milky coffee  200 278 10.6 
Malted drink   200 304 12 
Hot chocolate  200 306 10.6 
 
3.4.2 ONS Intervention in addition to standard care (3.4.3) 
 
Nursing and/or senior care staff within the 2 homes allocated to ONS 
intervention, received instruction by the primary researcher to increase the daily 
nutritional intake of participating residents by approximately 600kcal and 24g protein. 
The intervention consisted of 2 liquid ONS (Table 12), provided to residents under 
the control of a registered dietitian. Staff recorded intervention intake on the daily 
drugs chart as a proportion taken (All; ¾; ½; ¼; refused). 
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Table 12: Composition of the ONS types used within this trial 
 
 
ONS Volume (ml) Kcal/ml Energy content 
(kcal) per serving 
Protein content (g) 
per serving 
Fortisip Bottle 
(Nutricia Advanced 
Medical Nutrition)  
200 1.5 300 12 
Fortisip Compact 
(Nutricia Advanced 
Medical Nutrition) 
125 2.4 300 12 
Nutriplen  
(Nualtra Ltd) 
125 2.4 300 12 
*Nutritional information taken from: http://www.nutricia.ie/products and http://nualtra.ie/information-for/dietitian. Fortisip/Fortisip 
Compact was provided by Nutricia for the first 3-months of the trial. Nutriplen was provided by Nualtra for the second 3-months 
of the trial. 
 
The primary researcher determined compliance with the FB and ONS 
interventions at 3- and 6-months, by calculating average intake from 3 non-
consecutive FRCs or drugs charts. Compliance was categorised into ‘compliant’, if ≥ 
75% of the advised food/beverage or ONS was consumed daily and ‘non-compliant’ 
if <75% was consumed.  
3.4.3 Standard care (SC) arm  
 
The purpose of the SC intervention is to provide a calorie-dense diet 
(Department of Health, 1992), through the provision of small, frequent, energy-
enriched meals, alongside prompting and assistance from staff where required. SC 
was provided within all 6 homes, to ensure that no resident at risk of malnutrition was 
denied access to first-line treatment (National Ethics Advisory Committee, 2008). 
The 2 care homes allocated to SC only, continued to receive visits from the primary 
researcher, but individualised resident plans were not provided.  
 
3.4.4 Intervention safety considerations 
The primary researcher continued to make dietetic visits to all 6 care homes 
on a monthly basis. If a resident did not tolerate the allocated intervention (SC, FB or 
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ONS), or experienced a significant decline in nutritional status, a change in 
nutritional intervention was considered in accordance with local guidelines. 
Intervention change was recorded for all 3 trial arms at 3- and 6-months. 
3.4.4.1 Adverse Events (AEs) and Serious Adverse Events (SAEs) (Appendix 
8, p169-170)  
 
This trial was considered low risk, because the nutritional interventions were 
already established options within the participating homes. Expected adverse events 
included: 
- Mild gastro-intestinal side effects in response to a fortified diet or prescribed 
ONS, including diarrhoea, bloating, nausea and satiety.  
 
It was decided to collect only targeted nutritional intervention related AEs and, 
serious AEs (SAEs) requiring hospital admissions that were due to avoidable 
malnutrition or dehydration (Appendix 13). 
3.4.4.2 Risk of re-feeding syndrome on initiation of FB or ONS intervention 
Re-feeding syndrome describes the severe, and potentially fatal electrolyte 
and fluid shifts that may be associated with metabolic abnormalities in malnourished 
individuals undergoing re-feeding by oral, enteral or parenteral means (Crook et al., 
2001) after a period of starvation or fasting (Solomon and Kirby, 1990). Nutrition was 
commenced at 10kcal/kg/day for those residents identified as being at risk (Table 15) 
within the care homes allocated to FB or ONS intervention, increasing to provide the 
additional 600kcal and 20-25g protein by day 7. The care home GP was asked to 
monitor electrolytes and glucose for 3-days after intervention initiation (NICE, 2006). 
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3.4.4.3 Deteriorating swallow function (dysphagia) and increased risk of 
aspiration 
 
Where onset of dysphagia was suspected by the care home staff or primary 
researcher during the 6-month intervention, a referral was made to the Speech and 
Language Therapy (SaLT) team as per usual practice. The intervention was adjusted 
to meet any subsequent modifications to dietary texture or consistency. 
 
3.5 Measures 
3.5.1 Process Measures 
 
The primary interest was in assessing the feasibility and acceptability of, 
procedures for recruiting care homes and residents, the intervention types and 
schedule, retention of care homes and residents, procedures for measuring 
outcomes, and completeness of data collection (Table 13). 
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Table 13: Process Measures: Feasibility and Acceptability 
Feasibility Considerations: Assessment: 
Recruitment of care homes Number and proportion of homes approached 
and homes consented 
 
The suitability of resident eligibility criteria Number and proportion of residents at risk of 
malnutrition considered eligible and not eligible 
 
Residents’ willingness to participate in 
PROMs 
Number and proportion of eligible residents that 
provided consent 
 
Resident retention in the trial Number and proportion of recruited residents 
remaining at 3-months and at 6-months, number 
and proportion of recruited residents that died 
during the trial 
Data collection Number and proportion of questionnaires and 
records that were available and unavailable or 
incomplete 
Physical outcome measurement Number and proportion of recruited residents that 
could and could not be measured at each data 
collection interval 
Acceptability Considerations: 
 
Assessment: 
Resident acceptability of allocated 
interventions 
Compliance and change of intervention in each 
trial arm 
Staff acceptability of allocated interventions Adherence and non-adherence to intervention 
plan 
Resident acceptability of physical 
measurements 
Number and proportion of recruited residents that 
accepted and refused measurements 
Resident acceptability of PROM’s data 
collection tools: Appetite and dietary 
satisfaction VAS tool, EQ5D VAS and 
questionnaire, COOP quality of life tool. 
Number and proportion of questionnaires 
completed and not completed/refused 
PROMs= Participant Reported Outcome Measures; VAS= Visual Analogue Scale 
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3.5.2 Demographic variables and resident characteristics      
(Appendix 14). 
  
Following confirmation of eligibility, care home staff recorded data for each 
resident on gender, primary diagnosis, capacity, height, and diagnosis of dementia 
and dysphagia (Table 14). 
 
Table 14: Demographic variables and characteristics collected at baseline 
Characteristic: Reason for baseline data collection  
Height (m) 
In each care home, 
height is measured 
and documented 
within a resident’s 
care record on 
admission 
 
-Height is required to determine Body Mass Index (BMI) (Weight(kg)/Height 
(m
2)
) 
-Reliable measurement can be challenging within the elderly population owing 
to vertebral compression, reduced muscle tone and changes to posture 
(World Health Organisation, 1995). 
-If measurement with a freestanding stadiometer is not possible, staff are 
trained to ask residents or relatives for self-reported height or to use ulna 
length to estimate height from the length of the forearm 
-Ulna length is measured in accordance with ‘MUST’ (Elia, 2003), between the 
olecranon process and the styloid process, with the resident’s arm bent 
across the chest. Measured values are used to calculate height using 
standard equations (Bassey, 1986; Elia, 2003). 
The technique used by care home staff to measure height was recorded 
for each resident; to assess the most frequently used measure within 
this population. 
Diagnosis of 
Dementia 
The presence of dementia could pose a challenge to the assessment of 
physical outcome measures (Stange et al., 2013).  
 
Diagnosis of dementia was determined from care home records 
 
Diagnosis of 
Dysphagia, defined 
as a difficulty in 
swallowing 
-Presence of dysphagia can affect nutritional status, and the acceptability of 
the nutritional interventions. A relationship between dysphagia and 
malnutrition has been demonstrated in Finnish nursing home residents 
(Suominem et al., 2005).  
Diagnosis of Dysphagia and any recommendations for modified texture 
and/or consistency of food and fluids were determined from care home 
records  
Risk of re-feeding 
syndrome 
Residents at risk were identified at baseline through ‘MUST’ screening, if they 
had:  
a. BMI < 16kg/m
2
 
b. Weight loss >15% during the last 3- 6 months 
c. No/negligible dietary intake for 10 consecutive days  
(NICE, 2006). 
 
(Management throughout the trial is described in section 3.4.4.2) 
‘MUST’ = Malnutrition Universal Screening Tool  
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3.5.3 Outcome measures 
The systematic review (section 2.3) found a lack of low risk of bias, high 
quality evidence for all reported outcomes within the care home setting. One 
objective of this trial (Primary objective 5, Table 9) was to evaluate feasibility and 
acceptability of a range of outcome measurements, to establish those most 
appropriate for a definitive trial (Table 15). Missing outcomes data is a potential 
source of attrition bias, which may affect estimation of intervention effect, 
comparability of intervention arms, and representativeness of the trial sample 
(European Medicines Agency, 2001). National guidelines (National Research 
Council, 2010), advocate a considered approach to trial design to limit missing data 
to less than 20% (Schulz and Grimes, 2002). In this trial, data completeness of ≥ 
80% was required (Section 3.9.2), for an outcome to be considered for a definitive 
trial. Outcome measures were assessed in the 3 arms at baseline (following consent, 
prior to randomisation and group allocation), and at 3- and 6-months of intervention 
duration. The primary researcher and the care home staff were responsible for 
assessment on all participating residents. To enhance the quality and consistency of 
staff assessed outcomes, a training session led by the primary researcher was 
provided, consisting of: 
- Training on the protocols surrounding assessment and recording of outcome 
measurements 
- Discussion on adverse events and their reporting 
- Mock completion of data collection instruments and forms
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Table 15: Outcome measures piloted in the trial 
Measure Completed 
by 
Assessment time Measurement properties 
B 3-
months 
6-
months 
 
Physical outcome measures 
Weight (kg) 
 
Care homes are required to 
weigh residents at least monthly 
to promote adequate monitoring 
(CQC, 2010). 
Care home 
staff 
√ √ √ - Serial measurements of body weight can identify a change in nutritional status 
(Loreck et al., 2012). Unintentional weight loss of greater than 10% within 3 - 6 
months indicates PEM (NICE, 2006). 
 
- Measurement in care homes can be problematic due to immobility, disability or a lack 
of appropriate equipment (Hickson and Frost, 2003). The number and proportion of 
residents that could or could not be weighed was recorded at each data collection 
interval. 
 
- Guidelines for weighing procedures in care homes recommend routinely weighing 
residents on the same type of class III approved scale to ensure consistency and 
minimise error (Simmons et al., 2009). To assess adherence to guidelines, the type of 
scale used (Standing, Chair or Hoist) was recorded at each data collection interval. 
 
Weight does not differentiate between fat, fat free mass (FFM) and fluid. Fluid 
retention, oedema and ascites can therefore limit the usefulness of body weight 
assessment. A correction can be subtracted from measured weight to account for the 
presence of additional fluid (Elia, 2003). 
Body Mass Index: BMI (kg/m
2
) 
 
Calculated monthly by care 
home staff using: 
BMI = Weight(kg) / Height(m
2
) 
 
Care home 
staff 
√ √ √ - BMI is used for ‘MUST’ screening and for calculating nutritional requirements 
(Todorovic and Micklewright, 2011). A BMI of less than 18.5kg/m2 is a universal 
indicator of PEM (NICE, 2006). The cut off range is based on the effect on morbidity 
and mortality (WHO, 2004). 
 
- BMI ranges were derived from individuals aged 18-65 years. The use of BMI to define 
underweight in the older adult population is therefore associated with some 
limitations: 
- - BMI is unable to distinguish between FFM and fat mass and therefore does not 
reflect the redistribution of body fat in older age.  
- - BMI assumes the relationship between weight and height is constant throughout the 
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adult lifespan, excluding height reduction and resulting in an underestimation of 
underweight in the older adult population (Hickson and Frost, 2003).This limitation 
has led to the increased use of alternative height measures when accurate standing 
height cannot be determined (section 3.5.2) 
- - BMI  is based on weight and therefore may be unreliable in the presence of 
confounding factors such as distorted fluid balance (oedema, ascites or dehydration) 
(Prentice and Jebb, 2001). 
 
- BMI should be used as part of the overall assessment and not as a standalone 
measure of nutritional status (Beck et al., 2013) 
 
BMI was collected from care home ‘MUST’ records at each data collection interval. At 
three- and six-months, the primary researcher calculated a repeat ‘MUST’ score for 
two randomly selected residents per care home and compared the overall score and 
the scores for each step with that recorded by staff. This enabled competence in 
calculating BMI and malnutrition risk to be assessed. 
Mid Upper Arm Circumference 
(MAC) (cm) 
Primary 
researcher 
√ √ √ - Measurement of the circumferences of the extremities is an alternative approach to 
determine body composition (Loreck et al., 2012) and is particularly useful when 
oedema is present as the upper arms are not usually affected. 
- MAC provides an estimate of subcutaneous fat and arm muscle (Bruno de Carvalho-
Silva, 2012) and has been established as a useful indicator of malnutrition risk 
(Powell-Tuck and Hennessey, 2003; Harris et al., 2008). It is an independent 
predictor of mortality in older adult care home residents (Allard et al., 2004). 
 
- A recent cross-sectional study showed that the reproducibility of MAC when 
measured by 2 different observers is acceptable for clinical purposes in a care home 
setting (mean difference 0.3cm (-0.16 to 1.3cm). Mean differences between an 
upright and a laying down position were also assessed for each observer. No 
systematic differences were observed: 0.1cm (-2.0 to 2.2cm) and 0cm (-1.9 to 2.0cm) 
respectively) (Wijnhoven et al., 2012). 
 
The primary researcher measured MAC in centimetres using a tape measure (SECA 
201) according to standardised procedures. Where possible, the mean of 3 
measurements was recorded to minimise measurement error (NHANES III, 1988). To 
assess the feasibility and acceptability of this measurement in the care home 
population, the number of residents that refused to have the measurements 
undertaken, or for whom measurement was not possible, was recorded.  
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Tricep Skinfold thickness  
(TSF ) (mm) 
Primary 
researcher 
√ √ √ - TSF is reflective of subcutaneous fat mass and distribution (Bruno de Carvalho-Silva, 
2012). It can be used alongside MAC as an alternative approach to evaluate body 
composition and to assess nutritional status, particularly in individuals with fluid 
retention. TSF is regarded as an easy to access and reproducible measurement 
(Wang et al., 2000), although inter observer reliability was shown to be problematic in 
a large epidemiological study (Ulijaszek and Kerr, 1999).  
-  
- To assess the feasibility and acceptability of measurement in the care home 
population the number of residents that refused to have the measurements 
undertaken, or for whom measurement was not possible, was recorded.  
-  
- An acknowledged drawback of the technique is the lack of sensitivity to small 
changes (<0.5kg), which may hamper the ability to detect nutritional depletion (Loreck 
et al., 2012). In this trial, TSF was primarily used to enable MAMC to be calculated 
(see below). 
The primary researcher measured TSF with a Slimguide calliper (HaB Essentials), 
according to standardised procedures. Where possible, the mean of 3 measurements 
was recorded to minimise measurement error (NHANES III, 1988). 
Mid Arm Muscle 
Circumference (MAMC) (cm) 
 
MAMC (cm) = MUAC (cm)- 3.14 X 
TSF (cm) 
Primary 
researcher 
√ √ √ - MAC and TSF can be used to calculate Mid Arm Muscle Circumference (MAMC), an 
indicator of protein stores and an estimate of lean muscle mass. This measurement 
is regarded as an early indicator of nutritional depletion (Wannamethee et al., 2007) 
- MAMC has been shown to be a better surrogate of DEXA- measured Lean Body 
Mass (LBM) than BMI (Gibney and Ljungqvist, 2005; Nooro et al., 2010). It’s 
reduction, may be a sign of PEM or sarcopenia (Nooro et al., 2010) 
Handgrip strength (kg) Primary 
researcher 
√ √ √ - Handgrip strength is an index of general upper extremity strength, strongly associated 
with functionality (Takata et al., 2008; Sallinen et al., 2010). Low values are 
associated with falls (Sayer et al., 2006), disability, poor health-related quality of life 
(Syddall et al., 2009) and increased hospital stay (Kerr et al., 2006).  
- Recently, the measurement has gained attention as an indicator of nutritional 
depletion and because of a potential capability to detect improvements in nutritional 
status following nutrition support intervention (Norman et al., 2010).  
 
- The psychometric properties of the technique have been found to be valid and 
reliable in populations without cognitive impairment (Peolsson et al., 2001), but not 
when used on elderly subjects with severe dementia (Alencar et al., 2012). To assess 
feasibility in a population with varying levels of cognitive impairment, the number of 
residents that refused to participate, or for whom the measurement was not feasible, 
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was recorded.  
 
- Handgrip strength was measured using the Smedley hand held dynamometer (Model 
12-0286) on the non-dominant arm (Todorovic and Micklewright, 2011). Where 
possible, residents were asked to complete the measurement 3 times on the 
dominant arm. Due to varying levels of cognitive impairment, it was felt that resident 
understanding of how to undertake the measure would be poor initially, but improve 
during the process. The highest achieved measure was therefore recorded.  
Nutritional intake assessment 
Energy (kcal) 
 
 
 
Primary 
researcher 
from care 
home staff 
completed 
records 
 
 
 
 
 
√ √ √ - To ensure compliance with Outcome 5 (Meeting nutritional needs) of the Essential 
Standards of Quality and Safety (CQC, 2010; RCN, 2010), care home staff are 
required to complete daily food record charts (FRCs) and fluid charts (FCs), to 
monitor the dietary intake of those with, or at risk of malnutrition.  
-  
- Meals and snacks are recorded on the FRC alongside portion size consumed (All, 
3/4, ½, ¼ or refused). All fluids (type and volume) taken are recorded on the FC. 
-  
- The primary researcher measured and recorded the size/capacity of usual tableware 
(bowls, plates, glasses) within each care home, at baseline.  At each data collection 
interval, the FRCs and FCs were used to assess the average daily food and fluid 
intake over 3 non-consecutive days. The primary researcher determined daily energy 
(kcal) and protein (g) intake using the dietary analysis software, Diet Plan 6 
(Forestfield Software Ltd, UK). This software is pre-installed with the complete set of 
UK food tables. 
-  
- The feasibility and acceptability of using care home documentation to evaluate 
nutritional intake was assessed. The number of unavailable or incomplete FRCs and 
FCs were recorded for each care home. 
 
 
 
 
 
 
 
 
Protein (g) 
 
 
√ √ √ 
Fluid (ml) √ √ √ 
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Healthcare resource usage (HCRU) 
HCRU Questionnaire Care home 
staff 
 √ √ - Health-care resource usage data is used alongside health outcomes data to calculate 
the Incremental Cost-effectiveness ratio (ICER) (Weinstein and Stason, 1977), 
defined as the ratio of the difference in cost, to the difference in effectiveness 
between two intervention strategies. Effectiveness can be defined as a clinically 
meaningful event experienced by an individual, for example Quality Adjusted Life 
Years (QALYs) (calculated from the EQ5D tool- see below).  
 
- Health Economists use many instruments to estimate resource use for cost-
effectiveness evaluations, but a 2012 review established little evidence of reliability 
testing (Ridyard et al., 2012).The healthcare resource-usage questionnaire (Appendix 
15) piloted within this trial was developed from consideration of existing instruments 
submitted for use in residential care settings on the ‘MRC Database of Instruments 
for Resource Use Measurement’ (DIRUM). The questionnaire was piloted by the care 
home staff, from baseline to 3-months, and from 3-months to 6-months for each 
eligible resident.  
 
- Data was collected on all hospital admissions (emergency and appointment; short 
and long stay), GP call-outs (not routine) and visits from, district nurses, tissue 
viability nurses, consultants, dietitians and speech and language therapists (SaLT). 
Participant Reported Outcome Measures (PROMs) 
Health state: EQ5D-5L
3
 Eligible 
residents 
√ √ √ - A core component of economic evaluations in healthcare is the use of preference-
based instruments to measure changes in health state. The EuroQol-5D (EQ5D-5L) 
questionnaire, a standardised multi-dimensional health state classification (Brazier et 
al., 2004) was piloted within this trial. 
 
- The questionnaire consists of a Visual Analogue Scale (VAS), which records self-
perceived health status on a scale of 0-100, and a descriptive system, comprising 5 
dimensions of health (mobility, self-care, usual activities, pain/discomfort, and 
anxiety/depression), recorded with an ordinal five level code. The descriptive system 
                                                          
3 The Euroqol group granted permission to use the tool within this trial 
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can be used to generate a single index-value for health state (Rabin and De Charro, 
2001), scored in this trial using an algorithm based on a sample from the adult UK 
population (Herdman et al., 2011).  
 
- The EQ-5D has been demonstrated to be responsive, reliable and internally 
consistent in the normal population and with those that have dementia (Ankri et al., 
2003) 
Appetite and dietary 
satisfaction: Visual Analogue 
Scale (VAS) 
Eligible 
residents 
√ √ √ - A VAS is a measurement instrument used to measure a characteristic or attitude that 
ranges across a continuum of values (Wewers and Lowe, 1990). The scale is 
composed of a horizontal line, 100mm in length, anchored by word descriptors at 
each end. Participants are asked to mark along the line, at the point corresponding to 
their overall feelings.  
 
- VAS are often used within appetite research and several studies have indicated that 
measured food intake appears to be related to the perceptions of hunger and fullness 
assessed using VAS (Flint et al., 2000; Parker et al., 2004).  In this trial, ‘hunger’, 
‘appetite’, ‘dietary satisfaction’, ‘pleasantness of meals’, ‘pleasantness of snacks’ and 
‘pleasantness of drinks’ were each measured across a 100mm VAS (Appendix 16).  
Quality of life: COOP
4
 Eligible 
residents 
√ √ √ - Quality of life was assessed using the Dartmouth Primary Care Cooperative 
Information Project (COOP) Quality of life chart, a brief, easy to complete 
questionnaire that is sensitive to subjectively important change (Jenkinson et al., 
1995).  
- The COOP has been validated in general primary care settings (McHorney et al., 
1992), and was piloted in this trial with a care home population.  
Loss to follow-up 
Loss to follow-up Care home 
staff 
√ √ √ - The number of residents that changed intervention arms, that were withdrawn from 
the trial, or that died during the trial (Appendix 17) was collected by care home staff, 
along with reasons given. Residents that withdrew or died were not replaced. 
                                                          
4 The Dartmouth COOP project granted permission to use the chart within this trial 
 
MUST = Malnutrition Universal Screening Tool; PEM= Protein Energy Malnutrition; FFM= Fat Free Mass; DEXA= Dual Energy X-Ray Absorptiometry; NHANES = National Health and Nutrition 
Examination Survey ; CQC= Care Quality Commission; RCN= Royal College of Nursing; MRC= Medical Research Council 
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3.6 Sample size  
 
No formal sample size calculation was performed, as the key outcomes were 
concerned with recruitment, retention and the feasibility and acceptability of the trial 
(Arain et al., 2010).  Any investigations of changes in study parameters were 
exploratory only. Based on the capacity of the selected care homes (29 residents, to 
72 residents) and the risk of malnutrition within the UK care home population (30-
42%), it was estimated that between 9 (30% of 29) and 30 (42% of 72) residents 
could be considered for receipt of the nutritional intervention within each care home. 
It was decided that this estimated sample size of n= 50 (6 x 9) to n=180 (6 x 30) 
would provide sufficient data to assess trial feasibility (Lancaster, 2004). 
 
3.7 Cluster randomisation (Figure 4) 
3.7.1 Sequence generation 
  The random allocation sequence was generated using a computer-generated 
random number list at the University of Birmingham Clinical Trials Unit. To minimise 
the time delay between care homes agreeing to participate and implementation of 
the interventions, care homes were randomised once eligible residents had been 
identified. This approach is recognised as a means of overcoming delays between 
recruitment and intervention implementation in cluster trials and was felt to be 
particularly relevant with the frail, care home population (Eldridge et al., 2009).  
 
3.7.2 Allocation concealment mechanism 
 Concealment of intervention allocation was achieved by giving responsibility 
for sequence generation and allocation to a statistician independent of the running of 
the trial. Completing the screening and consent process prior to sequence 
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Care Homes stratified 
and matched by type 
(nursing/nursing and 
residential or residential) 
Matched pairs of care 
homes allocated to 6-
months of: 
 
Standard care home 
intervention  for those at 
risk of malnutrition 
 
(SC) 
 
SC plus dietetic-led Food-
based intervention: Addition 
of 600kcal and 20-25g 
protein daily using 
conventional 
food/beverages 
(FB) 
 
SC plus dietetic-led ONS 
intervention: Addition of 
600kcal and 24g protein 
daily using 2 liquid ONS 
 
(ONS) 
generation also minimised selection bias, by ensuring that decisions were not 
influenced by the assigned intervention. 
 
3.7.3 Implementation 
 The primary researcher provided the statistician with the list of care homes 
that had consented. The statistician stratified and matched clusters according to care 
type (1 nursing and 1 residential home per pair) and then consecutively numbered all 
matched pairs. The random allocation sequence was generated and pairs were 
assigned to intervention allocation. The statistician notified the primary researcher of 
the allocations and each care home was then informed. Staff within each site 
received training from the primary researcher to support delivery of the allocated 
intervention and/or a refresher on SC.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: The randomisation process: Randomisation was stratified for type of care 
(residential or nursing/nursing and residential) to minimise differences in care home characteristics 
over the interventions. 
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3.7.4 Blinding 
 
Residents were recruited prior to random allocation of care homes to the 3 
arms. As consent was sought at the care home level (aside from PROMs), individual 
residents were not told of the care home intervention assignment. If a resident 
questioned the different drink, or snack provided, they were told it had been ordered 
by the dietitian and would be good for them. This approach mirrored usual care.  
Due to the nature of the interventions and the obvious differences between 
them, it was not possible to blind the staff delivering them. This means that there 
may have been differences in the way residents were treated in the dietetic-
intervention (FB or ONS) and SC homes, perhaps exposing them to external factors 
other than the interventions of interest. However, nutrition support interventions often 
involve contextual factors that cannot be separated from the intervention itself, such 
as who delivered the intervention, assistance provided and the setting. It is also 
acknowledged that the care homes allocated to SC were not providing a placebo. 
This trial arm also involved delivery of nutrition support, which may have minimised 
the differences in resident treatment between trial arms.  
Blinding of outcome assessors and data collectors is important to ensure the 
unbiased ascertainment of outcomes and the internal validity of a RCT (Karanicolas 
et al., 2010). This trial had only 1 primary researcher, responsible for communicating 
intervention allocation to participating homes and conducting outcome assessments. 
It was therefore impossible to blind the researcher to the assigned intervention. To 
minimise bias, the chosen outcome measures were objective and not easily 
influenced by the observer. In a definitive trial with funding for additional research 
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staff, it should be possible to use observers who assess outcome measures without 
knowledge of the intervention group.  
3.8 Research Governance  
 
3.8.1 Data Monitoring/Trial Steering Committee (DM/TSC) 
 
A joint DMC/TSC, which included 3 independent members (a statistician; a 
dietitian and a member of a patient and public involvement panel), was established 
prior to trial commencement (August 2013). The DMC/TSC met in January, April and 
July 2014 to review AEs, mortality and intervention changes. A final meeting was 
held in November 2014 to discuss the trial findings and inform the evaluation. 
3.8.2 Data handling (Appendix 8, p174-175) 
In accordance with the ICHGCP (2002) and the RGF for Health and Social 
Care (2005), all participant data that allows identification must be protected. Each 
eligible resident was assigned a unique trial identification code by care home staff. 
The list of codes was held at the care home site, in a locked cupboard. No resident 
identifiable information left the site, with the exception of a signature, for residents 
that consented to PROMs. All information collected for the trial was entered onto a 
secure computer database, accessed by the primary researcher only. 
 
3.9 Statistical Methodology  
Statistical analyses were performed using IBM SPSS, version 21 and Microsoft 
Access 2010. 
3.9.1 Data analysis  
As effective hypothesis testing requires a powered sample size (Arain et al., 
2010), analysis was limited to, descriptive statistics and an exploratory analysis 
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to provide estimates of key parameters and inform the design of a definitive trial 
(Lancaster et al., 2004). 
Baseline categorical variables were summarised using proportions (n (%)) and were 
compared between intervention arms using the chi-square test, or the Fisher’s exact 
test when 1 or more cells had an expected frequency of 5 or less. All continuous 
baseline data were tested for normality using Kolmogmorov-Smirnov and were 
summarised as mean (standard deviation (SD)) or median (interquartile range 
(IQR)). Where data was normally distributed, variables were compared between 
intervention arms using one-way ANOVA; otherwise Kruskall-Wallis was used. 
Analysis of baseline data was used to characterise the overall sample and highlight 
imbalances between the trial arms.   
Screening logs completed within each care home provided information on the 
numbers of residents screened using ‘MUST’, and the reasons for not entering the 
trial. This data, alongside categorical data collected on care home and resident 
withdrawals, changes to resident intervention, mortality, healthcare resource usage, 
adverse events and compliance was summarised (n (%)) and used to inform aspects 
of feasibility and acceptability reporting (Table 16). Continuous outcome measures 
were summarised as means (SD) or medians (IQR) at 3- and 6-months and mean 
changes were calculated from baseline to 3- months and 6- months, along with 95% 
confidence intervals. The mean difference between ONS and SC and FB and SC 
were calculated at 3- and 6-months, along with 95% confidence intervals. This data 
was used to review the sensitivity of the outcome measures to change and inform 
which outcome measures are most appropriate to take forwards into a definitive trial. 
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3.9.2 Assessment of feasibility and acceptability 
A priori, it was specified that the 5 primary trial objectives (Table 9 and Table 
16) would be considered successful if the following were met: 
Table 16: Feasibility and acceptability success criteria 
Primary objectives Success criteria 
1. Recruitment of care homes:  
Recruitment target of 6 met in the time available (3 
months)  
 
2. Resident eligibility criteria and recruitment 
Favourable difference shown in number at risk of 
malnutrition and number that were deemed eligible 
(≤20% difference) 
 
Estimated resident recruitment target of n≥50 met 
(Section 3.6) 
3. Retention of care homes and residents 
Retention of 100% for care home sites  
Retention of ≥65% for residents at 6-months follow 
up, accounting for expected high mortality (Shah et 
al, 2012) and attrition rate (Manders et al., 2009; 
Parsons et al., 2011; Leslie et al, 2012). 
 
4. Intervention acceptability to residents and 
staff 
Intervention change of ≤10% for each intervention 
Given that the clinical benefits of ONS (unknown for 
FB) are seen with 1-3 servings (300-900kcal) daily 
(NICE, 2006; Stratton and Elia, 2007): 
o - ≥80% of residents to be compliant with ≥50% 
dietetic-led intervention dose (≥300-450kcal),  
o - ≥60% of residents to be compliant with ≥75% of 
the dietetic-led intervention dose (≥450-600kcal) 
 
≥85% staff adherence to intervention schedule 
5. Feasibility and acceptability of the 
outcomes piloted 
Data completeness of ≥ 80% (see section 3.5.3) 
Reported and recorded values were considered 
complete. Unknown and blank values (due to lack of 
recording, resident refusal, inability to measure) 
were considered missing values. 
ONS= Oral nutritional Supplements; FB= Food-Based  
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3.9.3 The Intracluster correlation coefficient (ICC) 
 
To determine the optimal sample size for a definitive cluster RCT, calculations 
will be required, which involve the number of clusters, the number of individuals 
within clusters and the power, significance level and effect size being sought 
(Donner et al., 2003). As the residents within a care home are more likely to be 
similar, the variability of treatment effects within clusters and the power to detect true 
differences between intervention arms is reduced (MRC, 2000). To account for this, 
an estimate of the magnitude of the Intracluster Correlation Coefficient (ICC), which 
compares within-group variance to between-group variance (Killip et al., 2004) will 
be required for the primary outcome measure to be taken forward (Secondary 
Objective 5, Table 9).   
                      
  
 
To determine the most appropriate primary outcome for a definitive trial, completion 
rates and missing data were summarised for all outcome measures, along with 
estimates and variances.  
3.10 The Broader Methodological Framework of the trial 
To fully address the research question and trial objectives, a sequential, 
explanatory mixed method design was chosen (Cresswell, 2009) (Figure 5), but due 
to time constraints, it was not realistic to transcribe and analyse the qualitative data 
within the scope of this MRes. A mixed methods framework was felt to be necessary, 
to provide a comprehensive analysis of the feasibility and acceptability issues 
ICC =                         Between cluster variability 
  (Within cluster variability + Between cluster variability) 
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associated with delivering and evaluating nutritional interventions in the care home 
setting.  
 
 
 
 
 
 
 
 
Figure 5: The sequential trial design (Adapted from, Cresswell, 2009) 
‘Quan’ and ‘qual’ stand for quantitative and qualitative respectively; Capitalisation indicates an emphasis or priority 
on an approach or method  
 
Existing studies of malnutrition interventions have used a quantitative 
approach, which whilst useful for determining quantitative outcomes such as nutrient 
intake and weight change, have provided limited information on, resident and staff 
perspectives and, the reasons why the care home environment poses challenges to 
the researcher. During the last 20 years, researchers have identified the need for 
employing a range of methodologies to enhance understanding of healthcare 
complexities and to ensure that disempowered groups are heard (O’Cathain et al., 
2007). It was felt that the use of interviews and focus groups in a qualitative phase 
would enable the feasibility outcomes to be further explored with the trial 
participants, ensuring that resident and staff perspectives can be used to inform 
design and conduct for a definitive trial. The qualitative methodology has not been 
reported on in this chapter, but further information can be found within the trial 
protocol (Appendix 8, p156, 166-167, 173) and Appendix 18. 
 
 
 
 
 
 
 
QUAN   QUAN   qual   qual  Interpretation 
Data    Data   Data   Data  of entire 
Collection   Analysis  Collection  Analysis Analysis 
 
 
 
qual QUAN 
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CHAPTER FOUR: RESULTS
5
 
 
4.1 Recruitment to the trial: care homes and residents 
All 6 care homes approached, consented to participate in the trial within the 3-
month care home recruitment period (Sept 2013- Dec 2013). Table 17 shows the 
characteristics of the care homes. There were some identified differences in access 
to healthcare professionals (GP’s and Nurses) between care home types (nursing 
and/or residential). 
Table 17: Characteristics of the included care homes  
 
Characteristics Care Home 
CH01 CH02 CH03 CH04 CH05 CH06 
Care home type N and R R N N and R R R 
Nursing staff 
onsite (Yes/No) 
Yes No Yes Yes No No 
Weekly GP 
rounds (Yes/No) 
Yes No* Yes Yes Yes No* 
Food record 
chart/Fluid chart 
for all residents 
 No**  No**  No** Yes Yes Yes 
 
N=nursing, R=residential 
 
*GP called out as needed; **Charts only completed for those residents identified as eating or drinking poorly 
All 280 residents living across the 6 care homes were screened using ‘MUST’ and 
110 (39%) were at medium or high risk of malnutrition. 93 (84.5%) of these 110 
residents were eligible to enter the trial and receive the intervention (Figure 6). 
Reasons for the remaining 17 residents not entering the trial are detailed in Table 18. 
 
                                                          
5 All of the trial data is stored in a Microsoft Access database, available on request.  
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Table 18: Reasons for residents not being eligible to participate (n = 17) 
 
Reasons given Residents not eligible to enter the trial 
 
n (%) 
Already receiving dietetic-led nutrition support 13(76) 
In hospital 2(12) 
Not registered with a Solihull GP 1(6) 
Non-English speaking 1(6) 
Data are numbers (%). 
 
Of the 32 residents within the care homes assigned to SC (CH03, CH05), 2 
moved out and 11 died by 6-months. Of the 32 residents within the care homes 
assigned to FB intervention (CH04, CH06), 2 entered end of life care, 1 moved out 
and 6 died. Of the 29 residents within the care homes assigned to ONS intervention 
(CH01, CH02), 1 moved out, 1 was admitted to hospital and 6 died. 63 residents 
completed the trial and were included in the analyses (Figure 6).  
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CONSORT Flow Diagram (2010) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Residents assessed for eligibility to 
receive the intervention (n=280) 
Excluded (n=170) Not at risk of malnutrition  
 
 
Completed trial (n=23) 
 
Lost to follow-up (n=4) 
- Died (n=3) 
- Entered end of life care (n=1) 
Intervention crossover (n=0) 
 
Left in the trial (n =27) 
 
 
  
 
1 Nursing home (CH04) and 1 
Residential home (CH06) allocated to FB 
intervention (n=32) 
Received allocated intervention (n=31) 
 
Did not receive intervention (n=1) 
- Entered end of life care (n=1) 
Lost to follow-up (n=6)  
- Hospital (n=1) 
- Died (n=5) 
Intervention crossover to FB (n= 1) 
 
Left in the trial (n=21) 
 
1 Nursing home (CH01) and 1 
Residential home (CH02) allocated to 
ONS intervention (n=29) 
Received allocated intervention (n=27) 
 
Did not receive intervention (n=2) 
- Died (n=1) 
- Moved out (n=1) ) 
Completed trial (n=21) 
 
 
Allocation (Dec 2013) 
3 month follow-Up (March 2014) 
Analysis 
Eligible residents (n=93) 
 
Recruitment of 6 care 
homes: 
3 Nursing homes 
(CH01, CH03, CH04) 
3 Residential homes 
(CH02, CH05, CH06) 
Randomised care homes (6) 
1 Nursing home (CH03) and 1 Residential 
home allocated to SC (CH05) (n=32) 
 
Received allocated intervention (n=32) 
 
Lost to follow-up (n=13)  
- Moved out (n=2) 
- Died (n=11) 
Intervention crossover (n=2) 
- to FB (n=1) 
- to ONS (n=1) 
Left in the trial (n=19) 
 
6 month follow-Up (June 2014) 
Lost to follow-up (n=4)  
- Moved out (n=1) 
- Died (n=3) 
Intervention crossover (n=0) 
 
 
 
Lost to follow-up (n=0) 
 
Intervention crossover (n=0) 
 
 
 
 
Lost to follow-up (n=0) 
 
Intervention crossover (n=0) 
 
 
 
Figure 6: Consolidated Standards of Reporting Trials (CONSORT) flow diagram of the conduct of the trial, including the 
outcome for all residents (Schulz et al., 2010) 
Completed trial (n=19) 
 
At risk of malnutrition (n=110) 
 
Excluded (n=17) 
   Receiving nutrition support (n=13) 
   In hospital (n=2) 
   Not registered with Solihull GP (n=1) 
   Non English speaking (n=1) 
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4.1.1 Baseline characteristics of residents 
 
Included residents were mostly female (82%), with dementia the most 
prominent primary diagnosis (75%). Table 19 summarises the resident 
characteristics (variables) at baseline. It is acknowledged that testing for baseline 
differences between intervention arms in RCTs is usually not appropriate, given that 
any identified differences are caused by chance (Grobbee and Hoes, 2009; 
CONSORT statement, 2010). However, it was considered useful to assess for 
imbalances at baseline within this feasibility trial of few clusters (6), to inform the 
sample size for a definitive trial. All variables were statistically homogeneous 
according to chi-squared (χ2) test for independent samples of categorical data (all p> 
0.05), with the exception of the proportion of residents at medium and high risk of 
malnutrition in the care home assigned to FB intervention (34% high risk compared 
to >60% for the other 2 arms).  
Table 19: Characteristics of residents at baseline (n = 93) 
 
Variables 
SC (n=32) FB (n=32) ONS (n=29) 
 
P 
n (%) n (%) n (%) 
Gender F: 27(84.4), 
M: 5(15.6) 
 
F: 26(81.3) 
M: 6(18.8) 
F: 23(79) 
M: 6(21) 
0.9 
Capacity 5 (15.6) 4 (12.5) 7(24.1) 0.5
a 
Diagnosed 
dementia 
25 (78.1) 25 (78.1) 20 (69) 0.6 
Diagnosed 
dysphagia 
7 (21.9) 4 (12.5) 7 (24.1) 0.5 
Risk of re-
feeding 
3 (9.4) 0 (0) 4(13.8) 0.1
a 
Malnutrition 
risk  
High risk: 20(62.5) 
Med risk: 12(38) 
High risk:11(34.4) 
Med risk: 20(63) 
High risk:19(65.5) 
Med risk:  9(31) 
SC vs FB      <0.05 
SC vs ONS  0.6 
FB vs ONS  0.01 
 
SC= Standard Care; FB= Food-based intervention; ONS= Oral nutritional supplement intervention. F= female, M = 
Male.       
 
Data are presented as numbers (%). Comparisons between intervention arms has been conducted using chi-squared for 
categorical data, or 
a
Fisher’s Exact text where 1 or more cells has an expected frequency of <5,  
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Table 20 summarises the clinical and nutritional characteristics of residents at 
baseline. 
Table 20: Clinical and nutritional characteristics of residents at baseline  
Characteristic SC (n=32) FB (n=32) ONS (n=29)  
P 
Weight (kg) Weighed (n=31) 
 
48.6 (9.1) 
Weighed (n=32) 
 
55.9 (1.8) 
Weighed (n=29) 
 
48.2 (10.9) 
<0.01 
BMI (kg/m
2
) n=31 
 
19 (17.0-20.5)
* 
n=32 
 
20.1 (18.7-24.8)
* 
 
n=29 
 
18.4 (17.6-21.6)
* 
 
<0.01
** 
 
MAC (cm) Measured (n=27) 
21.9 (2.7)     
Measured (n=28) 
 
23 (2.5) 
 
Measured (n=25) 
 
22 (3.0) 
0.1 
TSF (mm) Measured (n=24) 
 
9.3 (2.8) 
 
Measured (n=22) 
 
13.2 (5.6) 
Measured (n=23) 
 
8.4 (3.1) 
<0.001 
MAMC (cm) n=24 
 
18.9 (2.5) 
n=22 
 
18.9 (1.7) 
 
n=23 
 
18.5 (2.5) 
 
0.7 
 
HgD (kg) Measured (n=14) 
 
5.65 (3.9-8.3)* 
Measured (n=22) 
 
6.9 (4.0-11.5)* 
Measured (n=13) 
 
5.6 (3.2-10.3)* 
 
0.8** 
Energy Intake 
(kcal) 
Available (n=29) 
 
1553 (470) 
 
Available (n=31) 
 
1916 (496) 
 
Available (n=27) 
 
1535 (562) 
 
<0.01 
 
Protein Intake 
(g) 
Available (n=29) 
 
41 (14.6) 
 
Available (n=31) 
 
78 (22) 
 
Available (n=27) 
 
54 (20) 
 
<0.001 
 
Fluid Intake 
(ml) 
Available (n=27) 
 
1109 (237) 
 
Available (n=31) 
 
1332 (310) 
Available (n=27) 
 
1037 (260) 
<0.001 
 
 
SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements; BMI= Body Mass Index; MAM= Mid Upper 
Arm Circumference; TSF= Tricep Skinfold Thickness; MAMC= Mid Arm Muscle Circumference; HGD= Handgrip 
Dynamometer.  
 
The number of residents included is indicated for each characteristic. Normal data is presented as Mean (Standard Deviation), 
otherwise is Median (Interquartile Range) (indicated by *). Comparisons between intervention arms has been conducted using 
one-way ANOVA for normal data, otherwise Kruskall Wallis (indicated by **) has been used. 
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There was a significant difference in mean, weight (kg), TSF (mm), energy 
intake (kcal) and fluid intake (ml) (p ≤ 0.05) between the residents within the care 
homes allocated to FB intervention (higher weight, BMI and intake values) and the 
residents within the care homes allocated to SC and ONS. There was a significant 
difference in mean BMI (kg/m2) and protein intake (g) across all 3 arms (p ≤ 0.05).  
Of the 93 residents deemed eligible to receive the interventions at baseline, 
only 16 (17%) were determined by care home staff to have the capacity to consent to 
PROMs. Written informed consent was obtained from 11 residents, 3 residents 
declined, 1 resident was too unwell to be approached and 1 resident declined due to 
family influence.  Table 21 summarises the PROM responses at baseline.  
 
Table 21: Participant Reported Outcome Measure (PROM) responses at baseline 
PROM 
 
SC (n=3) 
 
FB (n=2) ONS (n=6) 
COOP QoL score 5 (5-7)*
 
4 (2-6)*
 
5.5 (4-6)*
 
EQ5D VAS 53 (16) 70 (28) 61 (21) 
EQ5D index value -0.16 (0.4) 0.15 (0.3) 0.33 (0.3) 
Hunger 4 (3) 5 (7) 4 (4) 
Appetite 6 (4) 5.5 (6) 5 (4) 
Dietary Satisfaction 9 (0.6) 8.5 (2) 8.5 (2) 
Pleasantness of meals 9 (1) 6 (4) 6 (3) 
Pleasantness of snacks 7 (1.5) 8 (1.4) 6 (4) 
Pleasantness of drinks 9(8-10)*
 
9(9-9)*
 
10(8-10)*
 
 
SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements; QoL= Quality of Life; VAS= Visual 
Analogue Scale 
 
Normal continuous data is presented as Mean (Standard Deviation), otherwise is Median (Interquartile Range) (indicated by *).  
Ordinal data (COOP) is presented as Median (Interquartile Range). EQ-5D index value ranges from -0.59 to 1, with higher 
scores corresponding to a better health state. COOP score ranges from 1 to 10, with higher scores corresponding to a better 
QoL 
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4.2 Retention in the trial 
 
 
4.2.1 Mortality and termination of involvement 
All 6 care homes completed the trial. Of the 93 residents deemed eligible to 
receive a nutritional intervention, 67 (72%) remained at month-3 and 63 (68%) 
completed the 6-month intervention. Table 22 summarises resident mortality and 
other loss to follow-up recorded throughout the trial. 
 
Table 22 Resident mortality and other loss to follow up by 3-months (T1) and 6-
months (T2) 
 SC FB ONS 
T1(n=32) T2(n=19) T1(n=32) T2(n=27) T1(n=29) T2(n=21) 
n(%) n(%) n(%) 
Mortality 
 
11 (34) 
 
0 3 (9.4) 3 (11) 6 (21) 0 
Other loss 
to follow up 
2  (6) 0 2 (6)* 1 (4) 2 (7)* 0 
 
SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements; T1= Month-3; T2= Month-6 
 
Data are numbers (%). Other reasons for loss to follow up included residents moving out (n=4), entering end of life care (n=2), 
and being admitted to hospital with no planned return (n=1). *The figures include those residents that left prior to receiving the 
allocated intervention 
 
In total, 23 residents died during the trial (25% mortality), 17 (74%) of whom 
were at high risk of malnutrition and 6 (26%) at medium risk of malnutrition. Of those 
23, 87% died during T1. The 1 care home providing solely nursing care (SC arm) 
experienced the highest mortality rate during this interval. It is likely that the 
residents at risk of malnutrition in this care home would have had a condition or 
illness requiring medical care, compared to the residents within the homes providing 
both nursing and residential, or solely residential care. 
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4.3 Acceptability of the allocated interventions 
 
4.3.1 Compliance 
Compliance with the dietetic-led interventions (FB and ONS) was determined 
at 3- and 6-months (Table 23).  
 
Table 23: Resident compliance with dietetic interventions at T1 and at T2 
 FB ONS 
T1(n=27) T2(n=23) T1(n=21) T2(n=19)* 
n(%) n(%) 
Compliance with intervention (≥75% / 
450-600kcal consumed daily) 
21 (78) 16 (70) 14 (67) 12 (63) 
 
FB= Food-Based; ONS= Oral Nutritional Supplements; T1= Baseline- 3months; T2= 3months- 6months 
 
Data are numbers (%). 3 of the residents deemed compliant with the FB intervention at T1 were being given a different fortified 
drink or snack to that initially agreed at baseline, however the nutritional content was approximately equivalent. 
*n=2 not included as 1 resident switched to FB intervention before month-3 and 1 resident was not provided with the 
intervention dose by staff 
 
 
The proportion of fully compliant residents reduced from 74% at T1 to 67% by 
T2, although 86% of residents during both T1 and T2 consumed at least half of the 
provided amount (≥300kcal) of either FB or ONS intervention. Residents assigned to 
FB intervention had greater compliance compared with ONS at both T1 (78% versus 
67%) and T2 (70% versus 63%). Reasons for non-compliance were given (Table 24) 
Table 24: Reasons given by care home staff for resident non-compliance with 
dietetic-led intervention 
 
Reason for non-
compliance  
FB intervention  ONS intervention 
T1 (n=6) T2 (n=7) T1 (n=7) T2 (n=7) 
n(%) n(%) 
Consumed 50-75% of 
intervention dose 
(~300-444kcal) 
4 (67) 2 (29) 4 (57) 6 (86) 
Refused intervention  2 (33)  1 (14) 1 (14) 
Poor overall intake, 
including intervention 
 5 (71) 1 (14)  
Change to different 
intervention 
  1 (14)  
 
FB= Food-Based; ONS= Oral Nutritional Supplements 
Data are numbers (%). 
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Non-compliance in the ONS arm was largely associated with low intake of the 
intervention (50-75%). In the FB arm, reasons for non-compliance during T1 were 
low intake or refusal. Where a dislike of a FB intervention was identified at three-
months, the choice of fortified snacks and/or drinks was adjusted to accommodate 
the changing preferences of the individual, whilst continuing to provide the additional 
600kcal and 20-25g protein (Appendix 12). During T2, the majority (71%) of non-
compliance was less specific to the intervention and instead due to a decline in 
appetite and overall intake.  
4.3.2 Staff adherence to intervention schedule 
 
4.3.2.1 ONS intervention 
At T1, staff adherence to the intervention schedule was 100%. The ONS 
provided and the ONS consumed was documented on each resident’s drugs chart. 
At T2, staff adherence was 95%. Drug chart documentation and discussions with 
staff, revealed that 1 resident in CH01 was not consistently provided with the agreed 
dose.  
4.3.2.2 Food-based intervention 
At T1, the staff demonstrated 100% adherence to the intervention schedule, but 
there were some deviations from the documented FB snacks/drinks for 3 residents 
within CH04. Following initial discussions, the staff had decided that a different 
combination (Appendix 12) may suit these residents better and had provided these 
revised options daily. The nutritional content was approximately equivalent to the 
plan initially discussed. At T2, staff adherence with the intervention schedule was 
100% and there were no deviations from the agreed plans.  
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4.3.3 Adverse events (AEs) 
Three adverse events were recorded by care home staff throughout the trial, 1 
in each intervention arm. Details are shown in Table 25.  
Table 25: Details of the reported adverse events (n=3) and how these were addressed 
Adverse Event Data collection 
Interval 
Was the 
event 
expected? 
Intervention 
Arm 
How the event was 
addressed 
Reduced BMI, 
placing 
resident at re-
feeding risk 
Baseline- 
3months 
Yes SC Changed to FB 
intervention (Table 26 
and 27) and followed 
NICE guidance (2006) 
Reduced BMI, 
placing 
resident at re-
feeding risk 
Baseline- 
3months 
Yes FB GP was investigating 
an underlying clinical 
cause. No changes to 
intervention. 
Poorly 
controlled 
blood glucose 
levels, 
reportedly 
exacerbated by 
ONS intake 
Baseline- 
3months 
No ONS 
 
Changed to FB 
intervention (Table 26 
and 27). Care home 
staff monitored blood 
glucose levels daily. 
 
SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements; BMI= Body Mass Index 
4.3.4 Change of intervention 
Intervention change is summarised in Table 26.  
Table 26: Change of interventions recorded throughout the trial 
 
 
SC FB ONS 
T1 
(n=32) 
T1 
(n=32) 
T1 
(n=29) 
n(%) n(%) n(%) 
Changed intervention 2 (6) 
 
0 
 
1 (3) 
 
Intervention not 
started 
0 1 (3) 2 (10) 
 
SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements 
 Data are numbers (%).
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Three residents never received their initial intervention, 1 (allocated to FB 
intervention) entered end-of-life care, 1 died (allocated to ONS) and 1 moved out 
(allocated to ONS). No residents within the care homes allocated to FB intervention, 
2 residents within the care homes allocated to SC and 1 resident within the care 
homes allocated to ONS were required to change following intervention 
commencement. The details are shown in Table 27. 
 
Table 27: Details of the intervention changes (n=3) 
Reason  Data collection 
Interval 
Intervention Arm Intervention 
switched to 
Poor blood sugar control 
exacerbated by 
intervention (Table 25) 
 
Baseline- 3months ONS FB 
Decline in nutritional 
status and ACBS criteria 
met 
 
Baseline- 3months SC ONS 
Decline in nutritional 
status, at risk of re-
feeding syndrome (Table 
25) 
 
Baseline- 3months SC FB 
SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements; ACBS= Advisory Committee on Borderline 
Substances 
4.4 Completion of tools and questionnaires by care home staff 
 
4.4.1 ‘MUST’ 
Malnutrition risk category (low, medium or high) was available in the care 
home records for 100% of the residents remaining in the trial at T1 and T2. The 
primary researcher calculated a repeat ‘MUST’ score for 2 randomly selected 
residents per care home (n=12). At T1, 11 ‘MUST’ scores had been calculated 
correctly (92%). Step 2 (unintentional weight loss) had been calculated over 1 
month, rather than 3-to-6 months for 1 resident. At T2, all 12 records (100%) detailed 
a correctly calculated score.  
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4.4.2 Healthcare resource usage 
Staff were asked to complete the relevant healthcare resource usage 
information from the care records. The questionnaires were completed in full for 
100% of the residents in the trial at T1 and at T2.  
4.5 Acceptability and feasibility of the outcome measurements 
 
4.5.1 Physical measurement data collection 
 
4.5.1.1 Measured by care home staff 
Height 
Height, and the measurement technique used, was documented in the care 
home records for all 93 residents in receipt of an intervention. 61 residents (66%) 
had been measured using a freestanding stadiometer, 29 (31%) had their height 
estimated from ulna length and 2 (2%) had self-reported their height. 
 
Weight 
At baseline, only 1 resident, across all 6 sites was unable to be weighed by 
the care home staff, due to a decline in clinical condition. Of the remaining 92 
residents, 7 (8%) were weighed with standing scales, 63 (70%) with chair scales and 
19 (21%) with hoist scales. At T1, all 67 remaining residents were able to be 
weighed, but 1 resident, weighed by chair scales at baseline, was weighed using 
hoist scales, because of reduced mobility. At T2, this resident was again weighed 
using chair scales. All other residents in the trial at T1 (n=66) and T2 (n=62) were 
weighed using the same weighing scales as at baseline.  
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4.5.1.2 Measured by the primary researcher  
Mid Upper Arm Circumference (MAC), Tricep Skinfold Thickness (TSF) and 
Handgrip strength (HGD) 
 
Table 28 shows the number and percentage of residents at each data 
collection interval that either, consented, refused, or were unable to be measured.  
Table 28: Resident acceptability of physical outcome measurement at baseline (B), 3-
months (T1) and 6-months (T2) 
 MAC 
 
TSF HGD 
B 
(n=90) 
T1 
(n=67) 
T2 
(n=63) 
B 
(n=90) 
T1 
(n=67) 
T2 
(n=63) 
B 
(n=90) 
T1 
(n=67) 
T2 
(n=63) 
n(%) n(%) n(%) 
Measured
 
80(89) 59(88) 55(87) 69(77) 49(73) 50(79) 49(54) 39(58) 31(49) 
Mean
 
88 76 54 
Refused
 
8(9) 7(10) 6(9.5) 12(13) 12(18) 10(16) 10(11) 9(13) 9(14) 
Mean
 
9.5 16 13 
Unable to 
measure
 
2(2) 1(1.5) 2(3) 9(10) 6(9) 3(5) 31(34) 19(28) 23(37) 
 
Mean
 
2.2 8 33 
MAC= Mid Upper Arm Circumference; TSF= Tricep Skinfold Thickness; HGD= Handgrip Dynamometer; B= Baseline; 
T1 = Month-3; T2= Month-6
 
*In the time between randomisation and baseline measurement, three residents had already left the trial, hence n=90 at B
* 
 
Over the 3 data collection intervals, 88% of residents had MAC measured, 
76% had TSF measured and 54% had HGD measured. The lower percentage for 
HGD was largely attributable to difficulties in understanding the instruction, or to 
physical difficulties when attempting to grip the dynamometer. It was not always the 
same residents that declined or were unable to take part in the measurements. This 
fluctuation in ability and willingness to participate may be a consequence of the high 
number of residents with cognitive impairment. 
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4.5.2 Nutritional intake data collection 
Food record charts (FRC) and Fluid charts (FC) were collected from care 
home records, at baseline, T1, and T2, to enable average energy, protein and fluid 
intake to be determined. Table 29 shows the number and percentage of FRCs and 
FCs that were either, available and complete, available but incomplete, or 
unavailable at each data collection interval. 
Table 29: The availability of FRCs and FC’s at baseline (B), 3-months (T1) and 6-
months (T2) 
 FRC FC 
B 
(n=90) 
T1 
(n=67) 
T2 
(n=63) 
B 
(n=90) 
T1 
(n=67) 
T2 
(n=63) 
n(%) n(%) 
Available and complete 71(79) 55(82) 52(83) 76(84) 60(90) 54(86) 
Mean 81 87 
Available but 
incomplete 
15(17) 12(18) 8(13) 9(10) 7(10) 7(11) 
Mean 16 10 
Unavailable 4(4) 0  3(5) 5(5.5) 0  2(3) 
Mean 3 3 
FRC= Food Record Chart; FC= Fluid Chart; B= Baseline; T1= Month-3; T2= Month-6
 
 
Over the 3 data collection intervals, 81% of FRCs and 87% of FCs were 
available and complete, but there were some limitations to this method of information 
collection. Whilst the care home staff indicated how much of a meal or snack had 
been consumed by the resident as a proportion (All, ¾, ½, ¼, refused), there was 
little to no information on what part of the meal had been eaten. There was also 
minimal information on the recipes used or on specifying whether ingredients had 
been added to enrich the calorie content. This lack of information may have reduced 
the accuracy of the subsequent dietary analysis and estimation of daily energy, 
protein and fluid intake. 
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4.5.3 Participant-reported outcome measures: PROMs 
At each data collection interval, the EQ5D-5L questionnaire, the COOP quality 
of life chart and the VAS tool were provided to the residents by the care home staff. 
All eligible residents received the questionnaires at baseline (n=11), at 3-months 
(n=8) and at 6-months (n=7) and 100% of the questionnaires were completed in full. 
All residents required the care home staff to read the questionnaires to them (due to 
poor eyesight) and to mark on their responses (due to poor dexterity). 
The number of eligible residents reduced from 11, to 7 over the course of the 
trial, with 5 of the residents remaining at T2 allocated to ONS intervention. Due to the 
lack of available data, there will be no further analysis here, but the data recorded 
has been summarised descriptively (Appendix 20). Resident and staff perceptions of 
the questionnaires and the perceived ease or difficulty of taking part in PROMs will 
be explored further within the qualitative phase.
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4.5.4 Healthcare resource usage (HCRU): Piloting of a questionnaire 
The HCRU questionnaire completed at T1 and T2 collected information on all hospital admissions, GP call-outs (not routine) 
and visits from, district nurses, tissue viability nurses, consultants, dietitians and speech and language therapists (SaLT). Table 30 
summarises hospital admissions and professional visits recorded across the care home sites. 
Table 30: Hospital admissions and Healthcare professional visits recorded throughout the trial 
 CH01 
 
CH02 
 
CH03 
 
CH04 
 
CH05 
 
CH06 
 
 (n=12) 
 
 (n=9) 
 
(n=8)  (n=18) 
 
 (n=11) 
 
 (n=9) 
 
Hospital 
admissions 
2 for 1 resident 2 for 2 residents 2 for 1 resident 9 for 5 residents 2 for 2 residents 7 for 5 residents 
GP call-outs  22 for 10 residents 
 
14 for 7 residents 28 for 9 residents 18 for 11 residents 24 for 10 residents 11 for 7 residents 
District Nurse 0 
 
3 for 1 resident 0 0 8 for 7 residents 52 for 8 residents 
Dietitian  0 0 1 for 1 resident 0 4 for 3 residents 1 for 1 resident 
SaLT 0 1 for 1 resident 1 for 1 resident 0 0 2 for 2 residents 
Consultant 2 for 2 residents 
 
0 3 for 3 residents 0 0 2 for 2 residents 
Tissue 
Viability Nurse 
3  for 2 resident 
 
0 2 for 2 residents 0 0 0 
 
CH= Care Home; SaLT= Speech and Language Therapist 
*Data are shown as the number of admissions or visits, for the number of residents
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24 hospital admissions were recorded for 16 residents during the trial. 
Admissions to Accident and Emergency (A&E) accounted for 46% of the recorded 
admissions, followed by outpatient appointments (37.5%) and inpatient admissions 
(17%). The majority of A&E admissions were for falls (82%) (Appendix 21). The staff 
did not indicate that nutritional status was a factor in falling, nor did they directly 
attribute any of the outpatient appointments (Appendix 21) or inpatient admissions to 
nutritional status or an allocated intervention.  
117 GP call-outs were recorded for 54 residents throughout the trial. The 
fewest number were recorded for CH02 and CH06, the only 2 care homes that do 
not receive weekly GP rounds (Table 17). Although routine check-ups were not 
recorded (Appendix 22), it is possible that more frequent, scheduled visitations, 
resulted in more documented GP assessments in the other 4 homes. The most 
frequently recorded reasons for call-outs were, chest examinations (suspected chest 
infection) (26%), medication reviews (19%) and urinary tract infections (15.4%) 
(Appendix 22). The staff did not directly attribute any of the call-outs to nutritional 
status. 
District Nurse Visits were usually scheduled to deliver wound care (37%) and 
to check pressure areas (49%) (Appendix 22). The number of recorded visits differed 
substantially between CH06, the smallest home in the trial, and the other 5 care 
homes. CH06 is a residential home, which arranges regular District Nurse visits to 
replace the nursing duties conducted by staff in the care homes providing nursing 
care (Table 17). The other recorded visits were also for residential homes (CH02 and 
CH05); although less reliance appeared to be placed on District Nurses by these 2 
care homes. The staff within the 3 care homes did not directly attribute any visits to a 
decline in a resident’s nutritional status or to the allocated intervention.  
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The 5 recorded dietitian appointments were arranged in response to a decline 
in nutritional status. Two residents subsequently switched intervention arms (section 
4.3.4). The remaining 3 residents were referred late during T2 and continued to be 
followed up after trial completion. The care home staff requested SaLT visits, 
because of concerns relating to swallowing function. Two visits during T2 resulted in 
recommendations to modify food texture (normal to fork-mashable). 
4.6 Change in outcomes  
 
4.6.1 Change in anthropometric indicators and nutrient intake  
Table 31 shows the intervention effects on physical outcome measures and 
nutrient intake by T1 (see Table 20 for baseline data and Appendix 23 for data at 3-
months). Where the 95% confidence interval (CI) of the mean difference (MD) does 
not cross zero, this suggests sensitivity to change and a difference between the trial 
arms. This was observed for weight change, BMI change and change in energy 
intake for the comparison between each of the dietetic-led intervention arms (net 
increase) and the SC arm (net decrease) during T1, but was not observed when the 
2 dietetic-led intervention arms were compared. The 95% CI also implied a 
difference between the ONS arm and the SC arm for change in protein intake and 
fluid intake and although there was a decline in MAMC in all 3 arms, this was 
minimised in the FB arm, when compared to the SC arm. 
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Table 31: Intervention effects on anthropometric indicators and nutrient intake from baseline to 3-months (n = 67) 
Outcome SC (n=19) FB (n=27) ONS (n=21) SC vs. FB SC vs. ONS FB vs. ONS 
    Mean 
Difference 
(MD) 
 
 [95% CI]  Mean 
Difference 
(MD) 
 
 [95% CI]  Mean 
Difference 
(MD) 
 
 
 [95% CI] 
Weight 
change 
(kg) 
Weighed (n=19) 
 
-1.5 (3.3) 
Weighed (n=27) 
 
0.42 (2.4) 
 
Weighed (n=21) 
 
0.82 (2.7) 
-1.9 
 
 [-3.6, -0.23] -2.3 
 
 [-4.3, -0.40] -0.4 
 
 [-1.9, 1.1] 
BMI 
change  
(kg/m
2
) 
n=19 
 
-0.55 (1.2) 
n=27 
 
0.16 (1.0) 
n=21 
 
0.33 (1.2) 
-0.7 
 
 [-1.4, -0.06] -0.88 
 
 [-1.65, -0.11] -0.17 
 
 [-0.79, 0.44] 
MAC 
change 
(cm) 
Measured 
(n=13) 
 
-1.06 (1.5) 
 
Measured (n=24) 
 
-0.29 (1.2) 
 
Measured (n=18) 
 
-0.39 (1.8) 
 
-0.77 
 
 [-1.7, 0.14] -0.67 
 
 [-1.9, 0.57]   
TSF 
change 
(mm) 
Measured 
(n=11) 
 
0.86 (1.5) 
 
Measured (n=19) 
 
-0.29 (2.0) 
 
Measured (n=15) 
 
1.6 (3.6) 
 
1.15 
 
 [-0.26, 2.6] -0.77 
 
[-2.9, 1.38]   
MAMC 
change 
n=10 
 
-1.36 (0.8) 
 
n=19 
 
-0.18 (1.5) 
n=16 
 
-0.65 (0.9) 
 
-1.17 
 
 [-2.2, -0.14] 
 
 
-0.71 
 
 [-1.44, 0.02]   
HgD 
change 
(kg) 
Measured (n=7) 
 
0.16 (2.4) 
Measured (n=17) 
 
-0.82 (3.4) 
Measured (n=6) 
 
-1.5 (2.5) 
0.97 
 
 [-1.9, 3.9] 1.62 
 
 [-1.34, 4.65]   
Change in 
energy 
intake 
(kcal) 
Available (n=18) 
 
-103 (275) 
 
Available (n=27) 
 
277 (250) 
 
Available (n=21) 
 
376 (375) 
-380 
 
 [-550, -226] -479 
 
 [-697, -263] -99 
 
 [-281, 83] 
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Change in 
protein 
intake (g) 
Available (n=18) 
 
0.72 (6.5) 
 
Available (n=27) 
 
3 (12.9) 
Available (n=21) 
 
16.7 (12.5) 
 
-2.3 
 
[-8.9, 4.3] -16 
 
 [-226, -9.4]   
Change in 
fluid 
intake (ml) 
Available (n=18) 
 
400 (100 - 500)
* 
 
Available (n=27) 
 
100 (-20 - 400)
* 
Available (n=21) 
 
250 (112.5 -250)
* 
 
 Mann-
Whitney U = 
164** 
 
Mann- 
Whitney U = 
110** 
  
 
MD = Mean Difference; SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements; BMI= Body Mass Index; MAC= Mid Upper Arm Circumference; TSF= Tricep Skinfold 
Thickness; MAMC= Mid Arm Muscle Circumference; HgD= Handgrip Dynamometer 
 
Normal data is presented as Mean change (Standard Deviation), otherwise is Median change (Interquartile Range) (indicated by *).  The mean difference (MD) between each dietetic-led intervention 
arm (FB and ONS) and the SC arm has been calculated for normal data alongside 95% confidence intervals (CIs), otherwise the Mann-Whitney U Test (indicated by **) has been used.  Where 
sensitivity to change is suggested by the CI, the MD between the FB and ONS arms has then been calculated (final column).  
 
Table 32 shows the intervention effects on physical outcome measures and nutrient intake by T2 (see Appendix 23 for 
absolute data at 3-months and at 6-months).  There remained a suggested difference in the change in energy intake between each 
of the dietetic-led intervention arms (net increase) and the SC arm (net decrease) from baseline to 6-months (T2). As at T1, this 
was not observed when the 2 dietetic-led intervention arms were compared. The mean change in kcal from baseline to 6-months 
was less than the added intervention for both of the dietetic-led intervention arms, suggesting that not all residents were compliant 
with the interventions (Table 23) and some may have reduced their intake of other foods and drinks (Table 24).  
The mean change in weight and in BMI over the full 6-month intervention was negative in the SC arm, compared with 
positive change in each of the dietetic-led intervention arms. However, the 95% CI crossed zero for each comparison, which 
suggests these outcomes were less sensitive to change at T2 compared to T1. 
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Table 32: Intervention effects on anthropometric indicators and nutrient intake from baseline to 6-months (n = 63) 
Outcome SC (n=19) FB (n=23) ONS (n=21) SC vs. FB SC vs. ONS FB vs. ONS 
   Mean 
Difference 
(MD) 
 [95% CI] Mean 
Difference 
(MD) 
 [95% CI] Mean 
Difference 
(MD) 
 [95% CI] 
Weight 
change 
(kg) 
Weighed 
(n=19) 
 
-0.57 (3.5) 
Weighed 
(n=23) 
 
0.87 (3.4) 
Weighed 
(n=21) 
 
0.84 (2.5) 
 
-1.4 
 
 [-3.6, 0.73] -1.4 
 
 [-3.3, 0.51]   
BMI 
change  
(kg/m
2
) 
n=19 
 
-0.16 (1.3) 
n=23 
 
0.33 (1.3) 
n=21 
 
0.34 (1.1) 
-0.49 
 
 [-1.3, 0.35] -0.50 
 
 [-1.3, 0.27]   
MAC 
change 
(cm) 
Measured 
(n=13) 
 
-0.96 (1.6) 
Measured 
(n=19) 
 
-0.29 (1.2) 
 
Measured 
(n=18) 
 
-0.14 (2.1) 
 
-0.67 
 
 [-1.68, 0.34] -0.82 
 
 [-2.2, 0.59]   
TSF 
change 
(mm) 
Measured 
(n=11) 
 
0.68 (2.6) 
 
Measured 
(n=16) 
 
0.66 (2.9) 
 
Measured 
(n=13) 
 
1.65 (4.0) 
 
0.03 
 
 [-2.2, 2.26] -0.97 
 
 [-3.8, 1.86]   
MAMC 
change 
n=11 
 
-1.08 (1.1) 
n=15 
 
-0.40 (1.1) 
 
n=14 
 
-0.29 (1.5) 
 
-0.68 
 
 [-1.58, 0.22] -0.71 
 
 [-1.90, 0.33]   
HgD 
change 
(kg) 
Measured 
(n=6) 
 
1.8 (2.2) 
Measured 
(n=11) 
 
-0.42 (2.6) 
 
Measured 
(n=6) 
 
-0.35 (2.1) 
 
2.2 
 
 [-0.50, 4.9] 2.2 
 
 [-0.61, 4.9]   
Change in 
energy 
Available 
(n=17) 
Available 
(n=23) 
Available 
(n=21) 
-255 
 
 [-401, -109] -400 
 
[-577, -223] -145 
 
 [-319,29.1] 
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intake 
(kcal) 
 
-50.9 (183) 
 
204 (251) 
 
349 (319) 
Change in 
protein 
intake (g) 
Available 
(n=17) 
 
1.0 (-3.5 -4.5)
* 
 
Available 
(n=23) 
 
3.0 (-10 - 6)
* 
 
Available 
(n=21) 
 
9.0 (2 - 26.5)
* 
 
 Mann-
Whitney U = 
175** 
 
Mann-
Whitney U = 
68.5** 
  
Change in 
fluid 
intake (ml) 
Available 
(n=17) 
 
120 (223) 
 
Available 
(n=23) 
 
199 (210) 
 
Available 
(n=21) 
 
224 (196) 
 
-79 
 
 [-219, 60.9] -104 
 
 [-242, 34.5]   
MD= Mean Difference; SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements;  BMI= Body Mass Index; MAC= Mid Upper Arm Circumference; TSF= Tricep Skinfold 
Thickness; MAMC= Mid Arm Muscle Circumference; HgD= Handgrip Dynamometer 
 
Normal data is presented as Mean change (Standard Deviation), otherwise is Median change (Interquartile Range) (indicated by *).  The mean difference (MD) between each dietetic-led intervention 
arm (FB and ONS) and the SC arm has been calculated for normal data alongside 95% confidence intervals (CIs), otherwise the Mann-Whitney U Test (indicated by **) has been used.  Where 
sensitivity to change is suggested by the CI, the MD between the FB and ONS arms has then been calculated (final column).  
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4.7 Assessing feasibility and acceptability 
Table 33: Assessment of feasibility and acceptability criteria 
Primary 
objectives 
Success criteria Met or not met 
1. Recruitment of care 
homes:  
 
Recruitment target of 6 met in the time 
available (3 months).  
Met 
6 care homes recruited within 3 
months 
2. Resident eligibility 
criteria and recruitment 
 
Favourable difference in number at risk of 
malnutrition and number that were deemed 
eligible (≤20% difference) 
Estimated resident recruitment target of n≥50 
met (Section 3.6) 
Met 
84.5% of those at risk of 
malnutrition were eligible for 
the intervention 
93 residents recruited 
3. Retention of care 
homes and residents 
 
Retention of 100% for care home sites  
Retention of ≥65% for residents at 6-months 
follow up, accounting for expected high 
mortality (Shah et al, 2012) and attrition rate 
(Manders et al., 2009; Parsons et al., 2011; 
Leslie et al, 2012). 
Met 
100% care homes retained 
68% of residents retained at 6-
months 
4. Intervention 
acceptability to 
residents and staff 
 
Intervention change of ≤10% for each trial arm 
Given that the clinical benefits of ONS 
(unknown for food-based) are seen with 1-3 
servings (300-900kcal) daily (NICE, 2006; 
Stratton and Elia, 2007) :  
o - ≥80% of residents to be compliant with ≥50% 
dietetic-led intervention dose (≥300-450kcal) 
o   
o  
o - ≥60% of residents to be compliant with ≥75% 
of the dietetic-led intervention dose (≥450-
600kcal) 
 
 
≥85% staff adherence to intervention schedule 
Met 
Intervention change of 7.4% for 
SC arm, 4.3% for ONS arm and 
0% for FB arm 
 
 
86% of residents compliant with 
≥50% of dietetic-led 
intervention dose at T1 and T2 
 
Resident compliance with 
≥75% of the dietetic-led 
intervention dose at T1 and T2: 
FB: 78% and 70%; ONS: 67% 
and 63% 
 
Staff adherence: 100% for FB 
at T1 and T2. 100% for ONS at 
T1 and 95% at T2 
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5. Feasibility and 
acceptability of the 
outcomes piloted 
 
Data completeness of ≥ 80% (see section 
3.5.3) 
Reported and recorded values considered 
complete. Unknown and blank values (due to 
lack of recording, resident refusal, inability to 
measure) considered missing values. 
 
Met for 
Weight, BMI, MAC, Energy, 
protein, fluid intake (>80% data 
completeness) 
Not met for 
HgD and TSF (completeness of 
54% and 78% respectively) 
SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements; BMI= Body Mass Index; MAC= Mid Upper Arm 
Circumference; TSF= Tricep Skinfold Thickness; HgD= Handgrip Dynamometer; T1= Baseline- 3months; T2= 3months- 6 
months 
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CHAPTER FIVE: DISCUSSION 
This chapter reviews the key findings of the trial, in terms of the feasibility and 
acceptability objectives and considers how these may inform future clinical practice and 
a definitive trial in the care home setting. 
5.1 Recruitment and retention 
 
5.1.1 Recruitment of care homes and participating residents (Primary 
objectives 1 and 2) 
All 6 care homes provided written consent and remained in the trial until 
completion. Prior to trial commencement, the primary researcher had established good 
working relationships with the care home managers and staff, within a clinical role. This 
existing rapport may have been central to successful recruitment and in enabling 
specific roles to be allocated to staff during the trial process. The importance of taking a 
personal approach when seeking consent from care home managers has been 
demonstrated within previous research in this setting (Zermansky, 2007; Luff et al., 
2011).  In a definitive trial, it may be necessary to build-in time for researcher visits to 
potential care homes, to establish trust and good communication prior to starting 
recruitment.  
‘MUST’ screening across the 6 care homes, identified 110 residents (39%) at 
risk of malnutrition, a similar percentage to that reported within another care home 
nutritional intervention trial conducted in Hampshire (37%) (Parsons et al., 2011). 
84.5% of those at risk met the eligibility criteria to enter the trial, enabling the 
recruitment target to be met (Table 33) and supporting the case for a definitive trial in 
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this setting. A large proportion (75%) of the eligible population presented with a primary 
diagnosis of dementia. An ONS intervention RCT conducted in German Nursing 
homes, which also included residents with cognitive impairment, reported a comparable 
percentage (71.4%) (Stange et al., 2013). The decision was made to include residents 
with dementia, in order to assess feasibility and acceptability of the trial design with a 
representative care home population (Gillette-Guyonnet et al., 2007; Johansson et al., 
2009; Wirth et al., 2011).  
Assessment of resident characteristics at baseline, highlighted imbalances 
between the intervention arms and indicates a need to recruit a large number of care 
homes within a definitive trial (secondary objective 5), to increase the likelihood of 
producing balance across cluster-level covariates. The minimum number of clusters 
recommended per arm to ensure statistical validity, is at least 4 (Campbell et al., 2012). 
With fewer units per arm, parametric tests may be unreliable and it becomes 
impossible to achieve statistical significance at p<0.05 using a non-parametric test 
(Donner and Klar, 1994). 
5.1.2 Retention of participating residents (Primary objective 3) 
Despite the fragility of the participating population, it was possible to complete 
follow-up on 68% of residents, achieving the retention target at 6-months (Table 33). 
Mortality was the primary reason for residents leaving the trial (23, from 93 in six-
months, 25%) and appeared to be associated with ‘MUST’ risk category (17, from 23 
were high risk, 74%), a relationship demonstrated previously in the acute setting 
(Stratton et al., 2006). Mortality was expected to be high, on consideration of other care 
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home nutritional intervention trials (17%, in 3-months (Leslie et al., 2012; Stange et al., 
2013)) and a cohort study describing 1 year mortality in UK care home residents (26% 
(Shah et al., 2012)). The attrition data from this feasibility trial could be used to estimate 
expected mortality and loss to follow-up in a definitive trial, informing the sample size 
calculation (secondary objective 5) and preventing statistical validity being 
compromised (Whitley and Ball, 2002). 
Of the 23 residents that passed away, 20 (87%) had died by month-3, 
suggesting that at least a proportion may have been nearing end-of-life, at recruitment. 
Being on an end-of-life care pathway was defined as an exclusion criteria, however it is 
acknowledged that a significant proportion of care home residents are either palliative 
or have reached an end-of-life stage, which can sometimes last for many months. The 
restrictions imposed by the approving REC required care home staff to assess resident 
eligibility. Those responsible may have found it challenging to distinguish between 
residents that may benefit from nutritional intervention and those that were end-stage 
palliative. In clinical practice, when a resident is referred following ‘MUST’ screening, 
the dietitian undertakes a comprehensive nutritional assessment prior to the initiation of 
nutrition support, which includes assessment of medical and surgical history.  In a 
definitive trial, not subject to the same ethical restrictions, dietetic assessment using a 
validated method, such as, The Subjective Global Assessment (SGA) (Detsky et al., 
1987) could be considered following ‘MUST’ screening to identify where malnutrition is 
an indication of end-stage disease, as opposed to an indication of inadequate 
nutritional intake that may respond to intervention.  
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The highest mortality rate was observed within the 1 care home providing solely 
nursing care. This is perhaps reflective of the greater severity of condition and level of 
dependency of the nursing residents in the trial. The last large scale study investigating 
survival rates in UK care homes was commissioned by BUPA, 1 of the UK’s largest 
care home providers (Forder and Fernandez, 2011). Analysis of a large sample 
(>10,000) suggested that survival was 25% shorter for residents in nursing beds, 
compared to those in residential beds. This again highlights the need to sample a large 
number of care homes within a definitive trial (secondary objective 5), to achieve a 
representative population of care home types. 
 
5.2 Acceptability of the interventions (Primary objective 4) 
 
5.2.1 Acceptability to residents 
In assessing intervention acceptability to residents; compliance, crossover and 
intervention-related adverse events were considered. The feasibility success criteria for 
compliance were met, with over 60% of the residents assigned to FB and to ONS 
compliant with 450-600kcal/day and over 80% compliant with at least 300-450kcal/day 
(Table 33). Compliance with FB was higher than ONS at 3- and 6-months, perhaps due 
to the greater variety and flexibility offered by this intervention.   
A systematic review conducted in 2012, identified 46 studies of ONS intervention 
(9 in the care home setting), which included compliance data. The review reported 
mean compliance of 78% (37%-100%) and mean intake of 433kcal/day. Greater 
compliance was noted with reduced volume, energy-dense ONS (1.5-2kcal/ml) and 
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when a variety of flavours was offered (Hubbard et al., 2012), both of which are 
reported in clinical practice. In this feasibility trial, 3 nutritionally equivalent ONS were 
used, 2 of which were 1.5kcal/ml varieties. The ONS were supplied free of charge by 2 
medical nutrition companies and the bottle size and flavours delivered were dictated by 
availability. In a fully-funded definitive trial, ONS compliance may be improved by 
specifying use of the 1.5kcal/ml ONS bottles and by offering residents a choice of 
flavours.  
The FB options included both snacks and drinks and could be adjusted at the 3-
month review to take account of any change in preferences.  There is considerably less 
in the literature on the compliance to FB intervention, but the information available 
suggests compliance is generally good. Two trials included in the systematic review 
(Chapter 2) reported mean compliance of 99% (380kcal) (Beck et al., 2002) and 98.5% 
(Kwok et al., 2001) respectively. Further qualitative work being undertaken aims to 
explore the influence of resident and care staff attitudes to FB and ONS intervention, 
on compliance.  
Only 3 residents were required to change interventions during the trial. Two 
residents allocated to SC experienced a decline in their nutritional status, which 
necessitated a move onto dietetic-led intervention. Consumption of ONS was 
reportedly found to affect the blood sugar control of the third resident, who was 
subsequently moved onto FB intervention. Three adverse events were recorded, 2 of 
which, were associated with a decline in nutritional status. Both residents were 
assessed as being at risk of refeeding syndrome (Section 3.4.4.2) on the basis of low 
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BMI (Table 14). National guidelines advise staged hypocaloric nutritional support and 
electrolyte supplementation for those at risk (NICE, 2006). However, not all individuals 
that meet the criteria develop symptoms during nutritional repletion (Zeki et al., 2011) 
and guideline adherence may delay adequate nutrition. In this trial, the 2 residents had 
been eating reasonably well, but were continuing to lose weight, possibly due to 
undiagnosed disease. Although the guidelines were adhered to, further research is 
required in this setting, to determine whether individuals are still at risk of the 
physiological consequences of refeeding without having undergone a period of 
starvation. The small percentage of intervention changes and adverse events overall 
(<10%), suggests that all 3 interventions were largely acceptable to residents and to 
staff monitoring nutritional status and could therefore be considered within a definitive 
trial. 
5.2.2 Staff acceptability of the intervention schedule 
 Staff adherence with the intervention schedules was found to be high, with 100% 
of residents receiving the interventions during the first 3-months and 100% of residents 
allocated to FB and 95% of residents allocated to ONS receiving the interventions 
during the second 3-months. The primary researcher was able to find documented 
evidence of intervention intake on FRCs and drugs charts. By contrast, studies within 
the published literature that have relied on care home staff to provide ONS have found 
that the intervention is not provided in accordance with instructions and documentation 
of consumption is poor (Johnson et al., 1993; Kayser-Jones et al., 1998; Simmons and 
Patel, 2006). It is possible that the established relationships with the participating care 
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homes improved the willingness of staff to adhere to the trial protocol. This topic will be 
further explored with staff during the qualitative phase.  
5.3 Acceptability and feasibility of the outcome measures and 
data collection methods (Primary objective 5) 
 
5.3.1 Care home staff measured 
 The available literature suggests that recording of nutritional care processes in 
the care home setting lacks uniformity and accuracy, particularly when compared to 
independent assessments by researchers using standardised protocols (Zermansky, 
2007; Simmons et al., 2009). However, in order to ensure clinical applicability, it was 
decided that as much data as possible should be collected using methods consistent 
with usual procedures (Maas et al., 2002). The following assessments were made by 
staff and collected retrospectively by the primary researcher. 
5.3.1.1 ‘MUST’ Screening 
National guidance recommends malnutrition screening on admission to care 
homes, followed by ongoing monitoring according to risk category (NICE, 2006). The 
literature suggests that recording and accuracy of screening is variable, compromising 
care for those at risk (Woodcock et al., 2011). The high level of accuracy in this trial 
(section 4.4), suggests that the staff are competent in undertaking screening, which 
may be attributed to the ‘MUST’ training provided by the dietetic service prior to trial 
commencement. Self-perceived confidence and competence with screening will be 
further explored with staff during the qualitative phase. Other dietetic-led projects have 
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demonstrated improvements in ‘MUST’ documentation and accuracy following tailored 
staff training (Cawood et al., 2008; Woodcock et al., 2011), suggesting that training 
would need to be a requirement for all care homes recruited to a definitive trial.  
5.3.1.2 Height, weight and BMI 
 Height was collected from ‘MUST’ records for 100% of residents at baseline. 
The measurement techniques used had been clearly documented. The majority had 
been measured using a freestanding stadiometer (66%), but where this was not 
possible, estimation by ulna length was the most frequently used alternative measure 
(31%). Surrogate methods of height estimation are required for those who are 
bedridden, confined to a wheelchair, or unable to stand straight (Hickson and Frost, 
2003). A recent study concluded that ulna length appears to be the most appropriate 
surrogate measure for height in females over 65 years and for those unable to self-
report (Reidlinger et al., 2014). Staff training on the measurement of ulna length had 
been provided within all participating homes. The documented use of the technique 
highlights the importance of training on nutritional assessment prior to research or 
within clinical practice, to increase the efficiency and completeness of documentation.  
 Measured body weight and calculated BMI were collected from ‘MUST’ 
documentation at the 3 data collection intervals. Just 1 resident had not been weighed 
at baseline, following a decline in clinical condition and a decision by staff that weighing 
would be an unnecessary burden. It was possible to retrieve the required information 
for the remaining 92 residents at baseline and 100% of the residents remaining at 3- 
and 6-months. Inconsistencies in the weighing equipment used can increase the risk of 
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errors in malnutrition risk assessment and subsequently impact on patient care 
(Department of Health, 2010; Clarkson, 2012). Throughout the trial, only one resident 
was weighed using different types of scale, justified by the staff, in terms of reduced 
mobility at the 3-month interval. The success criteria for weight and BMI were achieved 
(Table 33), indicating that assessment is acceptable to the majority of residents and is 
feasible for staff to undertake.  
5.3.1.3 Nutritional Intake  
 Studies that have evaluated the accuracy of staff documentation of dietary 
intake have shown it to be erroneous when compared to independent assessments 
made by research staff (Simmons and Reuben, 2000; Castellanos and Andrews, 
2002). In this trial, the primary researcher did not have capacity to observe resident 
food and fluid intake and in a definitive trial, intake assessment by research staff would 
risk losing an important element of testing interventions in the ‘real world’ setting. The 
majority of FRCs and FCs were available and complete, meeting the success criteria 
for data completeness (Table 33). However, limitations relating to the usefulness of the 
data were observed (section 4.5.1.2).   
The most widely used method of estimating resident food intake was used in all 
6 homes; the assessment of mealtime servings as a whole, following which a 
proportion consumed is assigned (Kayser-Jones et al., 1997). A study, which compared 
this method with weighed food intake, discovered that staff were correct less than 45% 
of the time (Castellanos and Andrews, 2002). Improvements in the accuracy of 
recording could be made through greater emphasis on recording exactly what food was 
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eaten, or by taking photographs of the plate before and after mealtimes (Heath and 
Sturdy, 2009). A validation study, which compared three methods of assessing intake 
(Simmons and Reuben, 2000), found the photographic method to be reliable and time-
efficient and a possible solution for increasing the accuracy of estimation. In a definitive 
trial, a member of staff could be assigned to photograph each resident’s plate before 
and after a meal, enabling comparisons to be made in a more accurate manner that 
does not rely on staff memory. In routine care, photographs could be used to estimate 
nutritional intake and to form important evidence during a CQC inspection. 
5.3.2 Measured by the primary researcher 
 
5.3.2.1 Mid-Upper arm circumference (MAC) 
MAC is included in the ‘MUST’ as an alternative measure for BMI (BAPEN, 
2003) and because of its relatively simplistic assessment, has been deemed suitable 
for use in the care home setting (Wijnhoven et al., 2013). The MAC assessment was 
found to be acceptable to the majority of residents (88%), enabling the success criteria 
to be met (Table 33). However if MAC is to be used as a determinant of undernutrition 
within a definitive trial, more than 1 researcher may become responsible for the 
assessments. A recent cross-sectional care home study compared 2 observers 
independently assessing MAC on 3 occasions over an 8-day period.  The study found 
no systematic differences between observers and concluded that MAC is acceptable 
for clinical use in a care home setting (Wijnhoven et al., 2013). Training and use of a 
standardised protocol is however essential to ensure accurate and appropriate 
measurements are undertaken. 
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5.3.2.2 Tricep Skinfold thickness (TSF) 
An average of 76% of residents in the trial had TSF measured, narrowly missing 
the success criteria for data completeness (Table 33).  A number of challenges were 
encountered during measuring, including difficulties encouraging residents to be still, 
inappropriate positioning of bedridden residents and anxiety in relation to the visual 
perception of the calliper. This experience is similar to that described in a feasibility trial 
conducted with persons with severe or profound intellectual and sensory disabilities 
(SIMD) (Waninge et al., 2009) and suggests that it may prove challenging to accurately 
perform the measurement in a population with fluctuating capacity and challenging 
behaviours. Other studies have demonstrated the successful use of TSF assessment in 
care home residents with dementia (Wouters-Wesseling et al., 2006; Aukner et al., 
2013), however, the study by Aukner et al (2013), excluded residents that exhibited 
aggressive and volatile behaviour, on the basis that the measurements would not be 
possible. No such exclusion criteria were applied in this trial, to enable assessment of 
feasibility in the general care home population.  
Primary problems associated with the TSF measurement include measurement 
error due to poor technique and substantial differences when measurements are made 
on the same individual by different observers (Ulijaszek and Kerr, 1999). The 
challenges encountered within this trial suggest that these sources of error are likely to 
be emphasised within the care home population, limiting potential use within a definitive 
trial.   
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5.3.2.3 Handgrip strength 
 Handgrip strength is the technique most often recommended for measurement 
of muscle strength and assessment of muscle function in clinical practice (Cruz-Jentoft 
et al., 2010). Only 54% of residents in this trial were able to undertake the test and 
therefore the success criteria for data completeness was not met (Table 33). Cognitive 
impairments made it difficult for residents to understand and follow the instructions and 
physical limitations meant some residents were unable to attempt the measure. This is 
a similar outcome to that noted within other trials conducted in the care home setting 
where no residents were excluded on the basis of cognitive or physical impairment. In a 
cluster randomised feasibility trial investigating the efficacy of a rehabilitation 
intervention in UK care home residents, percentage-missing values for handgrip 
strength ranged from 36 to 53% (Hoppitt et al., 2010). Similarly, Stange et al (2013) 
were unable to measure handgrip strength in 38% of the residents recruited to their 
nutritional intervention trial. These findings suggest that handgrip strength, in its current 
form does not enable assessment of muscle strength in the general care home 
population. The observed lack of acceptability suggests there is a requirement for new 
measurement outcomes for use in a UK care home setting, for elderly with functional 
impairments.  
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5.4 Participant reported outcome measures (PROMs) (Primary 
objective 5, Secondary objective 2) 
  There is a lack of literature investigating the relationship between nutrition 
support and PROMs in the care home population (Stange et al., 2013). In the absence 
of any nutrition specific measures of quality of life or health state, this trial assessed the 
feasibility and acceptability of existing generic tools (EQ5D and COOP), alongside 
piloting of a VAS to assess appetite and dietary satisfaction. Adults lacking capacity 
could not be included (Section 3.2) on the basis that their involvement would not benefit 
other people with the same or similar impairing condition (Mental Capacity Act, 2005). 
Only 17% of the residents that entered the trial had capacity and of those, 11 (65%) 
consented to participate. At each data collection interval, all questionnaires were 
provided by staff to the participating residents and all of the tools were returned, 
completed, to the primary researcher. The residents were able to understand the tools, 
but all had poor hearing and vision, together with poor dexterity, which led to a 
requirement for staff to read out the questions and mark on responses. The low 
numbers recruited, significantly reduced the data available to assess feasibility and 
acceptability and as the tools were not evaluated with those lacking capacity, the 
proportion of residents that may be able to respond in a definitive trial remains 
unknown.  
The inclusion of PROMs is important to assess the impact of interventions on 
resident-reported outcomes and to determine Quality Adjusted Life years (QALYs), 
which form an important part of the economic evaluation of interventions (Table 15). 
Some care home studies have used proxy respondent, by a family member or 
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caregiver familiar with the status of the resident (Stange et al., 2013), however 
problems may arise if caregivers report on different aspects than residents and the 
perspectives become complementary rather than interchangeable (Arons et al., 2013). 
At the risk of overestimating participant-centred outcome measures for the resident 
cohort, because the most severely cognitively impaired cannot respond, data from 
proxy respondents could be collected and analysed separately within a definitive trial. 
As it is unlikely that all residents would be able to complete the tools, PROMs would not 
be considered as primary outcome measures within a definitive trial. The perceived 
importance and burden of taking part in PROMs, alongside the opinions of staff and 
residents in relation to whether others could have taken part will be explored within the 
qualitative phase. 
 
5.5 Piloting of a Healthcare resource usage (HCRU) 
questionnaire (Secondary objective 1 and 3)  
5.5.1 Acceptability, feasibility and usefulness 
 Few studies have analysed the large-scale economic consequences of 
malnutrition, but the cost is estimated to be high; £5 billion for direct health care (Guest 
et al., 2011; Wilson, 2013) and £13 billion for associated health and social care (Elia 
and Russell, 2009). The extent by which nutritional interventions can improve outcomes 
in a cost effective manner is currently unknown. In the absence of a standardised 
HCRU questionnaire for malnutrition, the questionnaire piloted in this trial was designed 
to collect information on healthcare professional visits and hospital admissions. Care 
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home staff completed 100% of the questionnaires at 3- and 6-months, obtaining all of 
the required data from resident care records and GP visit logs.  
The greatest limitation was that the type of care provided and the baseline 
provision of healthcare resources (Table 17) influenced the number of outside 
healthcare professional visits. Residents requiring personal care only, had their nursing 
needs met by the NHS through district nurse and GP visits. If, on the other hand, a 
resident required full-time nursing care and was placed within a nursing or dual care 
home, the nursing staff within the home would meet some or all of these needs. The 
questionnaire was able to collect useful data on hospital admissions, visits by 
consultants and professional visits not delivered in-house (dietitian, speech and 
language therapist), but the data on district nurse and GP visits was likely influenced by 
the type of care being funded.  To enable the questionnaire to be used within a 
definitive trial, to inform an economic evaluation of the interventions (Table 15), the 
usefulness of data on GP visits could be improved by providing thorough staff training 
regarding the need to document GP call-outs only. The limitations with the collection of 
data on nursing visits could possibly be addressed by focusing instead on the reasons 
for residents requiring nursing care (5.5.2.3). 
5.5.2 Reasons for healthcare resource usage 
The majority of hospital admissions were due to falls, a high proportion of GP 
call-outs were for assessment or treatment of suspected infections and the majority of 
district nurse visits were related to pressure sore care. Although previous research has 
suggested that poor nutritional status is associated with these outcomes (Table 34), 
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neither the care home staff nor the GP attributed any admissions or visits to a 
resident’s malnourished status, perhaps indicating that awareness of the wide-ranging 
consequences of malnutrition (BAPEN, 2009) is limited. It is proposed that the 
incidence of falls, infections and pressure sores could be collected as independent 
secondary outcome measures within a definitive trial. The average cost of treating an 
infection (chest or urinary tract) or a pressure sore could be used alongside the 
frequency of occurrence to inform the economic evaluation of the interventions, 
reducing the reliance on GP or district nurse visit data. Further piloting would be 
required initially to establish the accessibility and reliability of the necessary data in the 
care home setting. 
Table 34: The primary reasons for HCRU in this trial and their possible 
association with nutritional status 
 
Reason for HCRU identified 
 
Association with PEM 
Falls  
 PEM leads to reduced muscle mass and strength (Chevalier 
et al., 2008; Smoliner et al., 2008; Suzana et al., 2013), both 
of which are identified risk factors for falls (Kim et al., 2010; 
Johnson, 2003; Neyens et al., 2013). 
Infections (Chest and Urinary 
Tract) 
 
 Malnutrition is a major factor in the age-related reduction of 
the immune defence system (Strausbaugh, 2001; Koch et al., 
2009) referred to as immunosenescence (Fulop et al., 2005). 
 
 Previous research has shown that a 10% loss of lean tissue, 
even in previously healthy older adults, impairs immunity and 
increases infection risk (Broadwin et al, 2001; Landers et al, 
2001). 
Pressure sores  
 PEM has been shown to increase the risk of pressure ulcer 
development (Thomas, 2001; Mathus-Vliegen, 2004) and 
impair healing and recovery (Williams and Barbul, 2003; 
Harris and Fraser, 2004). 
PEM= Protein Energy Malnutrition; HCRU= Healthcare Resource Usage 
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5.6 Change in outcomes (Secondary objective 4) 
 Whilst the feasibility and acceptability of outcome measures was a primary 
objective for the trial, sensitivity to change was also assessed, by comparing mean 
change in outcomes between the intervention arms at 3- and 6-months. Due to the lack 
of data for handgrip strength and PROMs, sensitivity to change in those outcome 
measures will not be discussed further. 
5.6.1 Energy intake 
 For estimated energy (kcal) intake, positive changes favouring the dietetic-led 
intervention arms were observed at 3- and 6-months, but there was no difference noted 
between the FB and ONS intervention arms. Increase in total energy intake has been 
demonstrated in a number of care home malnutrition intervention trials using both FB 
(Turic et al., 1998; Odlund et al., 2003; Iuliano et al., 2013) and ONS (Turic et al., 1998; 
Manders et al., 2009; Parsons et al., 2011) intervention, which suggests that residents 
increase their overall energy intake when specific calorie-dense interventions are 
provided to them on a daily basis.  
Improved nutritional intake is understood to be a key component in the causal 
pathway leading to improved clinical outcomes. Change in energy and protein intake 
should be included within a definitive trial as secondary outcome measures, to examine 
this relationship further. More accurate means of reporting intake (section 5.3.1.3) 
would enable use alongside compliance data, to determine whether habitual intake 
changes to compensate for the introduction of an intervention. Several care home ONS 
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intervention studies observed a reduction in energy intake from ‘normal’ food, when 
ONS was introduced into the diet (Fiatarone et al., 2000; Manders et al., 2009), but no 
comparison has been made with FB intervention. This evaluation may have important 
implications for clinical practice. 
5.6.2 Weight and BMI 
 For recorded weight and BMI, positive changes favouring the dietetic-led 
interventions were observed when each intervention was compared with SC at 3- and 
6-months. Again, there was no observed difference between the FB and ONS arms. An 
increase in weight and BMI has been reported in a number of care home malnutrition 
intervention trials using both FB (Kwok, 2001; Leslie et al., 2012) and ONS (Lauque et 
al., 2000; Wouters-Wesseling et al., 2002; Manders et al., 2009; Lee et al., 2013; 
Stange et al., 2013) intervention. Whilst such findings suggest these outcomes are 
sensitive to positive changes in dietary intake, the composition of weight gain is 
unknown. In terms of delivering functional benefit, a gain of fat mass will not result in 
improved muscle strength (Milne et al., 2009) and given that assessment was 
undertaken by care home staff, confounding factors such as oedema or ascites 
(Campillo et al., 2002; McKinlay, 2004)  may not have been accounted for. The 
limitations associated with weight and BMI as outcomes of clinical relevance has led to 
calls for more focus on improvement in functional status or quality of life as primary trial 
outcomes. However, weight and BMI continue to be used in clinical practice as the 
primary outcome measures for nutrition support interventions.  
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The effect of nutrition support on weight gain is unlikely to be universal, given 
the diverse aetiology of unintentional weight loss. Sarcopenia, associated with loss of 
strength and increased frailty, is believed to occur regardless of energy balance 
(Rolland et al., 2011a) and evidence to date suggests the most effective intervention is 
a combination of adequate nutrition and resistance training (Rolland et al., 2011b). As 
there are no screening tools for the identification of sarcopenia, diagnosis is usually 
made through clinical judgement, adding weight to the case for dietetic assessment 
following ‘MUST’ screening in a definitive trial. A significant proportion of care home 
residents may be exhibiting signs of sarcopenia. Awareness may enable sub-group 
analysis and exploration of the impact of conventional nutritional support on PEM with 
or without age-related nutritional decline. 
5.6.3 MAC, TSF and MAMC 
 Negative change was observed for MAC and MAMC over the 6-month 
intervention in all 3 arms, whilst positive change was observed for TSF.  Whilst this 
suggests that weight gain may have been primarily due to an increase in fat mass, 
observed trends should not be overemphasised due to the feasibility nature of the trial 
and the lack of complete data for these outcomes. Significant difference in MAC 
change was demonstrated in 2 of the ONS intervention trials (Lee et al., 2013; Stange 
et al., 2013) included in the systematic review (Chapter 2). There is evidence to 
suggest that a low MAC is a more feasible and valid determinant of undernutrition in 
older adults than a low BMI (Powell-Tuck and Hennessy, 2003; Wijnhoven et al., 2010), 
as it is not influenced by spinal deformities and is less affected by fluid changes (Harris 
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et al., 2008). In a definitive trial, change in MAC could be included as an outcome 
measure, alongside weight and BMI. It should be noted however, that as for weight, the 
presence of sarcopenia may reduce MAC, irrespective of nutrition support.  
Body composition is important, because of the association between muscle 
mass and, physical function, strength and morbidity. In older adults, low MAMC, a 
measure of arm muscle area, has been shown to have greater association with 
mortality than low BMI (Miller et al., 2002). Unfortunately, determining MAMC requires 
TSF measurement and additional calculation, which can hamper practical 
implementation. A systematic review (Allen et al., 2013), which analysed the impact of 
ONS consumption on skinfold thickness and MAMC in those with long-term cognitive 
impairment, found no overall statistically significant difference between ONS and 
control groups in the 6 reviewed studies. The challenges faced within this feasibility trial 
when attempting to accurately measure TSF, alongside the results of this systematic 
review (Allen et al., 2013), suggests that skinfold measurement, and therefore, also 
MAMC, are not appropriate for monitoring short-term changes in body composition, 
particularly with a population where accurate measurement may be hampered.   
5.7 Data to inform calculation of the Intraclass Correlation 
Coefficient (ICC) for a definitive trial (Secondary objective 5) 
In order to conduct a well-designed definitive trial with the aim of comparing 
efficacy of nutritional interventions, the ICC should be known beforehand to estimate 
required sample size and statistical power to reduce the chances of type II error 
(Murray et al., 2004).The ICC can be selected from previous work with a similar 
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population, it can be calculated from preliminary trial data and/or it can be estimated 
from the literature. Whilst the data collected in this trial could be used to inform the 
calculation, further literature searching and piloting is required first, to identify the most 
appropriate primary outcome measure with clinical relevance for an older care home 
population and to estimate the key population parameters needed to calculate sample 
size. The method of calculating the ICC is outlined in Appendix 24. 
5.8 Trial Limitations  
 The care homes recruited into this trial do not necessarily represent the national 
care home population. All 6 had received long-term, regular input from the local dietetic 
team and were enrolled on a rolling program of staff training. The primary researcher 
had an excellent rapport established with the managers and staff, which may have 
made it easier to recruit all of the approached sites, to conduct the trial within the 
required timeframes and to encourage staff to adhere to the protocol. Evaluation of 
feasibility was undertaken in interested and motivated care homes, thus the 
transferability of the findings would be dependent upon tailoring to the local context.  
The restrictions imposed by the approving REC led to limitations within the 
conduct of the trial. The absence of clinical dietetic assessment following ‘MUST’ 
screening, may have resulted in a number of end-stage palliative care home residents 
entering the trial and receiving interventions, which were unlikely to deliver nutritional 
benefit. This lack of expert assessment may have contributed to the high mortality rate 
during the first 3-months of the trial, reducing the observed effectiveness of the 
interventions and increasing the risk of attrition bias. Limitations in the design of the trial 
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also increased the risk of performance and detection bias through a lack of double 
blinding. Whilst the nature of the nutritional interventions under investigation makes it 
impossible to blind the care home staff to treatment allocation, it should be possible in a 
fully-funded definitive trial, for research staff measuring outcomes and collecting data to 
be blinded to the allocated intervention. 
5.9 Implications for future research  
 Qualitative trial designs are particularly needed within care homes, to better 
understand the setting and the opinions and experiences of the residents, relatives and 
staff involved (Maas et al., 2002).  It is likely that the perceived value of nutritional 
interventions by key stakeholders such as managers, care staff, residents, relatives 
and GPs, affects intervention compliance. One study, which used Normalisation 
Process Theory (NPT) to explore facilitators and barriers to the use of nutrition 
guidelines in care homes, reported a number of barriers to implementation, which were 
strongly associated with staff views (Bamford et al., 2012). Beyond the scope of the 
qualitative work being conducted following this trial, further qualitative research may be 
required to explore the nutritional and clinical priorities of those working and residing in 
the care home setting, alongside the perceived value of nutritional interventions. The 
results could be interpreted alongside the feasibility outcomes, to provide an enhanced 
understanding of nutritional care complexities (Cresswell, 2009) within care homes, and 
to further inform the design of a definitive trial and choice of primary outcome measure.
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5.10 Conclusions and summary  
The data presented in this thesis enable several conclusions to be drawn, which 
address the research question and trial objectives. The trial design was feasible to 
undertake within the care home setting. With commitment from staff and management, 
it was possible to obtain consent from 6 care homes and to identify 93 residents who 
were eligible to receive the allocated interventions, meeting the recruitment targets for 
homes and residents. The success criteria for the retention of care homes and 
residents throughout the trial were also met; however resident mortality was high, 
particularly during the initial 3-months. In a definitive trial it is proposed that dietetic 
assessment using a validated method could be used following ‘MUST’ screening, to 
identify where malnutrition is an indication of end-stage disease and intervention may 
not be appropriate.  
The 3 nutritional interventions were considered acceptable to care home 
residents and staff, on the basis of low crossover rates, satisfaction of the success 
criteria for resident compliance and, high staff adherence to the intervention schedules. 
The established relationships between the primary researcher and each of the care 
home sites may have improved the willingness of staff to follow the trial protocol. Whilst 
this will be explored further during the qualitative phase, it is likely that researcher visits 
to establish trust and to deliver training will need to be accounted for within the 
timeframe of a definitive trial, to aid with successful recruitment of care homes and 
residents and to culture good relationships with staff teams. 
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Of the outcome measures piloted, weight, BMI, MAC and nutritional intake were 
found to be feasible and acceptable measurements to undertake in this population, 
meeting the success criteria for data completeness and consideration for use within a 
definitive trial. Although the trial was not powered to examine intervention outcomes, 
the direction of effect for weight, BMI and energy intake was in favour of the FB and 
ONS interventions, highlighting sensitivity to change for these outcome measures. In 
the care home setting, weight and BMI are frequently used as outcome measures of 
nutrition support within routine practice. This trial has demonstrated that a definitive trial 
comparing the efficacy of FB, ONS and SC interventions in increasing weight and BMI 
in malnourished care home residents is both feasible and acceptable to undertake. 
Such a trial could provide useful information as to whether continued NHS expenditure 
on prescribed ONS is warranted in this setting.  
Whilst the design was feasible to undertake, this trial has highlighted a lack of 
clinically relevant outcome measures, appropriate to this setting, for both research and 
clinical practice. Many older adults consider functional independence to be more 
important than the prevention of disease (Warburton et al., 2001; Paterson et al., 
2004), which supports the use of a measure of functional effects as a primary outcome 
for a future malnutrition intervention trial. This trial identified a need for a more simple 
measure of functional status, which considers the impediments of functional tests in the 
care home population. Development of such a test or measure may be a goal for future 
research, to enable nutrition support interventions to be compared within the care home 
setting using primary outcomes of greater clinical and patient relevance. 
WORD COUNT: 15,043 (excluding appendices, tables, figure legends, references and 
footnotes) 
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Care Home         
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TRIAL INVITATION  
 
A cluster randomised feasibility study evaluating current dietary interventions in the 
treatment of malnutrition in care home-dwelling adults 
Dear (insert name of Manager) 
We are carrying out a pilot study, managed by the Heart of England NHS Foundation Trust, to assess 
the feasibility and acceptability of running a full-scale study, comparing and evaluating three existing 
dietary interventions for malnutrition, within the care home setting. 
Further to the delivery of nutrition support training and the establishment of nutrition focus groups 
within your care home, we would like to invite you to take part in this pilot malnutrition research.  
  
There is limited evidence to guide the appropriate use of nutritional treatment for malnutrition, 
particularly in the care home setting. Commonly used interventions, include, dietetic-led food-based 
intervention, dietetic-led oral nutritional supplement (ONS) intervention and the standard care home 
diet for malnutrition. It is important that we compare and evaluate the effectiveness of these already 
established and widely used dietary interventions. 
In this pilot, we will assess the feasibility and acceptability of the three dietary plans and the study 
design to both care home residents and staff.  
Each care home that agrees to participate will be allocated at random to either one of the dietetic-led 
intervention arms or will be asked to continue to provide the standard care home dietary intervention 
plan for malnutrition. Residents within each care home will be deemed eligible to receive the dietary 
intervention on the basis that they require it to address malnutrition or risk of malnutrition. They will 
be identified using routine malnutrition (‘MUST’) screening and a review of care records, as per usual, 
standard practice. 
 
Within the care homes allocated to one of the dietetic-led intervention arms, a registered dietitian will 
deliver either the food-based or the ONS intervention, in accordance with local and national nutrition 
support guidelines. Within the care homes allocated to standard care without added dietetic 
intervention, residents with, or at risk of malnutrition will continue to receive a high-energy diet, in line 
with the training already provided by the local dietetic service.  
 
 
Nutritional status, change in anthropometry measures and compliance will be monitored for each 
resident in receipt of a dietary intervention plan, in line with usual, standard practice.  
Additional outcome measures, such as resident rated quality of life, health state and satisfaction with 
the dietary intervention plan will only be collected for those residents that have capacity and have 
consented to provide this additional information. 
APPENDIX 3: 
CARE HOME INVITATION LETTER 
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Outcomes will be assessed at baseline and at 3 and 6 months after entry to the study. All outcome 
measures will be anonymous to the dietitian researcher. 
 
The findings from this feasibility study will be used to inform the development and design of a future 
large-scale trial to compare dietetic-led food-based intervention, dietetic-led ONS intervention and the 
standard care home dietary intervention, in the treatment of malnutrition within care homes. The 
results of this future trial will inform decisions by dietitians, General practitioners, care home providers 
and commissioners, regarding the appropriate use of nutritional treatment for malnutrition in care 
homes.  
 
This study is designed to fit in with routine care home practice as far as possible and to impose 
minimal additional workload.  We enclose a care home information sheet for you, which describes the 
study in further detail. 
If you would you like to take part in this pilot study, would like to learn more about this pilot study or if 
you have any questions, please contact us using the address or telephone number detailed at the top 
of this letter. Alternatively, please complete and return the reply slip enclosed and we will contact you 
to discuss the study further 
 
If you would like to take part in the study, we can arrange a meeting with you to answer any 
questions that you may have  
 
Yours Sincerely 
 
 
 
Ruth Stow 
Nutrition Support Dietitian and Dietitian Researcher 
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Care Home Information Sheet 
Your care home is being invited to take part in a feasibility research study.  
Before you decide whether you would like to participate, it is important that you 
understand why the research is being done and what it involves. Please read the 
following information carefully and discuss it with your staff as appropriate. Ask us if 
there is anything that is not clear or if you would like more information. Take time to 
decide whether you wish to take part.  
 
Thank you for reading this.  
 
What is the purpose of the study?  
 
We want to know how dietetic-led food-based intervention, dietetic-led oral nutritional 
supplement (ONS) intervention and the standard care home dietary intervention 
plan, compare, in improving the outcomes of malnourished care home-dwelling 
adults.  
All three dietary interventions are widely used within the care home setting, but there 
is currently a lack of capacity within the dietetic service to deliver a dietetic-led 
intervention to each resident identified, with, or at risk of malnutrition. It is therefore 
important that the dietetic-led intervention plans and the standard care home dietary 
intervention plans are compared and evaluated. 
 
The care home setting is under-represented within research and therefore, the 
evidence to guide best care practices and improve quality of life is lacking. Currently 
there is no agreement on the best nutritional treatment for malnutrition and there are 
no published clinical trials comparing nutritional treatments of equal nutrient 
composition within a care home population. 
  
We hope to develop a large-scale trial, which will be used to inform decisions by 
dietitians, general practitioners, care home providers and commissioners, regarding 
the most appropriate nutritional treatment for malnutrition in care homes. 
Before this future large trial can take place, we need to ensure that we are able to 
compare and evaluate the three existing dietary interventions, within the care home 
setting.  
This pilot study will help us to assess the feasibility and acceptability of running the 
study on a larger scale and will inform the design of the future trial.  
Why have we been asked?  
 
The study will include six care homes located in Solihull. We are asking you to 
consider taking part, because you provide nutritional care for people with, or at risk 
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of malnutrition and you have already worked closely with the Nutrition Support 
Dietitian in improving screening and care planning practices. 
 
Do we have to take part?  
It is up to you and the staff at the home to decide whether you wish to take part in 
this study. If you do decide to take part, you will be given this information sheet to 
keep and will be asked to sign a care home consent form.  
 
What will happen if we do decide to take part?  
In this case, we do not know which way of providing dietary intervention is best and 
therefore, we need to make comparisons.  
 
The six care homes that agree to take part in the study will each be allocated to one 
of the three existing dietary intervention plans.  
This means that as a care home, you will be allocated at random to either dietetic led 
food-based intervention, dietetic-led ONS intervention or you will be asked to 
continue delivering your standard care home dietary intervention plan for 
malnutrition.  
The allocated dietary intervention will be delivered within the care home for a period 
of 6 months. 
Identification of eligible residents to receive the dietary plan 
All residents with, or at risk of malnutrition, who do not already have a dietetic 
treatment plan in place, but require a dietary intervention to meet their nutritional 
needs, will be considered for receipt of the plan that is allocated to the care home.  
They will be identified, through malnutrition screening and a review of care records, 
as per usual, standard practice, prior to initiation of a diet plan for malnutrition. 
 
The ‘Malnutrition Universal Screening Tool’ (‘MUST’) will be used to identify those at 
risk of malnutrition. You currently use ‘MUST’ within standard practice. We would ask 
that two of your staff are assigned the role of MUST screening within this study. A 
review training session will be delivered by the dietitian to ensure that the staff are 
competent with using the tool. 
Following ‘MUST’ screening your care home staff will consider the suitability of each 
identified resident, for receipt of a dietary plan. There are eligibility criteria that each 
resident must meet, to ensure that it is safe and appropriate for him or her to receive 
a dietary intervention for malnutrition. The staff will be able to discuss these criteria 
on an anonymous basis with the Dietitian researcher as required. 
 
Residents with, or at risk of malnutrition that are eligible to receive the dietary 
intervention, but are lacking the capacity to consent will only be included within those 
aspects of the study that reflect usual, standard practice. Outcomes that are 
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routinely measured within usual monitoring of nutritional status will continue to be 
conducted. This data will be collected, in an anonymised format. 
 
Residents who have capacity to consent, will further be asked to consent individually 
to provide information on quality of life, health state and dietary satisfaction through 
completion of anonymised questionnaires and self-reported scales and charts, and 
to be contacted regarding interviews, following the 6-month dietary plan.  
An information sheet will be provided to those residents that are eligible for 
involvement in this part of the trial. 
 
Baseline assessments 
Once the eligibility of your residents has been determined, baseline assessments will 
need to be undertaken.  
These assessments will include a calculation of average daily energy and protein 
intake (from three consecutive food record charts) and measurement of 
anthropometric indicators. These assessments are conducted within usual, standard 
care and will be repeated at 3 months and 6 months following care home allocation 
to a dietary plan.  
 
After 3 and 6 months of the dietary plan, the assigned care home staff will complete 
a resource usage questionnaire for each resident, answering questions concerning 
their use of health and social care resources. This information can be obtained from 
care records. 
 
Those residents that have capacity and have consented to further participation, will 
be asked to complete 3 brief questionnaires, to measure quality of life (COOP 
Chart), health state (the EQ-5D) and to measure perceived appetite and dietary 
satisfaction (Visual Analogue Scale). These questionnaires will also be repeated at 3 
months and 6 months following allocation to a dietary plan.  
The dietetic-led intervention arms 
If your care home is allocated to receive either food-based or ONS intervention, we 
will ask you to continue to provide eligible residents with a high-energy diet (current 
standard care) and the registered dietitian will put in place an intervention plan, 
which will provide an additional 600kcal of energy and 20-25g protein daily. The 
intervention will be tailored to meet the preferences of each resident.  
The dietitian will visit again at 3 months to review the dietary intervention plan and at 
6 months, when the collection of outcomes will terminate. 
 
If a resident does not tolerate the intervention, the care home staff will be advised to 
return the resident to the standard care home dietary intervention for malnutrition. 
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This is in line with the usual, standard, dietetic service provided to the care home 
residents.   
 
The Standard care arm 
If your care home is allocated to continue to provide the standard dietary intervention 
for malnutrition, we will ask you to continue to provide the eligible residents with a 
high-energy diet plan, in line with local and national guidance for first line nutritional 
therapy for malnutrition. 
If any resident receiving this dietary intervention, suffers a decline in their nutritional 
status, dietetic-led intervention (food-based or ONS) will be introduced after 6 weeks, 
as per local and national best practice guidelines and usual, standard practice. 
 
Interviews and Focus Groups 
Following the 6 months of dietary intervention plans, we will ask to interview some of 
the residents that have capacity, and to hold a focus group with 6-8 staff, to find out 
more about their experiences during the study. Interviews and Focus groups will take 
place with the dietitian.  
 
Residents with capacity have the opportunity to opt out of being considered for the 
interview process on the consent form for participant-reported outcome measures. 
 
If you do not want your staff to take part in the focus group sessions following the 6-
month dietary plan, you have the opportunity to opt out on the consent form provided 
with this information sheet. This will not affect your participation in the other parts of 
the study. 
 
What impact will the study have on staff time? 
The study has been designed to fit in with routine care as far as possible. The study 
duration is for 6 months on an allocated dietary plan. 
 
 It would be useful if you would assign two of your staff to undertake the initial 
screening (MUST) to ensure consistency of screening and to give staff an 
opportunity to choose to take on this role.  
 Weight, BMI and MUST score will be required again by the dietitian at 3 
months and 6 months. This information is collected as part of your usual 
practice and should not require additional workload. 
 Staff will be required to monitor the dietary intake and/or ONS intake of all 
residents within the study. Again this is in line with usual practice concerning 
residents with/at risk of malnutrition.   
 Additional responsibilities required of staff, will be to complete a resource 
usage questionnaire for each resident at 3 months and 6 months study 
duration. This questionnaire can be completed directly from the care records 
of the residents. 
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 The staff will also be asked to observe for any adverse side effects and to 
report these to the dietitian as soon as possible, as per usual practice on 
initiation of a prescribed ONS or a dietary change.  
 If allocated to a dietetic-led intervention arm, the staff (including catering staff, 
for food-based intervention) will be responsible for providing the resident with 
the agreed food/beverage/ONS on a daily basis. Again, this follows usual 
practice when the dietitian puts a treatment plan in place following a referral. 
 Following 6-months of delivering the allocated dietary intervention, we will ask 
to hold a focus group, to establish the collective opinions of the staff involved 
in the study. Alongside the resident interviews, this will ensure that the voice 
of your residents and their carers is used to design the future trial (optional). 
 What are the possible disadvantages and risks of taking part?  
We do not anticipate any disadvantages or risks in taking part.  
All three dietary interventions are currently used within usual standard practice. The 
residents that are identified as eligible to receive the dietary plan within your home 
will be monitored as per usual practice. Individual dietary plans will be adjusted, or 
changed if they are not tolerated, or they are not meeting individual nutritional needs. 
This will ensure no change from usual, standard practice at the individual resident 
level. 
There may be a small risk of mild side effects on initiating ONS or changing the diet; 
this can include diarrhoea, bloating, nausea and early satiety, but is rare and the 
dietitian will discuss monitoring with you. 
 
What are the possible benefits of taking part?  
Although there may not be a direct benefit from taking part in the study, the 
information we get from this study may help us to provide improved nutritional care 
for future care home residents with malnutrition. The findings from the study will be 
used to inform a future main trial and will be shared with the local care home 
community. 
Your residents may benefit from receiving a dietary intervention plan for 6-months, if 
it is effective at improving nutrient intake and anthropometric indicators. 
 
What if something goes wrong?  
If any harm comes to residents or staff taking part in this research, there are no 
special compensation arrangements. If harm is caused due to someone’s 
negligence, then you may have grounds to take legal action but you may have to pay 
for it. If you do wish to complain, or have any concerns about any aspect of the way 
your staff or residents have been approached or treated during the course of the 
study, the normal National Health Service complaints mechanisms are available: ask 
to speak to the complaints manager of the Heart of England NHS Foundation Trust. 
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If you have a concern about any aspect of this study you should ask to speak to the 
dietitian who will do their best to answer your questions  
. If you remain unhappy and wish to complain formally you can 
contact your local Patient Services Department (formerly PALS) on . 
Will our taking part in this study be kept confidential?  
All information collected in the study will be anonymous and will remain strictly 
confidential. The information will be put into a computer and analysed in an 
anonymous format. No personal, identifiable information will be collected by the 
dietitian. 
We will be asking for your permission to tell the care home GP(s) that you are taking 
part in the study, to let them know that some of their patients may be in receipt of an 
allocated dietary intervention plan.  The GP may ask you for further details of which 
residents are receiving the plan. 
 
What will happen to the results of the research study?  
The results of the study may be published in a nutrition and dietetics journal after the 
study has been completed but residents and care homes will not be identified in any 
report or publication.  
 
Who is organising and funding the research?  
The study is being conducted as part of a student project that the Dietitian is 
undertaking. It is self-funded and no payments will be made to the participants or 
clinical staff taking part in the study.  
 
Who has looked at the research? 
 All research in the NHS is looked at by an independent group of people within a 
Research Ethics Committee to protect the safety, rights, well-being and dignity of 
participants. This study has been reviewed and approved by insert committee and 
date 
 
Contact for Further Information  
Should you want further information about the study please contact:  
 
If you decide to take part in this study, you will be given a copy of this information 
sheet and a signed consent form to keep.  
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A cluster randomised feasibility study evaluating current dietary 
interventions in the treatment of malnutrition in care home-dwelling 
adults 
Please 
Care Home Name:               Initial Box 
1. I confirm that I have read and understand the information 
sheet dated insert date for the above study and have had 
the opportunity to ask questions. 
 
2. I understand that the participation of the care home and 
the residents is voluntary and residents are free to 
withdraw from the participant-reported outcome measures 
or individual interviews at any time, without the quality of 
their nutritional care being affected. 
 
3. I understand that relevant aspects of the resident care 
home records may be looked at by regulatory authorities. 
I give permission for these individuals to have access to 
the care home records. 
 
4. I agree for the care home to take part in the above study  
5. I agree to care home staff being considered for focus 
groups with the dietitian following the trial to discuss their 
experiences (optional) 
 
6. I give consent to the GP being informed about our 
participation in this study 
 
Name of person representing care home:   
Signature:      Date: 
Name of person providing information:    
Signature:      Date: 
For further information about the study please contact:  
 
APPENDIX 5: 
CARE HOME CONSENT FORM 
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Care Home name:  
Care Home address: 
 
 
 
 
Telephone Number:  
Assigned care home staff: 
 
 
--------------------------------------------------------------------------------------- 
Part A:  Malnutrition Screening 
Total number of residents screened using ‘MUST’:  
Number of residents at moderate risk of malnutrition 
Number of residents at high risk of malnutrition 
 
Part B: Care Home staff assessment 
Total number of resident’s staff assessed as ‘not suitable’  
to receive dietary treatment plan 
Please provide the main reasons for this assessment outcome: 
- 
- 
- 
- 
- 
 
APPENDIX 6: 
CARE HOME SCREENING LOG 
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Part C: Inclusion/Exclusion Criteria for receipt of dietary treatment plan 
Number of eligible residents receiving 
tube or parenteral nutrition 
 
Number of eligible residents unable to 
eat and drink 
 
Number of eligible residents not 
registered with a Solihull GP 
 
Number of eligible residents already 
receiving nutrition support (dietetic 
advice or prescribed ONS) 
 
Number of eligible residents on an end of 
life care pathway 
 
 
Number of eligible residents with a 
known eating disorder or illness, which 
requires a therapeutic diet incompatible 
with fortification and/or supplementation. 
 
Part D: Inclusion/Exclusion Criteria for additional participant-centric 
outcome measures: 
Number of eligible residents that are non-native English speaking  
Total number of eligible residents that lack the  
capacity to consent to further involvement 
Part E: Trial Details 
Date of care home randomisation:  
Care Home Trial Number: 
Treatment Allocation 
 
Number of residents eligible to receive dietary plan 
Number of residents with capacity to consent 
to additional outcomes 
Completed by (print name): 
 
Signed:     Date 
/               / 
 
               
             /               / 
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To calculate a malnutrition risk score, follow the 5 steps detailed below: 
STEP 1: 
Body Mass Index (BMI) score: 
Use height and weight (if possible) to 
get a BMI score. 
STEP 2: 
Unintentional weight loss score: 
Score for percentage unplanned 
weight loss in the last 3-6 months 
STEP 3: 
Acute Disease effect Score 
 
 
BMI >20                                       0 
 
BMI: 18.5-20                               1 
 
BMI <18.5                                    2 
<5% weight loss                        0 
 
5-10% weight loss                     1 
 
>10% weight loss                      2 
 
No problems with dietary intake          0 
 
No or negligible dietary intake 
 for >5 days in presence of  
acute disease                                      2                                            
 
STEP 4: Add the scores from steps 1, 2 and 3 together to obtain an overall risk of 
malnutrition.  
 A score of 0 is classed as ‘Low’ Risk (no further action required) 
 A score of 1 indicates ‘Moderate’ risk 
 A score of 2 or more indicates a ‘High’ risk of malnutrition 
STEP 5: For patients identified as moderate or high risk of undernutrition, implement the 
relevant core care plan and dietary interventions, documenting as an individualised care plan 
‘MUST’ Record 
Participant trial number:                        Care Home Trial number: 
Pre-assessment 
details 
Height (m):  Weight 3-6 months ago or usual weight (kg):  
 
Date: Present 
Weight 
(Kg): 
Step 1: 
BMI Category  
Score 
(0,1,2) 
Step 2:  
Weight loss 
category 
score 
(0,1,2) 
Step 3:  
(if appropriate) 
Acute disease 
effect 
(0,1,2) 
Total risk 
undernutrition 
score  
(add steps 1, 2 
and 3): 
Risk 
category 
(High, 
Moderate) 
   
 
    
   
 
    
  
 
     
APPENDIX 7: 
MALNUTRITION UNIVERSAL SCREENING 
TOOL (‘MUST’) 
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‘MUST’ score: 
The 'MUST' materials are reproduced here with the kind permission of BAPEN. The tool has 
been adapted from the original BAPEN tool, to make it easier to score for BMI and for weight 
loss. This simplified version was developed by the ‘Focus on Undernutrition’ team at County 
Durham and Darlington Community Health services and has been approved by BAPEN. The 
tool layout has been adapted slightly for use within this guidance. 
Copies of the 'MUST', an explanatory booklet for use in training and implementation and the 
'MUST' report are available from the BAPEN Office. See www.bapen.org.uk for details. 
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A cluster randomised feasibility trial 
evaluating current dietary interventions 
in the treatment of malnutrition in care 
home-dwelling adults 
Short title: Malnutrition in care homes: A feasibility 
study 
 
TRIAL PROTOCOL: VERSION 2.0 
Chief Investigator: Dr Alison Rushton 
Trial Sponsor: Heart of England NHS Foundation Trust 
 
Student Project: National Institute for Health Research 
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(Masters in Research) 
 
Contact Details:   
 
      
      
      
 
 
APPENDIX 8:  
TRIAL PROTOCOL 
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1. Trial Outline 
Design:  
A cluster randomised trial, assessing the feasibility and acceptability of comparing 
and evaluating existing dietary interventions in the treatment of malnutrition, within 
care homes for the elderly. 
Randomisation will take place at the level of the care home, using a computer –
generated random number list to allocate each home to either, dietetic-led food 
based intervention, dietetic-led oral nutritional supplement (ONS) intervention or the 
standard care home dietary intervention plan. The trial will need to be open-label due 
to the nature of the nutritional interventions under investigation. 
Aim of study 
To determine the feasibility and acceptability of running a full-scale cluster 
randomised trial comparing the efficacy of established dietary intervention plans for 
malnutrition, within care homes for the elderly. 
Using questionnaires, self-reported scales, resident interviews and staff focus 
groups, we will assess the acceptability of the different dietary plans to both care 
home residents and staff, the willingness of care homes to randomise to the 
established dietary plans, recruitment and retention rates, data collection processes 
and data completeness. 
Setting 
Six care homes within the Solihull area, selected specifically to establish feasibility 
within different types of care homes 
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Target population to receive the dietary plans 
Care home residents within the participating homes, with or at risk of malnutrition. 
Dietetic-led intervention Arms 
The Solihull Nutrition Support dietitians currently use both food-based intervention 
and ONS intervention as treatment options for malnutrition within the care home 
setting.  
Dietetic led food-based intervention will increase the daily calorie content of the 
diet by 600kcal and the daily protein content by 20-25g, alongside the standard care 
home diet for malnutrition, continued for 6 months. The content of the dietary 
intervention plan will follow locally agreed Nutrition Support guidelines. 
Dietetic led ONS intervention will increase the daily calorie content of the diet by 
600kcal and daily protein content by 24g, alongside the standard care home diet for 
malnutrition, continued for 6 months. The ONS intervention will use standard liquid 
sip feeds, in accordance with the local prescribing formulary and enteral feeding 
contract.  
Standard, care home intervention Arm 
The current standard care home diet for malnutrition, without added dietetic 
intervention, will be delivered to residents for the 6-month period, in line with the 
training already provided to care home staff (including catering teams) by the 
Registered Dietitian. The purpose of the standard dietary intervention is to provide 
and encourage a calorie dense diet (Department of Health, 1992), which may be 
achieved through provision of small, frequent meals, recipe enrichment with 
additional calories and prompting and assistance from care home staff where 
required.  
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The three dietary intervention options will be allocated at the level of the care home 
and the suitability of provision to each care home resident with, or at risk of 
malnutrition, will be determined at baseline. To ensure that this study does not 
change usual, nutritional care at the individual level, the nutritional status of each 
care home resident will be monitored throughout the 6-month dietary plan, using 
usual outcome measures.  
Should any of the residents not tolerate a dietetic-led intervention (food-based or 
ONS), the care home staff will be advised to return the resident to the standard care 
home dietary plan for malnutrition. This follows usual, standard practice. 
 Should any of the residents within the care homes that have been randomised to 
continue with the standard care home diet for malnutrition, experience a decline of 
nutritional status, dietetic-led intervention (food-based or ONS) will be introduced 
after 6 weeks of standard care. This follows local and national nutrition support 
guidelines and usual, standard practice within each of the care homes.  
Measurement of outcomes 
As this is a feasibility trial, there is no specified primary outcome measure.  
Existing studies investigating malnutrition interventions have used a variety of 
outcome measures including mortality, morbidity and measures of nutritional status. 
There is a lack of good quality evidence for all reported outcomes, particularly within 
the care home setting.  
This trial will collect and evaluate a range of outcome measures to use within the 
main trial. The outcome measures collected within usual monitoring, such as change 
in energy intake and anthropometric parameters (weight, BMI, handgrip strength and 
MAMC) will continue to be collected for all residents with, or at risk of malnutrition 
that are placed onto a dietary plan.  
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A healthcare resource-usage questionnaire will be trialled by care home staff within 
this trial to inform the development of a malnutrition specific instrument for the future 
trial. For residents who have the capacity to consent to join the trial, additional 
outcome measures will be collected, including: participant-reported quality of life 
(CO-OP Charts), health state (EQ-5D questionnaire), and participant rated appetite 
and dietary satisfaction (VAS tool). 
Interviews with a sample of residents and focus groups with care home staff will 
complement the quantitative data collection by further exploring the feasibility and 
acceptability of the trial design. 
Sample Size 
As this is a feasibility trial, no formal sample size calculation is required.  
Six local care homes will be recruited into the trial and will be randomised into the 
three dietary intervention arms of the trial.  
It is estimated that 30 to 42% of care home residents are at risk of malnutrition 
(Russell and Elia, 2010). Based on the capacity of the selected care homes, which 
range in size from 26 to 70 beds, we estimate that between 8 and 30 residents will 
be identified as moderate or high risk of malnutrition within each participating care 
home and will be considered for receipt of the allocated dietary intervention plan for 
malnutrition.  
Study Duration 
12 months study duration, including delivery of a 6-month dietary intervention plan. 
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1. Background  
 
1.1 Rationale 
Often unrecognised and under-treated, malnutrition6 predisposes individuals to 
disease, delays recovery from illness (McWilliams, 2008) and reduces quality of life 
(QoL) (Gaskill et al., 2008; Brotherton et al., 2010). Care home residents are 
especially vulnerable, with an estimated 30 to 42% at risk of malnutrition (Russell 
and Elia, 2010). In recent years, the NHS has focused attention on the increasing 
problem of malnutrition amongst hospitalised patients, where acute trusts have 
control over the dietary content of daily meal provision. In the community setting, 
tackling malnutrition can pose a greater challenge, particularly as independent 
providers run many of the care homes. 
 
There is currently no internationally agreed nutritional treatment for malnutrition 
(Baldwin and Weekes, 2011). Current techniques include food-based intervention 
(recipe enrichment/fortification, nourishing snacks and fortified drinks) and/or the use 
of prescribed oral nutritional supplements (ONS) (NICE, 2006). Although National 
recommendations by The British Dietetic Association (BDA) and The National 
Prescribing Centre (NPC) suggest improving nutritional intake first using 
conventional foods and secondly by prescribed means (Thomas, 2001; NPC, 2012), 
it is currently unclear whether food-based intervention is able to improve clinical and 
nutritional outcomes for malnourished individuals.  
Conventional food is less expensive than ONS, which incurred a national spend of 
£105 million to the NHS from 2010 to 2011, a 10% increase from 2009/10 (NHSBSA, 
                                                          
6
 Within this proposal, ‘malnutrition’ refers to under nutrition, not over nutrition or obesity. 
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2011). At this time, many primary care trusts and GP practices identified a significant 
and increasing spend on ONS, prompting a move by Medicines Management teams 
to impose stricter prescribing guidance and encourage increased use of food-based 
intervention (Hobday, 2010). It is therefore becoming increasingly important to 
assess whether conventional food is able to improve the nutritional and clinical 
outcomes of those at risk of malnutrition within care homes. 
 
In Solihull, the Heart of England NHS Foundation Trust, Community Nutrition 
Support Dietitians provide a monthly service to the local care homes, delivering 
advice, training and support to care home staff and facilitating good nutritional care 
for the care home residents. All of the local care homes conduct monthly nutritional 
screening and implement a standard dietary intervention plan for those residents 
with, or at risk of malnutrition.  
If a resident remains at high risk of malnutrition for 2 months, the care home staff will 
make a formal referral to the dietitian for an individual resident assessment and 
implementation of a dietetic intervention plan, using a food-based or an ONS 
approach, in line with local and national nutrition support and prescribing guidance. 
There is currently a lack of capacity within the dietetic service to deliver a dietetic-led 
intervention for each resident identified with, or at risk of malnutrition. To enable the 
current dietetic service provision within care homes to be evaluated, it is important 
that the dietetic-led and standard care home intervention plans are compared and 
evaluated. 
Undertaking a large-scale trial within a care home setting, will likely be met by a 
number of challenges. Care homes provide care to frail older people with high 
support needs and are arguably home to one of our most vulnerable populations 
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(Quince, 2013). Research is likely to challenge care homes and the staff that work 
there, as it adds an additional pressure on to what is already a heavily burdened 
care sector (Froggat et al, 2009).  
There is also limited data upon which to design a substantive trial or on which to 
base a sample size calculation.  We therefore propose to undertake a pilot study, 
randomised at the level of the care home, to evaluate the feasibility and acceptability 
of evaluating and comparing the three existing dietary intervention plans that are 
provided to those with, or at risk of, malnutrition within care homes for the elderly. 
These interventions are dietetic-led food-based intervention, dietetic-led ONS 
intervention and the standard care home intervention for malnutrition. They will be 
allocated to the care homes for a 6-month period.  
In addition to an evaluation of existing dietary interventions and routinely collected 
outcome measures, participant-reported outcomes will be collected, using 
questionnaires, charts and scales, from those residents that have the capacity to 
provide informed consent.  Individual interviews with a sample of these residents, 
alongside staff focus groups within each care home, will ensure that the voice of 
residents and their carers is embedded within the design of the future trial. 
 
The results of the pilot study will inform the development and design of a future 
cluster randomised controlled trial to compare dietetic-led food-based intervention, 
dietetic-led ONS intervention and the standard care home dietary intervention, in the 
treatment of malnutrition within the care home population. The future trial will aim to 
consider and compare a number of outcomes, including nutrient intake, 
anthropometric parameters, patient reported outcomes and cost effectiveness.  The 
results of the future trial will inform decisions by dietitians, General practitioners, care 
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home providers and commissioners, regarding the appropriate use of nutritional 
treatment for malnutrition in care homes. 
1.2 Existing Research 
2.2.1 Malnutrition Intervention 
Systematic reviews of malnutrition interventions (Stratton et al. (2003), Milne et al. 
(2005 and 2009), NICE (2006), Koretz (2007)), have tended to scrutinise the 
evidence base for the use of ONS, in a variety of clinical conditions and within the 
acute setting. A meta-analysis of 24 trials on oral energy and protein 
supplementation showed a reduction in mortality with ONS use, which was 
consistently significant in undernourished older adults over 75 years (Milne et al,  
2005). In 2006, NICE reviewed studies comparing groups in the acute setting 
receiving either ONS alongside dietary advice or no advice/intervention at all. The 
results demonstrated significant weight gain in the groups receiving the intervention 
and a meta-analysis indicated a significant reduction in complications and mortality 
rate (NICE, 2006). This study has formed the basis of national policy in the UK on 
the management of Disease Related Malnutrition (DRM), but due to considerable 
heterogeneity of the included studies, the effect size for ONS has not yet been 
determined. 
A 2007 review, which summarised a number of systematic reviews, covering a 
variety of clinical conditions within the acute setting, concluded that there is strong 
evidence to support the use of ONS in acutely ill patients with a wide range of clinical 
conditions (Stratton and Elia, 2007).  
In response to the increasing focus on prescribing practices in primary care, The 
Medical Nutrition International Industry (MNI) has recently released an ‘ONS Dossier’ 
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detailing the growing evidence that is available to support the use of ONS as an 
effective solution to improve patient outcomes and treat malnutrition (Engfer and 
Green, 2012). 
Impact of dietary advice/intervention on malnutrition:  
A Cochrane review conducted in 2007 and updated in 2011 became the first review 
to address the impact of dietary intervention and advice on DRM (Baldwin and 
Weekes, 2007; 2011), identifying 45 randomised controlled trials (RCTs) in four 
different comparisons: dietary advice to no advice; to ONS; to dietary advice plus 
ONS; and dietary advice plus ONS to no advice. 
Increasing nutritional intake through diet alone 
 
12 studies were identified for this comparison, one of which was conducted in elderly 
individuals, but not in a care home setting (Rydwik 2008, in Baldwin and Weeks, 
2011). Combined analysis suggested increased weight (9 studies with an average of 
81 participants), mid-arm muscle circumference (MAMC; 2 studies with an average 
of 65 participants) and energy intake (7 studies with an average of 67 participants) 
for subjects that received dietary advice compared to routine care. The authors 
advise caution when interpreting the findings on weight improvement as they were 
obtained from just one trial with high risk of bias (Macia, 1991, in Baldwin and 
Weekes, 2011). 
Dietary advice compared with ONS: 
8 studies were identified for this comparison, with just one study focused on elderly 
participants, not in a care home setting (Gray-Donald 1995, in Baldwin and Weekes, 
2011). Combined analysis demonstrated significantly greater weight gain (7 studies 
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with an average of 57 participants) in groups receiving ONS, but observed no 
statistically significant differences for any other outcomes. 
Dietary advice compared with dietary advice plus ONS: 
16 studies were identified for this comparison, but no studies specifically used elderly 
participants. Combined analysis of the studies, suggested that subjects receiving 
both dietary advice and ONS were less likely to be admitted to hospital (2 studies 
with an average of 54 participants). The analysis also indicated significantly 
increased MAMC (3 studies with an average of 164 participants), Tricep Skinfold 
Thickness (TSF; 6 studies with an average of 64 participants) and handgrip strength 
(4 studies with an average of 77 participants). 
Dietary advice plus ONS compared with no advice: 
14 studies were identified, 2 of which used a population of frail elderly participants 
(Chandra 1985; Persson 2007, in Baldwin and Weekes, 2011). Combined analysis 
indicated weight gain (9 studies with an average of 50 participants), improvements in 
TSF (1 study) and increased energy intake (6 studies with an average of 60 
participants) for those receiving dietary advice and ONS. None of these outcomes 
was seen within either of the studies using a population of frail elderly participants. 
Patient-reported outcome measures and cost effectiveness 
The Cochrane study highlighted a complete lack of evidence for the effects of dietary 
intervention on patient-reported outcomes such as quality of life and a similar lack of 
evidence regarding cost benefits. This has subsequently been highlighted as an area 
requiring further research. 
Limitations of the Cochrane review 
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As statistical and clinical heterogeneity existed across all groups of trials identified, it 
is not yet possible to evaluate the effects of dietary advice/intervention given with or 
without ONS in different practice settings, patient groups or clinical conditions.  Of 
the 45 studies reviewed, four were conducted with elderly participants, but no studies 
were described within the care home setting. 
The quality of evidence in the review has been described as low to moderate, with 
the majority of studies being small (average study size, n=75) and lacking in power. 
As such, there remains a lack of good quality evidence for all of the reported 
outcomes and the authors acknowledged a limited evidence base to indicate that 
dietary intervention and ONS have equal efficacy in managing DRM (Baldwin and 
Weekes, 2011). Almost no information was provided within the studies, concerning 
the specific intensity and content of the dietary intervention used (foods or 
combination of foods used), limiting the practical application of findings. It is essential 
that future studies detail the type, intensity and duration of dietary intervention used. 
 
2.2.2 Malnutrition Intervention in the care home population 
Despite a population of 400,000 residing in UK care homes (4% of the over 65 
population and 20% of the over 85 population), the care home setting is largely 
under-represented within research and as a result, the evidence to guide best care 
practices to improve quality of life is lacking (Cochrane Editorial Unit, 2013).  
Initial scoping has highlighted an insufficient literature base to conduct a systematic 
review of malnutrition intervention in the care home population.  A systematic search, 
highlighted a complete lack of RCTs, investigating the effectiveness of dietary 
intervention alone in the treatment of malnutrition, although a case-control study 
demonstrated significantly increased energy intake following 15-weeks of energy-
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fortified meals. However, as study participants were of a healthy body mass index 
(BMI) (median: 23kg/m²), the results cannot be generalised to a malnourished 
population (Odlund et al., 2003). 
The effectiveness of ONS within long-term care has received more attention. A 
prospective RCT of 88 nursing home residents randomised to ONS or usual diet, 
demonstrated significantly improved energy intakes, mini-nutritional assessment 
(MNA) scores and weight with ONS (Lauque et al., 2000). A double-blind placebo 
RCT investigating acceptance and effectiveness of ONS, demonstrated a 2.5% 
improvement in body weight (Wouters-Wesseling et al., 2003). 
Few RCTs have compared the effectiveness of malnutrition interventions in the care 
home population. One study, which compared three energy-dense snacks/drinks 
daily to three 300kcal ONS daily, demonstrated increased energy intake of 26-30% 
with snacks/drinks and 46-50% with ONS (Turic et al, 1998), but it was not clear 
whether the nutrient content of the interventions was comparable.  
A more recent trial conducted with elderly care home residents, compared ONS 
intervention with dietary advice, in the form of a standardised advice sheet. The 
study reported increased energy and protein intakes that were 32% and 25% higher 
respectively in the supplement group (Parsons et al., 2011). However, the 
comparison between a cognitive intervention (written advice) and a physical 
intervention (ONS) introduces study bias and ultimately limits practical application.  
2.2.3 Summary of existing research 
 
The analysis of systematic reviews of malnutrition intervention and an extended 
review focusing on the care home population has revealed a lack of published 
clinical trials comparing food-based interventions with ONS interventions of equal 
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nutrient composition. To enable the efficacy of food-based strategies to be compared 
with ONS provision within a care home population, an adequately powered RCT is 
required, using interventions that are homogenous in nutrient composition alongside 
a comparative standard care arm.  
Although both food-based and ONS interventions are established dietetic-led 
treatment options for malnutrition within care homes, existing studies provide 
insufficient information to plan a substantive trial in this care setting. It is therefore 
essential to show supportive data that the comparison and evaluation of these 
existing dietary interventions is acceptable and possible to implement within this 
population.  We propose to undertake a pilot study, cluster randomised at the level of 
the care home, to assess the feasibility and acceptability of running a large-scale trial 
comparing and evaluating dietetic-led food-based intervention, dietetic-led ONS 
intervention and the standard care home dietary intervention plan for malnutrition. 
 
2. Trial Design and Procedures  
Further to the Medical Research Council guidance (MRC, 2008), which describes the 
importance of piloting to investigate trial uncertainties, a feasibility trial is proposed, 
with the following objectives: 
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Process feasibility Objectives: Objectives to inform future trial design: 
Evaluation of the current dietary intervention 
plans for malnutrition: 
- Assess whether resident eligibility criteria for 
receipt of the dietary plans are too open or 
too restrictive 
- Assess recruitment and retention  
- Assess compliance and tolerance of each 
dietary plan 
- Assess whether assigned care home staff are 
able to complete the Malnutrition Universal 
Screening tool (‘MUST’)  
Research element: Resident and staff 
perspectives 
- Assess whether the dietary plans are 
acceptable to both residents and staff 
- Assess which outcome measures are most 
acceptable and feasible to use within the 
main trial, for both residents and care home 
staff 
- Assess whether residents are able to 
complete the study questionnaires 
- Assess whether assigned care home staff are 
able to complete the standardised mini 
mental state examination (sMMSE) and the 
healthcare resource usage questionnaire 
- Assess whether the nutrient content of the 
dietetic- led interventions is optimal to 
deliver an effect 
- Collect data to inform sample size 
calculation and estimate Intracluster 
Correlation Coefficient (ICC) for the main 
trial  
- Pilot a method of collecting healthcare 
resource usage data 
 
 
 
 
 
- Review of the most appropriate participant-
reported outcome measures to use within 
the main trial 
 
 
 
The feasibility trial will recruit a variety of care home types, including nursing, 
residential and dementia focused, which will allow the evaluation of feasibility and 
acceptability of the trial design and methodologies across a range of long-term care 
settings. Randomisation will take place at the care home level. All residents with, or 
at risk of malnutrition, who do not already have a dietetic-led plan in place at 
baseline, but require dietary intervention to meet their nutritional needs, will be 
considered for receipt of the plan that is allocated to the care home. The dietary plan 
will be allocated for a 6-month period, but to ensure that this trial does not change 
usual, nutritional care at the individual level, the nutritional status of each care home 
resident will be monitored throughout the 6-month dietary plan, using usual outcome 
measures. Should a resident that is deemed suitable for the intervention at baseline, 
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not tolerate the plan, refuse to comply with the allocated plan, or require adjustments 
to meet their changing nutritional needs, the dietary intervention will be altered 
accordingly, to meet individual need. 
 
In 2013, The Alzheimer’s Society estimated that 80% of residents in care homes 
suffer with Dementia or severe memory problems (Quince, C, 2013). The population 
of residents identified with, or at risk of malnutrition in each care home, is therefore 
likely to include individuals that lack the capacity to consent for themselves. 
Residents with, or at risk of malnutrition that are eligible to receive the dietary 
intervention, but are lacking the capacity to consent will only be included to the level 
of usual care for malnutrition. Outcomes that are routinely measured to monitor 
nutritional status within usual care will continue to be collected and will be provided 
to the dietitian researcher, in a resident anonymous format. Residents who have 
capacity to consent, as determined by trained care home staff, will further be asked 
to consent individually to provide information on quality of life, health state and 
dietary satisfaction, and to be contacted regarding interviews, following the 6-month 
plan. Participant reported outcomes will be measured through completion of 
anonymous questionnaires and self-reported scales. 
 
The feasibility trial will take the form of a sequential, explanatory mixed method design:   
 
 
 
 
 
Qualitative phase 
 
 
 
 
QUAN   QUAN   qual   qual  Interpretation 
Data    Data   Data   Data  of entire analysis 
Collection   Analysis   Collection  Analysis  
(usual, standard  (Descriptive  (Interviews  (Thematic) 
outcomes and                    Statistics)                           /Focus Groups) 
participant reported 
outcomes) 
 
‘Quan’ and ‘qual’ stand for quantitative and qualitative respectively.  
 
Figure 1 (Adapted from Cresswell, 2009) 
 
QUAN qual 
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Following delivery of the 6-month dietary plan within each care home, the participant-
reported outcomes, will be further explored with a sample of residents that have 
consented to take part in individual interviews. Upon receipt of management 
approval and staff consent, the acceptability and feasibility of the trial will also be 
discussed with care home staff using focus group techniques.   
Semi structured interviews will explore the experiences and perspectives of the 
residents receiving the diet plans and providing self-reported outcomes, whilst focus 
groups will establish and provide reasoning for the ‘collective’ views of the staff 
delivering the plans and conducting the screening and outcome measures. The 
findings will complement, explore and explain the quantitative data collection and will 
ensure that resident and staff perspectives are used to inform the future trial design.  
2.1 Entry Criteria  
 
2.1.1 Inclusion Criteria 
- Local Care Home that has received dietitian training 
All care home residents that require dietary intervention for malnutrition will receive 
the randomly allocated dietary plan, provided they meet the following criteria 
1. With/at risk of Disease related malnutrition using the Malnutrition Universal 
Screening tool (‘MUST’; Elia, 2003)  
2. Able to eat and drink 
3. Registered with a Solihull GP and subsequently eligible for the provision of 
healthcare services provided  by the Heart of England NHS foundation Trust 
(HEFT) 
 
 
 149 | P a g e  
 
3.1.2 Exclusion Criteria 
Residents will not receive the randomly allocated dietary plan if they, 
1. Currently receive (or are likely to receive in the next 6 months) tube or 
parenteral nutrition  
2. Currently receive nutrition support in the form of individualised dietetic advice or 
prescribed ONS.  
3. Have a known eating disorder or illness, which requires a therapeutic diet 
incompatible with fortification and/or supplementation. This may include but is 
not limited to, Galactosemia or known lactose intolerance, chronic renal 
disease requiring dialysis, poorly controlled diabetes, in receipt of active cancer 
treatment, or liver failure.   
4. Are on an end-of-life care pathway 
The eligibility criteria listed, are those used within usual, standard assessment for 
those with, or at risk of malnutrition that are being considered for receipt of a dietary 
intervention plan. 
Exclusion due to use/likelihood of parenteral nutrition or individualised nutritional 
support will be determined by the care staff, through review of current prescribed 
medications and a review of the current caseload of oral nutrition support patients 
held by the HEFT Nutrition Support Service and HEFT acute dietetic service. This 
review can take place without the involvement of the dietitian researcher. 
Exclusion Criteria for outcome measures outside of usual, standard 
monitoring of nutritional status: 
Participant- reported measures, requiring individual consent 
 
1. Non-native English speaking 
2. Lack the capacity to consent 
Receipt of Care 
Home consent 
Malnutrition Screening 
using 'MUST' as per 
standard care, 
identifying those with or 
at risk of malnutrition 
Care home staff assess 
resident eligibility to 
receive intervention 
plans 
Review of care records by staff 
to ensure that each resident 
meets all eligibility criteria for 
receipt of the plan (as per usual 
practice) 
Care staff assign each 
resident a number. 
Assessment of capacity 
by trained care home 
staff or care home GP Residents lacking capacity to 
be included for outcomes 
measured within usual 
monitoring only 
Receipt of consent for 
residents with capacity, to 
take part in participant- 
reported outcomes 
Randomisation of the 
care homes into the 3 
existing dietary 
intervention plans 
Training of assigned 
care home staff in 
accordance with 
allocated plan 
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Non-native English speaking residents with capacity will be excluded from 
participating in the collection of participant-reported outcome measures, and from the 
qualitative phase of the trial. The decision to include this exclusion criterion is based 
on existing knowledge and experience of the population group and a consideration of 
the finances available to run the pilot trial. The dietitian researcher practices clinically 
within Solihull care homes and estimates that less than 5% of the resident and staff 
population is non-native English speaking. Given that this trial will include a small 
cohort only, the number recruited is likely to be very small.  
This feasibility trial is being conducted as part of a student Masters project and as 
such, has no additional funding attached to it. This limits the option to translate 
information leaflets into different languages and to hire an interpreter. In the future 
main trial, it is anticipated that additional funding will be available to ensure that 
where necessary, participant information sheets are translated and trained 
professional interpreters are arranged to discuss trial participation where language 
between the researcher and the participant is not shared. 
Residents that lack the capacity to consent will be excluded from taking part in the 
participant-reported outcome measures. This part of the trial is additional to the 
evaluation of usual, standard nutritional care and therefore individual informed 
consent is required. As this is a feasibility trial, participation in these outcome 
measures will not be of benefit to the wider population of adults that lack capacity 
and therefore, the inclusion of this resident population in this part of the study cannot 
be justified (Mental Capacity Act, 2005). 
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3.2 Care home consent, resident eligibility and cluster 
randomisation 
Care Home Consent: 
The Dietitian Researcher will provide prospective care homes with a full explanation 
of the study.  An invitation letter and an enclosed Information sheet will be sent to the 
Home Manager or Head Office (if operating within a larger provider). This will be 
followed up one week later, by a face-to-face visit or a telephone call to allow for 
further discussion, following which, the care homes will be given adequate time to 
consider consenting to participate in the trial. They will then be asked to sign consent 
forms. Importantly, Managers that agree for care homes to participate in the trial, can 
still choose to opt out of staff participation in post dietary intervention focus groups. 
Nutritional screening using ‘MUST’: 
Residents that are eligible to receive the allocated dietary plan, within each care 
home that has agreed to take part, will be identified using routine malnutrition 
screening and a review of their care records by care home staff. This reflects the 
usual assessment process, prior to implementation of a dietary intervention plan for 
malnutrition. 
Two, assigned care home staff (Nurses or Senior Carers) per care home site will 
conduct nutritional screening using ‘MUST’ to identify those with/at risk of 
malnutrition.  ‘MUST’ classifies risk as low, medium or high on consideration of BMI, 
history of unintentional weight loss and acute illness effect (Elia, 2003; NICE, 2006). 
Those residents that are moderate or high risk will be considered for receipt of the 
dietary intervention plan that is allocated to the care home. 
Figure 2: Overview of the screening and consent process for the 
RCT Phase 
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 Monthly ‘MUST’ screening of care home residents is standard care within all of the 
selected care homes. The tool has been validated for use in adults, has very good to 
excellent inter-observer reliability in care homes (kappa values of 0.8-1.0) and has 
been found to be acceptable to both participants and healthcare workers (Elia, 
2003). To enhance the consistency of screening practice between care home sites, 
dietetic-led training will be provided to all assigned staff prior to commencement of 
the screening process. 
Review of Care Home Records in line with eligibility criteria 
 
Following ‘MUST’ screening, the care home staff will be asked to review the care 
records of those residents that have been identified as moderate or high risk of 
malnutrition. They will check that each resident meets all of the eligibility criteria to 
receive the allocated dietary plan. This process will ensure that the initiation of an 
intervention will be safe and appropriate for the individual.  
The care staff will be able to consult with the Nutrition Support dietetic service, or the 
care home GP, as required. Once the eligible residents have been identified, the 
care home staff will assign a number to each individual resident, to be detailed on all 
trial related materials. This will enable subsequent outcome data to be collected 
anonymously from each care home site. 
 
The care home staff will also complete a screening log for the care home site, 
detailing the number of residents screened, the number of residents eligible to 
receive the dietary intervention plan and the number of residents excluded for each 
of the eligibility criteria. This will be provided to the dietitian for data collection. The 
log will be completed on a 'whole home basis' and will include no personal or 
identifiable resident information. 
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The general practitioner (GP) for each care home site that is participating in the trial 
will be informed in writing of the involvement of the care home in the trial (with the 
care home consent to do so). The GP will be advised to consult with the care home 
staff, if further information is required regarding the involvement of individual 
residents under their care. 
Assessment of capacity and receipt of individual consent for 
additional participant-reported outcome measures 
For those parts of the trial, which fall outside of the evaluation of usual nutritional 
care and monitoring for malnutrition, including the collection of participant-reported 
outcome measures, individual resident interviews and staff focus groups, consent 
will be sought on an individual basis. Informed consent will be sought from individual 
residents that are assessed by trained care home staff or the care home GP as 
having capacity, to take part in additional participant-centric outcome measures and 
individual interviews.  
The care home staff will make the initial approach to residents that have capacity to 
consent, to discuss their possible involvement in this research. There is a risk the 
care home staff will suggest only the more compliant residents to be involved, but it 
is hoped that the care home information sheet and associated consultation with the 
dietitian will enable them to make an informed decision, concerning who would be 
able to take part. Their wealth of knowledge about the prospective participants will 
be invaluable to this part of the trial. 
If the approached resident would like to consider being involved in this aspect of the 
trial, which falls outside of usual nutritional care and monitoring, the care home staff 
will introduce them to the dietitian. The Dietitian Researcher will provide a full 
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explanation of the trial to each identified individual, alongside his or her Lead 
Nurse/Carer and family members, if preferred. A participant information sheet will be 
provided and the resident will be given sufficient time to read, ask further questions 
and decide whether they would like to participate in the additional outcome 
measures and whether they would like to be considered for an individual interview 
following the intervention phase. The resident will then be asked to sign a consent 
form. Importantly, residents that agree to the collection of additional participant-
reported outcome measures may still choose to opt out of being considered for 
individual interviews. 
 
Loss of capacity or fluctuating capacity during research: 
The capacity of residents will not be proactively monitored during the trial, but should 
it be brought to the attention of the Dietitian Researcher that a resident who has 
consented to the additional participant-reported outcome measures has lost capacity 
during the study; the following process will be adhered to:  
 
 
Resident 
loses 
capacity 
during the 
study 
Resident is 
withdrawn 
from the 
participant-
reported 
outcome 
measures 
and 
interview 
phase 
Continues to 
receive care 
home allocated 
diet plan. 
Usual, standard 
outcomes 
continue to be 
collected 
Figure 2: Loss of capacity during the study 
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Care Homes stratified 
by type (Nursing or 
residential) 
Cluster randomisation 
at the care home level.  
Care homes allocated 
to: 
Standard care home 
dietary plan for 
those at risk of 
malnutrition 
Standard Care Plus 
dietetic-led Food-based 
intervention: Addition 
of 600kcal and 20-25g 
protein daily using 
conventional 
food/beverages 
Standard Care Plus 
dietetic-led ONS 
intervention: Addition 
of 600kcal and 24g 
protein daily using 
prescribed ONS 
Cluster randomisation at the care home level 
 
 
 
 
 
 
 
 
Figure 3: The randomisation process 
 
Cluster randomisation using a computer-generated random number list will allocate 
each care home to either, dietetic-led food based intervention, dietetic-led ONS 
intervention or the standard care home dietary intervention for malnutrition. 
Stratification by care home type will ensure that one nursing home and one 
residential home is allocated to each intervention arm. The Dietitian researcher will 
communicate confirmation of the dietary plan allocation and the trial number to each 
participating care home.   
Assigned care home staff within each care home will receive dietitian-led training to 
support delivery of the 6-month allocated dietetic-led intervention plan and/or a 
refresher on the current standard care home dietary intervention for malnutrition. 
This training session will also cover the completion of required documentation and 
will provide an opportunity for any questions. 
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Sampling for Phase 2: Individual Interviews 
Following delivery of a 6-month dietary intervention plan within each care home, 
those residents that indicated on the consent form that they would like to be 
considered for individual interviews, will form the sampling frame for potential 
inclusion within the qualitative phase of the trial. 
 A non-random method of purposive sampling involving care home staff discussions 
and consideration of the findings from the participant-reported outcome measures 
will identify two-three potential participants per care home for individual semi 
structured interviews with the Dietitian researcher. The care home staff will again 
make the initial approach to the potential participants to discuss their possible 
involvement. Those that remain interested in participation will be introduced to the 
Dietitian, to provide further verbal and written information on this part of the study. 
 
A focus group of between two and eight staff will be identified within each care home 
site that has management approval for staff participation (Gill et al., 2008). Care 
Home staff will be selected on the basis that they have had experience of 
participating in the trial and will therefore have something to say. A focus group will 
be held within each individual care home to ensure that the staff are comfortable in 
speaking to each other (Richardson and Rabiee, 2001). The groups will be held at a 
date and a time that is suitable for the staff and will not affect staffing levels. This 
may need to be before, after, or between shifts and can be scheduled accordingly, 
as agreed with the care home manager. 
Topic guides for the resident interviews and the Staff Focus Groups have been 
developed using the feasibility objectives. Themes and core questions will be refined 
following the 6-month dietary intervention and collection of participant-reported 
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outcome measures.  Separate information sheets for residents and staff  and 
consent forms have been developed for this qualitative phase and will be presented 
to eligible residents and to staff prior to their inclusion. 
3.3 Baseline Assessments 
Resident Characteristics 
Following confirmation of resident eligibility to receive a dietary intervention plan, the 
care home staff will complete a baseline assessment form for each resident. This 
form will include the following information: 
 
1. Resident Number (assigned by care home staff following screening) 
2. Resident gender 
3. Care Home Type (Nursing, Residential, Dementia-specific) 
4. Primary Diagnosis 
5. Diagnosed Dysphagia (Yes or No). If Yes, to indicate recommended food and 
fluid modifications 
6. Diagnosis of Dementia (Yes or No) 
7. Risk of re-feeding syndrome (Yes or No). If yes, to indicate risk factor(s) 
8. Capacity (Yes or No) 
9. Informed consent received (Yes or NO) 
10. sMMSE Score (for those with capacity only) 
11. Height (to indicate whether measured, reported, or an alternative measure) 
This information is required within usual, clinical practice, prior to initiation of a 
dietary intervention.  
Baseline nutritional assessments (Table 1) 
Nutritional assessments undertaken within usual, standard practice, include, 
Dietitian Measured:  
1. Mean Nutrient Intake (energy, protein, fluid): Calculated from dietetic analysis 
of three consecutive 24-hour food record charts. Usual tableware such as bowls, 
plates and glasses will be measured in each care home at baseline and the 
size/capacity recorded. Nutrient intake will be determined using the dietary 
analysis software package Diet Plan 6 (Forestfield Software Ltd, UK). 
Food record charts are completed for those at risk of malnutrition as part of usual 
practice within each care home. The charts provided to the dietitian will be 
anonymous. 
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2. Anthropometry 
As per usual, standard practice, the care home staff will make the initial approach 
to each resident to discuss the anthropometry measures that the dietitian will 
take. These measures are used to monitor nutritional status in usual, standard 
care and will be measured by the dietitian, because they are clinically trained to 
do so. The measured data will be recorded in an anonymous format by the care 
staff. The dietitian may be provided with the first name of the resident to enable 
them to establish a rapport, but they will not need to access the resident’s care 
records or collect any personal data, in association with the following 
measurements: 
 
- Handgrip strength: An index of general upper extremity strength (function). 
Measured using a handgrip dynamometer on the non-dominant arm 
(Todorovic & Micklewright, 2011). Functional changes respond more quickly to 
nutritional support than other anthropometric parameters (Hornby et al, 2005). 
Limitations of the technique include the influence of debility, age and familiarity 
with the technique (Thomas and Bishop, 2007).  
 
- Mid Arm Muscle Circumference (MAMC): An estimate of muscle mass. 
Calculated using Mid Upper Arm Circumference (MUAC) (which will be 
measured with a tape measure by care home staff) and Tricep Skinfold 
Thickness (TSF) (Measured with a standardised skinfold calliper by the trained 
dietitian):  MAMC (cm) = MUAC (cm)- 3.14 X TSF (cm) 
TSF can be insensitive to small changes, which could limit its use as a short- 
term monitoring tool within this trial (Thomas and Bishop, 2007).  
Care Staff Measured:  
1. Anthropometry (anonymous data provided to the dietitian) 
 
- Height (m): Taken from clinical records, or measured using a stadiometer. 
Reliable measurement within the elderly population can be challenging due to 
vertebral compression, reduced muscle tone and changes to posture (WHO, 
1995). If standing height cannot be measured, self-reported height is considered 
the superior secondary method or ulna length can be measured to obtain an 
estimate (Thomas and Bishop, 2007). 
 
- Weight (Kg): Measured using clinical calibrated standing, chair or hoist scales 
(Todorovic & Micklewright, 2011). Body weight is affected by fluid retention, 
oedema and ascites (Thomas and Bishop, 2007). In the presence of such factors, 
a correction will be subtracted from measured weight (Todorovic & Micklewright, 
2011).  
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- Body Mass Index (BMI): A measure of adiposity, calculated by:                 
weight (kg)/height (m²). Validity is limited by the influence of gender, ethnicity 
and age on body composition (Prentice & Jebb, 2001). Reliability is questionable 
in the presence of confounding factors including oedema or ascites (Harris and 
Haboubi, 2005).  
Additional outcome measures for residents that have the 
capacity to consent 
Care Staff measured: 
- Standardised Mini Mental State Examination (sMMSE) Screening:  
Assigned care staff will use the sMMSE (Molloy and Standish, 1997) to assess 
the cognitive abilities of the residents that have consented to participate in the 
collection of additional outcome measures. sMMSE score will be determined at 
baseline only. This assessment is completed by senior care staff or by the GP 
within the care homes, as part of usual cognitive assessment. 
The sMMSE has significantly better inter-rater and intra-rater reliability than the 
Mini Mental State Examination MMSE (Folstein et al., 1975) and takes less time 
to administer (10 minutes). Permission has been granted by Professor Molloy to 
use this tool. 
The following outcome measures are not currently used within usual practice and 
may be considered an additional burden to residents. These outcomes will only be 
measured following the receipt of individual informed consent from the residents 
within each care home that have the capacity to do so. 
Participant rated: 
1. Health state, using The EuroQol-5D (EQ-5D) and  
Quality of life using the CO-OP Quality of life chart. There is no malnutrition 
specific measure of health state or quality of life for patients, so these well-
established and validated measures will be used. The Euroqol group and the 
Dartmouth CO-OP project have granted permission to use the tools. 
 
2. Appetite and Dietary Satisfaction, using a Visual Analogue Scale (VAS). 
Studies have indicated that measured food intake appears to be related to the 
perceptions of hunger and fullness assessed by VAS (Flint et al, 2000; Parker et 
al, 2004) 
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Table 1: Assessment Schedule 
 Assessment Time 
Measure Completed by Baseline 3 months 6 months 
Nutrient Intake Dietitian √ √ √ 
Texture modification Care Home staff √ √ √ 
Height Care Home staff √   
Weight Care Home staff √ √ √ 
BMI Care Home staff √ √ √ 
Handgrip Strength Dietitian √ √ √ 
MAMC Dietitian √ √ √ 
sMMSE Care Home Staff √   
1VAS Participant rated √ √ √ 
1EQ-5D Participant rated √ √ √ 
1CO-OP QoL Participant rated √ √ √ 
Healthcare resource usage Care Home Staff  √ √ 
Compliance Care Home staff  √ √ 
1
Participant-reported outcomes: data will only be collected from those residents that have 
capacity and have consented to completing the questionnaires and VAS. 
 
 
3.4 Interventions 
All of the residents with, or at risk of malnutrition within the participating care homes 
will continue to receive the standard care home dietary plan for malnutrition, with 
individualised dietetic-led interventions added for the residents within care homes 
randomised to the food-based or ONS intervention arms. A Registered Dietitian will 
deliver these interventions in the care homes, as per usual, standard practice. 
3.4.1 Dietary Intervention Arms  
 
Food-based Intervention  
The content of the food-based intervention will be based on the guidelines developed 
as part of the Solihull Nutrition Support Project (2012) and national guidance for best 
practice, including The Malnutrition pathway (2012), which has been developed and 
agreed by a multi-professional consensus panel.  
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Assigned care staff within the care homes randomised to food-based intervention will 
receive instruction by the dietitian to increase resident daily nutritional intake by 
600kcal and 20-25g protein, alongside the current standard dietary intervention plan 
for malnutrition.  
Techniques to achieve the required nutrient increase will include additional 
fortification of conventional food with ingredients that are energy/protein dense, 
provision of fortified fluids (as shots or drinks) and nourishing between meal snacks. 
The intervention will be resident-focused, with an emphasis on adaption of familiar 
and well-liked food and drink items that can be provided daily within the care home. 
This process follows usual, standard care for implementation of dietetic-led food 
based intervention in the treatment of malnutrition. 
The Dietitian researcher will determine compliance with the food-based treatment 
plan at 3 months and 6 months. The care home staff will be required to record 
resident intake of the recommended food-based intervention on the daily food record 
chart, as a proportion taken, as per usual, standard practice. The dietitian will 
calculate average intake from a 3-day anonymous chart at 3 months and 6 months. 
Compliance will be categorised into ‘compliant’, if more than 75% of the advised 
food/beverage is consumed daily and ‘non-compliant’ if less than 75% is consumed. 
ONS Intervention  
Assigned care staff within the care homes allocated to dietetic-led ONS intervention 
will receive instruction by the dietitian to increase resident daily intake by 600kcal 
and 24g protein, through the provision of 2 liquid ONS daily. The ONS will be 
provided alongside the current standard dietary intervention plan for malnutrition.  
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The ‘standard’ ready to drink ONS is comprised of a combination of macronutrients 
and micronutrients and is presented in liquid form (NPC, 2012). These widely used 
supplements provide approximately 300kcal and 12g of protein per serving (BMJ 
Group and the Royal Pharmaceutical Society of Great Britain 2011). Three ‘standard’ 
supplements will be used within this study:  
Fortisip 200ml bottle, Fortisip Compact 125ml bottle and Nutriplen 125ml 
bottle. 
Table 2: Oral nutritional supplement composition 
 
ONS Volume (ml) Kcal/ml Energy 
content (kcal) 
per serving 
Protein content 
(g) per serving 
Fortisip Bottle 
(Nutricia 
Advanced 
Medical Nutrition)  
200 1.5 300 12 
Fortisip Compact 
(Nutricia 
Advanced 
Medical Nutrition) 
125 2.4 300 12 
Nutriplen  
(Nualtra Ltd) 
125 2.4 300 12 
 
*Nutritional information taken from: http://www.nutricia.ie/products and http://nualtra.ie/information-for/dietitian.  
 
 
Fortisip bottle and Fortisip compact will be provided by Nutricia for the first 3-months 
of the trial. Nutriplen will be provided by Nualtra for the second 3-months of the trial. 
All of the ONS will be provided to residents under the control of a registered dietitian. 
The Fortisip Compact and the Nutriplen supplements are more nutrient dense per ml 
than Fortisip, but a bottle/serving of each supplement is equivalent in nutritional 
content. Each resident will be provided with 2 bottles/servings daily. The Dietitian 
researcher will determine compliance with the intervention at 3 months and 6 
months. The Care home staff will be required to record intake of ONS on the daily 
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drugs chart, as a proportion taken, as per usual, standard practice. The dietitian will 
calculate average intake from a 3-day anonymous drugs chart at 3 months and 6 
months. Compliance will be categorised into ‘compliant’, if more than 75% of the 
advised dose is consumed daily and ‘non-compliant’ if less than 75% is consumed. 
Standard Care Arm  
Residents within the care homes allocated to provide the current standard care 
home diet for malnutrition, without added dietetic intervention, will be provided with 
an energy-enriched diet plan, in line with the training already provided to care home 
staff (including catering teams) by the Registered Dietitian. This will ensure that no 
resident at risk of malnutrition is denied access to first-line treatment (NEAC, 2008). 
 The purpose of the standard care home dietary intervention, is to provide and 
encourage a calorie dense diet (Department of Health, 1992), which may be 
achieved through provision of small, frequent meals and/or recipe enrichment with 
additional calories alongside prompting and assistance from care home staff where 
required. The care homes randomised to standard care will continue to receive 
monthly visits from the Dietitian in line with standard local practice. The Dietitian will 
meet with the nutrition leads already established at each home, but will not provide 
individualised plans for residents.  
Although a specific dietary, intervention plan will be allocated to each participating 
care home, there will be no change to the usual, standard nutritional care and 
monitoring that is provided at the individual resident level. Should a resident not 
tolerate the allocated intervention plan, refuse to comply with the intervention plan, or 
require adjustments to meet their changing nutritional needs; the dietary intervention 
plan will be changed accordingly. The proportion of residents in receipt of the, 
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standard care home diet for malnutrition that ultimately require dietetic-led 
intervention within the 6-month period will be collected. 
If any resident suffers a significant decline in their nutritional status and the care 
home staff deem it appropriate to make a formal referral to the nutrition support 
dietetic service, the resident will be withdrawn from the trial and no further data will 
be collected. This will allow the dietitian to have access to the resident’s care home 
record and to conduct a full clinical assessment.  
3.5 Outcome measures 
3.5.1 Timing of Assessments 
Assessments will be made at baseline, at 3 months and at 6 months. All 
assessments will be conducted within the care homes, in line with usual, standard 
practice for monitoring of nutritional status. 
3.5.2 Pilot outcome measures 
As this is a feasibility trial, there is no specified primary outcome measure.  
Existing studies that have evaluated the effectiveness of ONS within the older 
malnourished community population (Hubbard et al., 2008; Parsons et al., 2011) 
have measured change in energy intake as the primary outcome measure. In theory,  
an increase in energy intake will result in weight maintenance or weight gain 
(Stratton et al., 2011), alongside changes in other anthropometry parameters (such 
as Handgrip strength and MAMC), which reflect clinical and nutritional status 
(Thomas and Bishop, 2007).   
The 2011 Cochrane review of malnutrition intervention studies, highlighted 
considerable heterogeneity in the outcome measures investigated, including 
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mortality, morbidity and a variety of measures of nutritional status (weight, change in 
nutritional intake and Mid Arm Muscle Circumference (MAMC)). There is a lack of 
good quality evidence for all reported outcomes, particularly within the care home 
setting.  
 
This trial will review the feasibility and acceptability of a range of outcome measures 
for use within the main trial. Outcome measures that are routinely collected within 
the usual monitoring of nutritional status, such as change in energy intake and 
anthropometric parameters (weight, BMI, handgrip strength and MAMC) will continue 
to be collected for all residents with, or at risk of malnutrition that are placed onto a 
dietary plan. This data will be provided anonymously to the dietitian. 
 
The Cochrane study highlighted a particular need for evidence for the effects of 
malnutrition interventions on patient reported outcomes. Additional, participant-
reported outcome measures such as quality of life (CO-OP Charts), health state 
(EQ-5D) and participant rated appetite and dietary satisfaction (VAS), will be 
explored with those residents that have capacity and have provided written informed 
consent to participate in the collection of this information. 
The EQ-5D, CO-OP Charts and VAS appetite tools are well-established research 
tools. They are considered quick and easy to complete (Bowling, 2009), but require 
piloting within the care home population, to inform as to whether they are appropriate 
for completion by care home residents that have been assessed as having capacity.  
 
This trial will also pilot a healthcare resource usage questionnaire, developed from 
consideration of existing instruments that have been submitted for use in residential 
care settings on the DIRUM database (http://www.dirum.org).This questionnaire has 
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been designed to only collect data that already forms part of the information that may 
be gathered by the Dietitian during usual, standard assessments and review 
consultations, but it will be piloted for completion by care home staff. Completed 
questionnaires will be provided to the dietitian in an anonymous format. There are no 
instruments specifically for malnutrition interventions, but the pilot findings may 
inform future development.   
Sequential Qualitative assessment 
 
Participant Semi Structured Interviews 
 
The dietitian researcher will use a semi structured interview approach with the 
residents recruited into the qualitative phase of the trial. The interviews will be 
organised around a topic guide, designed to explore the perspectives of the 
residents on taking part in research, and the experiences of residents within the care 
homes randomised to all three dietary intervention plans.  
The interviews will be conducted face-to-face, to provide a means of acquiring 
insight and understanding of the resident experience and values (Ritchie and Lewis, 
2003) and are anticipated to last for 30 to 60 minutes for each individual. 
The interview schedule will consist of the same predetermined open-ended 
questions for each resident, but it is anticipated that other questions will emerge 
during the interview process. Open-ended questions will be used to elicit the 
individual perspectives of each resident and to encourage them to reflect on their 
experiences (Warren and Karner, 2005).To gain further insight into the resident 
experiences; the Dietitian will use more probing questions as required. The basic 
research question to be explored will be the acceptability of participation in the trial. 
This will be explored in relation to the completion of the questionnaire, chart and 
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scale at baseline, 3 months and 6 months. The dietitian will also further explore 
quality of life and dietary satisfaction on the allocated dietary intervention plan. 
Staff Focus Groups 
The dietitian researcher will facilitate a focus group discussion with between 2 and 8 
staff within each care home that participates in the trial and for which management 
approval has been received for focus group participation. As with the resident 
interviews, the focus groups will be built around a topic guide, developed to expand 
on the quantitative findings, by exploring further the feasibility and acceptability of the 
trial. 
This technique has been chosen as a means of obtaining information about a range 
of staff experiences and to highlight any variations in perspectives between the staff 
within each home and between care home types (Rabiee, 2004). 
The groups are anticipated to last 1 to 2 hours duration. The staff will be informed 
about the time commitment required within the information sheet provided prior to 
the qualitative phase of the trial and the focus groups will be organised at a time 
when it is convenient and safe for the staff to attend. It is hoped that the focus 
groups will generate a lot of information in a relatively short amount of time.  As the 
staff within a care home work closely together, it is anticipated that they will be able 
to engage in discussion. 
 
The qualitative research phase will be iterative in nature. Questions may be altered 
as the subject is explored and better understood. Digressions from the topic guide 
may occur, as a means of further exploring a resident or a staff group’s interest or 
thoughts. In light of the possibility for digression, the interviews and focus groups will 
be audio taped, to enable transcription for analysis (Rubin and Rubin, 2005).  
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Audiotaping will allow the Dietitian Researcher to concentrate on interacting with the 
participants and will enable a more accurate transcription of the interview 
Permission to audio tape the interviews and focus groups will be obtained prior to the 
start of the qualitative phase. 
 
3. Safety Assessment and Reporting 
The Medicines and Healthcare products Regulatory Agency (MHRA) define ONS as 
Non Investigational Medicinal Products (NIMPs). ONS will be provided by Nutricia 
and used under the control of a Registered Nutrition Support Dietitian within this trial. 
 
Risk of re-feeding syndrome on initiation of an energy fortified diet or ONS: 
Those at risk of re-feeding syndrome will be identified through routine ‘MUST’ 
screening, if they have any of the following: a BMI of less than 16kg/m2, weight loss 
of greater than 15% over the last 3 to 6 months, no or negligible dietary intake for 10 
consecutive days (NICE, 2006). If any resident is identified as being at risk of re-
feeding syndrome at baseline, nutritional intervention will be commenced cautiously, 
at 10kcal/kg/day, increasing to provide the additional 600kcal and 20-25g protein by 
day seven. The dietitian may also request that the GP monitor electrolytes and 
glucose. This procedure is in line with usual, standard dietetic practice and national 
guidance (NICE, 2006). 
 
Deteriorating swallow function (dysphagia) and an increased risk of aspiration: 
If dysphagia is identified or suspected during the 6 month dietary intervention, by the 
care home staff or the dietitian researcher, this will prompt a referral to the Speech 
and Language Therapy (SaLT) team, as per usual standard practice. 
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3.1 Adverse Events (AEs) and Serious Adverse Events (SAEs) 
We consider this trial to be low risk. The delivery of existing and established dietary 
interventions will be conducted in line with usual, standard practice as part of an 
evaluation of current dietetic service provision to care home residents with, or at risk 
of malnutrition. 
The dietary interventions are well established and are currently in use to treat 
malnutrition in the care home population.  Expected adverse events may include: 
 A risk of mild side effects in response to a fortified diet or prescribed ONS, 
including diarrhoea, bloating, nausea and satiety. As diarrhoea is occasionally 
reported in practice on initiation of ONS, this has been stated clearly within the 
Care home information sheet. If a resident suffers with diarrhoea on commencing 
the ONS intervention, it will be classed as an adverse event (AE) and an 
indication that the supplement should be discontinued for that individual, with the 
option to change to the standard care home diet for malnutrition.  
No other risks are anticipated and therefore it is reasonable to collect only targeted 
dietary intervention related AEs and only serious adverse events (SAEs) requiring 
hospital admissions that are due to avoidable malnutrition or dehydration. 
3.2 Reporting of Adverse Events and Serious Adverse Events 
The care home staff will be required to inform the Dietitian Researcher if any 
AEs/SAEs relating to a resident’s malnutrition and/or its treatment are identified, 
through the completion and faxing of an anonymous adverse event form. The 
incidence and frequency of AEs will be recorded at 3 months and 6 months. 
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Care home staff will also report the incidence and frequency of hospital admissions, 
GP visits and specialist nurse visits on the resource usage form for each resident in 
receipt of a dietary intervention plan at 3 months and 6 months.  
Death from any cause should be reported by care home staff on an anonymous AE 
form and faxed to the dietitian researcher. 
3.3 Assessing severity and causality of AE and SAEs 
All AEs and SAEs should be evaluated by a doctor (the GP) to establish the severity 
and the causality between the dietary intervention allocation and the AE/SAE and will 
be reviewed by the joint Data Monitoring/Trial Steering Committee on a three 
monthly basis. 
 
4. Sample Size and Recruitment 
4.1 Sample Size 
 
As this is a feasibility trial, a formal sample size calculation is not needed (Arain et 
al., 2010). Six local care homes will be recruited into the trial and will be randomised 
into the three dietary intervention arms. Based on the capacity of the selected care 
homes and the risk of malnutrition within this population, we estimate that between 8 
and 30 residents will be identified as moderate or high risk of malnutrition within each 
participating care home and will be considered for receipt of the assigned dietary 
intervention plan.  
4.2 Recruitment 
As part of the Solihull Nutrition Support Project (February 2011 to present), dietetic 
led training has been delivered to 17 local care homes, to standardise and improve 
the identification and first-line nutritional management of malnutrition. Nutrition Leads 
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(Nurses or Senior Carers) have been established within each care home and meet 
regularly with the Dietitian to ensure continued best practice. To commence 
recruitment as soon as possible, 6 local care homes have been identified for the 
study, which reflect the variability of the care home population and are anticipated 
will be willing to participate, based on their support for the existing project work. 
5. Analysis 
Anonymous resident data, provided by each participating care home, will be 
analysed in the treatment group to which the care home was randomised, on the 
intention-to-treat (ITT) principle. The Birmingham Clinical Trials Unit (BCTU) will 
provide support with the analysis of data. 
6.1 Quantitative Analysis 
As effective hypothesis testing requires a powered sample size (Arain et al., 2010), 
analysis will be limited to, descriptive statistics and an exploratory analysis to provide 
estimates of key parameters and to inform the future trial design.  
The objective of the trial is to assess the feasibility and acceptability of a full-scale 
cluster randomised trial comparing food-based intervention, ONS intervention and 
standard care within a malnourished care home population. To inform the design of 
the full-scale trial, within this feasibility trial we will assess: 
 Feasibility 
 Resident and care home staff acceptability 
 Recruitment and retention 
Screening logs completed within each care home will provide valuable information 
on the numbers of residents screened using ‘MUST’, and the reasons for not 
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receiving the dietary treatment plan, particularly in relation to the eligibility criteria 
and assessment by care home staff. 
Data on care home withdrawals from the trial, changes to resident dietary 
intervention plans, mortality, adverse events and compliance will be collected 
throughout the trial. This data will allow assessment of retention rates, reasons for 
withdrawal from the trial, or the dietary plans, and will inform aspects of feasibility 
and acceptability reporting, including the acceptability or appropriateness of including 
a standard care arm.  
Data from this feasibility trial will also be used to inform suitability of participant-
reported outcome measures, provide data to inform a sample size calculation and 
pilot the healthcare resource usage questionnaire for the full-scale trial.   
 
Data is being collected on a number of outcome measures. The data collected will 
be summarised using summary statistics and an exploratory analysis will be 
performed. The differences between the arms at 3 months and 6 months, and in the 
change from baseline to 3 months and 6 months will be calculated for continuous 
outcome variables, such as nutrient intake and anthropometric parameters, along 
with 95% confidence intervals.   This data will be used to review the sensitivity of the 
outcome measures to change.  Appropriate techniques such as correlation methods 
will be used to assess and inform which outcome measures are most appropriate to 
take forwards into the substantive trial. 
The data collected within this trial will also provide the data necessary for a sample 
size calculation and will help inform a calculation of the Intracluster correlation 
coefficient (ICC) for a full scale trial. 
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6.2 Qualitative Analysis 
The qualitative data will be analysed using the Krueger (1994) and Ritchie and 
Spencer (1994) framework analyses, assisted by the NVivo computer program as 
required. The process of data analysis will begin during data collection, through the 
effective facilitation of the interview and focus group discussions, complemented by 
observational notes. Following data collection, the dietitian researcher will transcribe 
the audio tapes and identify major themes.  
Concepts, ideas and short phrases identified within the text, will be used to develop 
categories and a thematic framework. Once a framework has been developed, the 
data will be indexed using a process of sorting, highlighting and arranging quotes to 
make comparisons between and within cases. Once indexed, the quotes will be re-
arranged under the appropriate thematic content.  
The final stage of analysis will be mapping and interpreting the data, identifying links 
between the quotes and exploring and explaining patterns of association. 
The qualitative analysis will be interpreted alongside the quantitative feasibility and 
acceptability findings, to inform the design of the future main trial. 
6. Research Governance 
The conduct of the trial will be in accordance with the International Conference on 
Harmonisation guidance for Good Clinical Practice (ICH GCP) and the Department 
of Health’s Research Governance Framework (2nd ed, 2005). This student project is 
being conducted with on-going advice and support of BCTU. 
 
 
 174 | P a g e  
 
6.1 Ethics 
The trial will be submitted for NRES approval and for local Research and 
Development Department (R&D) approval at each care home site. 
6.2 Sponsor 
The Heart of England NHS Foundation Trust has agreed to sponsor the trial 
7.3 Joint Trial Steering Committee (TSC)/Data Monitoring 
Committee (DMC) 
The joint TSC/DMC will include the Dietitian Researcher, Chief Investigator of the 
pilot trial and three or more independent members.  The independent members will 
include an independent statistician, a dietitian not involved in the trial and care home 
staff, independent from the trial. The TSC/DMC will meet every 3 months to 
undertake safety monitoring. 
7.4 Confidentiality of Personal data 
This trial will collect anonymous resident data only. No personal information will be 
collected, with the exception of resident name and signature, for those residents that 
consent to take part in the participant-reported outcome measures and individual 
interviews. This information will be collected on paper consent forms and will be 
securely stored at the HEFT Nutrition Support Service office base, within locked 
cabinets. Residents will be asked to consent to this. 
Consent to provide the dietitian with anonymous outcome data will be received by 
each participating care home. The participating care homes will be informed that 
their trial data and information will be securely stored at HEFT Nutrition Support 
Service office base and will be asked to consent to this. The data will be entered 
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onto a secure computer database. All information collected for the trial will be treated 
as strictly confidential. Members of the existing care team only, will conduct a review 
of resident care records, prior to initiation of the allocated dietary intervention plan.  
7.5 Long-term storage of data 
In line with Good Clinical Practice guidelines, all essential documentation and data 
will be retained for at least 5 years. 
8 Trial Organisation 
 
8.1 Care Homes 
The Care home Manager and care staff will be involved throughout the trial process, 
as ‘research partners’ and will support the following aspects of the trial: 
 Recruitment and consent: the staff and residents have contributed to the 
development of the trial and participant information sheets. The senior care 
home staff will make decisions on capacity to consent, will undertake the 
malnutrition screening process using MUST and will review resident care 
records against the inclusion and exclusion criteria. 
 Delivering Interventions: The care home staff will be responsible for the 
delivery of the allocated dietetic-led intervention and/or standard care to the 
eligible residents. 
 Data gathering- Assigned care home staff will take responsibility for 
gathering data for the trial, including outcome measures: weight, height, BMI 
and resource utilisation. They will also record daily food intake, compliance 
with the interventions and will deliver the EQ-5D and VAS questionnaires to 
those residents that have capacity and have consented to participate in these 
additional outcome measures. 
 Interpretation of findings- Through focus groups and feedback.   
 Future trial design: The collective opinions and feedback from care home 
staff and residents will be used to inform the future trial design.  
 
 
 
 176 | P a g e  
 
8.2 Finance 
This trial is being undertaken as a student project, as part of the National Institute for 
Health Research (NIHR) Clinical Academic Training Programme for AHP’s (Masters 
in Research). The trial will be self-funded and will involve no research costs for the 
NHS trust as no additional follow up visits or investigations are needed, other than 
those that would normally be required for standard care of residents. 
8.3 Training 
A training session will be held within each care home for assigned care staff prior to 
commencement of the trial.  
9 Project Timetable  
 
Time: Action: 
September 2013 National Research Ethics Service application submitted and 
approval obtained 
October 2013 Local R&D approval applications submitted 
October/November 
2013 
Local R&D approvals obtained 
Care Home recruitment and training and resident consent and 
recruitment for participant-reported outcome measures commences 
December 2013 Baseline Assessments completed and 6-month intervention 
commenced in all 6 care homes. (Commencement may be 
staggered) 
July 2014  6 month follow up completed in all 6 care homes 
Quantitative  data analysis and qualitative data collection 
commences 
December 2014 Data analysis and write up of trial report completed 
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Resident perception of quality of life, health state, appetite and dietary 
satisfaction on a dietary plan for malnutrition 
Information Sheet 
 
 
 
Researcher/Dietitian Contact Details:  
 
      
      
 
  
      
  
Patient Services Department (formerly PALS):  
APPENDIX 9: 
PARTICIPANT INFORMATION SHEET FOR 
QUESTIONNAIRES 
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Participant Information Sheet 
You are being invited to provide information in a research 
study. Before you decide whether you would like to provide this 
information, it is important you understand why the study is 
being done and what your participation will involve. 
Please read the following information carefully and discuss it 
with others if you wish. Ask us if anything is not clear or if you 
would like more information.  
Take time to decide whether you wish to take part.  
Thank you for reading this. 
 
What is the purpose of the study?  
 
 
 We want to gather information on care home resident 
experiences of following a dietary plan for malnutrition 
(undernutrition). 
 
 We want to use this information to compare different dietary 
plans that are currently being used in care homes 
 
 This study will be a pilot (a small experiment) to help us to 
find out if our study plan works and if we need to change 
anything 
 
 We plan for a larger study in the future to give us information 
on which dietary plan works best 
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Why have I been asked to provide information?  
 
 Your care home is one of six that has agreed to allow us to 
evaluate a current dietary plan for malnutrition. 
 
 We are asking you to tell us about your experiences of 
receiving this dietary plan, because you are at risk of 
malnutrition (undernutrition) and your opinion of the diet will 
help us to decide how well it is working. 
 
Do I have to provide this information?  
 
 The decision is yours 
 
 If you decide to take part, you will be given this information 
sheet and we will ask you to sign a consent form 
 
 You can change your mind at any time, you do not have to 
give a reason 
 
 If you do not wish to take part or if you withdraw, this will not 
affect the care you receive 
 
How will I share my experiences of the diet that I am 
following?  
 
 Your care staff will ask you to complete 2 short 
questionnaires and 2 scales  
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 These questionnaires and scales will ask about your quality 
of life, your appetite and your satisfaction with your diet.  
 
 You will not have to write anything. The questions will ask 
you to tick a box or to place a mark on a scale. 
 
 You will not need to give your name. All the information you 
provide will be anonymous (your identity will be unknown) 
 
 You will be asked to complete these questionnaires, 3 times 
in 6 months  
 
After the six months 
 After 6 months, the Dietitian may wish  
to speak with you individually (interview)  
to find out more about your experiences   
of completing these questionnaires  
and your opinion of the diet you  
have been receiving 
 This is optional. You can tell us on the 
consent form if you do not wish to be interviewed  
 Even if you say ‘yes’ now, you can change your mind later 
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What are the possible disadvantages and risks of 
providing this information?  
 
 We do not think there are any disadvantages or risks to 
completing the questionnaires and scales to provide us with 
information. 
 
What are the possible benefits of taking part?  
 
 You may not get a direct benefit from taking part, but the 
information we get from you may help us to treat people 
better in the future 
 
 We will use our findings for a future bigger study 
 
What if I wish to make a complaint about my 
involvement? 
 
 
 If you wish to complain or have concerns about the way you 
have been treated, ask the care home staff if you can speak 
with the Heart of England NHS Foundation Trust complaints 
Manager.  
   You can also ask your carers or family to do this on your behalf 
 If you have any concerns or questions, please contact the 
Dietitian, who will do her best to answer your concerns: 
      
 If you remain unhappy and wish to complain formally, you can 
contact your Patient Services Department (formerly PALS) on 
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Will anyone know that I have taken part in this study?  
 All information you give us will remain anonymous, it will not 
be possible for anyone to work out that you have provided the 
information 
 
 No personal details will be collected, with the exception of 
your name and signature on the consent form. This form will 
be stored in a locked cabinet at the Heart of England NHS 
Foundation Trust Nutrition Support Service office base. 
 
 No names will be given when the results are written up 
 
 
What will happen to the results of the research study?  
 
 The results may be put into a nutrition journal after the study 
but no care homes or residents will be named 
 
Who is organising and funding the research?  
 
 The study is part of a student project that the Dietitian is 
completing 
 It is self-funded 
 No payments will be made to anyone involved in the study 
 
 
Who has looked at the research? 
 
 A group of people not involved in the study has looked at the 
research. This group is a Research Ethics Committee. 
 
 They look at the research idea to protect your safety, rights, 
well-being and dignity 
 
 This study has been reviewed and approved by insert 
committee and date 
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Contact for Further Information  
 
Should you want further information about the study please 
contact:  
 
  
 
   
 
 
If you decide to take part in this study, you will be given a copy of 
this information sheet and a signed consent form to keep.  
Thank you for taking the time to read this information sheet 
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Resident perception of quality of life, health state, appetite and dietary 
satisfaction on a dietary plan for malnutrition 
Please  
Initial Box 
7. I confirm that I have read and understand the information 
sheet dated insert date for the above study and have been 
able to ask questions. 
 
8. I understand that providing information to the dietitian is 
voluntary and I am free to withdraw or decline at any time 
without giving a reason,  
- without the quality of my nutritional care  
- or legal rights being affected. 
 
9. I agree to provide information to the dietitian, through the 
completion of anonymous questionnaires and visual scales 
 
10. I agree to being considered for an interview with the 
dietitian after the study to discuss my experiences (optional) 
 
11. I agree to this consent form being securely stored at an 
NHS office base 
 
Name of participant:      Date: 
Signature: 
Name of person informing participant:   
Date:     Signature: 
For further information about the study please contact:  
 
CARE HOME TRIAL NUMBER: 
APPENDIX 10: 
PARTICIPANT CONSENT FORM 
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APPENDIX 11 
FOOD-BASED INTERVENTION RECIPES 
 
Intervention: Recipe: 
Fruit fool 300ml fruit puree, 150g custard, 2tbsp milk powder, 
150ml evaporated milk, 1tbsp Honey (makes 3) 
 
Chocolate mousse 1 sachet instant chocolate dessert, 4tbsp milk powder, 
150ml double cream, 150ml full cream milk (makes 2) 
 
Milkshake 200ml full cream milk, 1tbsp milk powder, 1tbsp 
double cream, milkshake powder to taste 
 
Hot chocolate 200ml full cream milk, 1tbsp milk powder, 1tbsp 
double cream, drinking chocolate powder to taste 
 
Malted drink 200ml full cream milk, 1tbsp milk powder, 1tbsp 
double cream, malted powder (Horlicks/ovaltine or 
equivalent) to taste 
 
Coffee 200ml full cream milk, 1tbsp milk powder, 1 heaped 
tsp of coffee granules, 2tbsp double cream  
 
Fruit smoothie 200ml full cream milk, 2 tbsp milk powder, 3tbsp 
double cream, 1 ripe banana/other fruit, 30g ice cream 
 
Tbsp = Tablespoon 
The nutritional content of the above recipes was analysed by the Primary researcher 
using the nutritional software package, Diet Plan 6. 
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APPENDIX 12 
FOOD-BASED INTERVENTION CHOICES 
 
Table A12.1: Agreed FB intervention choices at Baseline and at the 
3-month review (T1) 
Resident 
number 
Agreed intervention 
B T1 
SG01 Fruit fool Fruit fool 
SG02 Fruit fool Fruit fool 
SG03 Chocolate mousse *Fruit fool 
SG04 Chocolate mousse Chocolate mousse 
SG05 Hot chocolate x 2 *Fruit fool 
SG06 Fruit fool Fruit fool 
SG07 Fruit fool Fruit fool 
SG08 Fruit fool Fruit fool 
SG09 Fruit fool Fruit fool 
SS01 Milkshake, malted drink Milkshake, malted drink 
SS03 Hot chocolate, malted drink Hot chocolate, malted drink 
SS04 Fruit fool *Hot chocolate, malted drink 
SS05 Milkshake, malted drink Milkshake, malted drink 
SS06 Milkshake, malted drink Milkshake, malted drink 
SS07 Milkshake, malted drink Milkshake, malted drink 
SS08 Fruit fool **Left trial 
SS09 Fruit fool Fruit fool 
SS10 Fruit fool Fruit fool 
SS11 Fruit fool Fruit fool 
SS12 Milkshake, malted drink Milkshake, malted drink 
SS13 Milkshake, malted drink **Left trial 
SS14 Milky coffee x 2 Milky coffee x 2 
SS15 Fruit fool Fruit fool 
SS16 Milkshake, malted drink **Left trial 
SS17 Fruit smoothie, malted drink *Malted drink, hot chocolate 
SS18 Fruit smoothie, malted drink *Malted drink, hot chocolate 
SS19 Milky coffee, malted drink Milky coffee, malted drink 
SS20 Milkshake, malted drink Milkshake, malted drink 
SS21 Malted drink x 2 Malted drink x 2 
SS22 Milkshake, malted drink **Left trial 
SS23 Fruit fool *Hot chocolate x 2 
*FB intervention alterations at T1 to accommodate for changing resident preferences; **resident had left the trial 
by the T1 data collection interval 
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The only adverse events being recorded in this trial are gastrointestinal symptoms 
(such as diarrhoea, bloating, nausea and early satiety) and serious adverse events 
requiring a hospital or GP visit that are due to avoidable malnutrition or dehydration. 
If such an adverse event is noted, please complete page 1 of this form and fax to 
 
 
 
Adverse Event: 
Date Event started: Date event ceased: 
Outcome:   Fatal:                  Recovered:                        Continuing: 
Details of Adverse Event: 
 
 
Causality (in the opinion of the GP or other professional): 
 
How was the event treated? (e.g. call out to GP) 
 
Did the event require hospitalisation?  Yes                   No 
If Yes, please indicate the number of days: 
 
Did the event require the resident to change dietary intervention plans?   
Yes             No 
Resident Number: 
 
Care Home Trial Number: 
APPENDIX 13: 
ADVERSE EVENT FORM 
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Would the event be considered:  
Expected  Unexpected 
(in accordance with the expected side effects/trial protocol) 
If expected, please tick one: 
GI symptoms             Re-feeding syndrome              Dysphagia/risk of aspiration  
 
Name of person reporting 
 
Signed     Dated:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reason why you consider the event to be related to nutritional status or treatment 
allocation : 
 
 
 
 
/               / 
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(To be completed by care home staff) 
Assigned Resident Number: 
 
Medical Details: 
Primary Diagnosis:  
 
Form Completed by (print name): 
Signed:_________________  Date:___________________ 
Care Home Name: 
Care Home Type: 
Care Home Trial Number: 
 
Diagnosis of Dysphagia? Yes                         No 
If YES,                                       FOOD 
                                                    
                                                  FLUID: 
Normal              Fork-mashable 
Thick puree       Thin Puree 
 
Stage 1             2            3 
 
Diagnosis of Dementia? Yes                         No 
Assessed as having capacity? Yes                          No 
If Yes, has informed consent been 
received for participant-reported 
outcomes? 
Yes                          No 
Height (m):  
Measured        
Reported  
Alternative measure  
APPENDIX 14: 
BASELINE RESIDENT ASSESSMENT FORM  
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To be completed by care home staff 
We would like to know how much use this resident has made of health services over 
the last 3 months. Please complete using care records after 3 months on the dietary 
intervention plan and after 6 months of the plan 
Resident number:      
Care Home Trial Number:     
Please indicate with a tick, which Questionnaire is being completed: 
   3 Months   6 Months 
 
1. Over the past 3 months, please indicate if and how often the 
following services have been used: 
Service No (service 
not used) 
Yes (service used) If yes, 
please 
indicate 
the number 
of visits 
GP    
District Nurse    
Dietitian    
Tissue Viability Nurse    
Another specialist nurse 
(e.g. respiratory, Heart 
Failure, Mental Health). If 
yes please specify the 
speciality 
   
Speech and Language 
Therapist 
   
If information not available, please tick  
 
APPENDIX 15: 
HEALTHCARE RESOURCE USAGE 
QUESTIONNAIRE 
 191 | P a g e  
 
2. Over the last 3 months, has the resident been admitted to hospital 
for any reason?  YES     NO 
For outpatient appointments go to 2a, A&E, go to 2b and inpatients, go to 2c  
If information not available on appt type, please tick box 
 
2a Outpatient appointments 
Episode Name of 
Hospital 
Reason for 
the 
appointment 
Department/speciality Number of 
appointments 
1st 
 
    
2nd 
 
    
3rd 
 
    
2b Accident and Emergency 
Episode Name of 
Hospital 
Reason for the visit Was this related to 
malnutrition/dehydration?  
1st 
 
   
2nd 
 
   
3rd 
 
   
2c Hospital Inpatients (If a day case, indicate ‘0’ under length of admission) 
Episode Name of 
Hospital 
Ward Type: Reason for Admission: Length of 
Admission: 
1st 
 
    
2nd 
 
    
3rd 
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We would like to know more about your appetite and satisfaction with your current 
diet. To help us to do this, please use a pen or a pencil to draw an ‘X’ on each of 
the lines below, to indicate how you are feeling in response to each of the questions: 
 How hungry do you feel today? 
Please indicate your feelings by marking the line below with an ‘X’: 
 
  
  
 
 
 
 Would you like to eat something now? 
Please indicate your feelings by marking the line below with an ‘X’: 
 
 
 
 How satisfied do you feel with your current diet? 
Please indicate your feelings by marking the line below with an ‘X’: 
 
 
 
 
CARE HOME TRIAL NUMBER: 
Not hungry at 
all 
Extremely 
hungry 
No, not at all Yes, very much 
Not satisfied at 
all 
Very Satisfied 
RESIDENT NUMBER: 
APPENDIX 16: 
VISUAL ANALOGUE SCALE (VAS) FOR 
APPETITE AND DIETARY SATISFACTION 
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 How pleasant are the meals provided? 
Please indicate your feelings by marking the line below with an ‘X’: 
 
 
 
 
 How pleasant are the ‘between-meal’ snacks provided? 
Please indicate your feelings by marking the line below with an ‘X’: 
 
 
 
 
 How pleasant are the drinks provided?  
Please indicate your feelings by marking the line below with an ‘X’: 
 
 
 
 
 
 
 
 
 
Not pleasant at 
all 
Very pleasant 
Not pleasant at 
all 
Very pleasant 
Not pleasant at 
all 
Very pleasant 
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To be completed by care home staff 
Resident Number: 
 
Care Home Trial Number: 
 
 
 
 
 
 
Your Care Home was randomised to the: 
[food-based intervention] / [ONS intervention] / [usual nutritional care] 
Form Completed by (print name): 
Signed:_________________  Date:______________
Plan terminated on (Date): 
 
Has the resident died?  
(please tick)                       
 
Yes  
No 
If yes, what was the cause of death? 
 
 
If No, what was the reason for 
terminating the plan? 
(Hospital admission, moved out of the care 
home, commencement of artificial feeding) 
 
 
Weight on terminating the plan (kg):  
BMI on terminating the plan (kg/m²)  
Malnutrition risk on terminating the plan (Low, 
Medium, High) 
 
APPENDIX 17: 
TERMINATION OF RESIDENT 
INVOLVEMENT FORM 
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APPENDIX 18 
QUALITATIVE METHODOLOGY 
 
A18.1 Objectives 
To explore with care home residents 
1. The reasons for compliance and non-compliance with the interventions and 
outcomes measurement  
2. Aspects of health, well-being and nutritional status with different nutritional 
interventions 
3. Understanding and perceptions of the study questionnaires 
 
To explore with care home staff, 
 
4. The reasons for residents not meeting the eligibility criteria for the trial, switching 
intervention arms or dropping out of the trial 
5. The reasons for compliance and non-compliance with the trial protocol in relation 
to provision of interventions, participant questionnaires and completion of 
nutritional screening 
6. Understanding and perceptions of the healthcare resource usage questionnaire 
and the ‘MUST’ tool 
7. Issues around retaining older adult care home residents in the RCT 
 
A 18.2 Qualitative design  
 
In phase 2 of the trial, the Primary researcher employed phenomenological 
methodology, to gather descriptions of resident and staff experiences of phase 1 of 
the trial. A semi structured interview approach was used with those residents 
recruited into the qualitative phase of the trial, whilst trial acceptability and feasibility 
was discussed with care home staff using focus group techniques.  It was decided 
that individual semi-structured interviews would be the most appropriate data 
collection tool for use with care home residents, because they enable the interviewer 
to explore more deeply into social and personal matters, than would be possible with 
the use of focus groups (Chilban, 1996; Johnson, 2002; Rubin and Rubin, 2005). 
Interviews can also offer greater validity, because respondents are able to ask for 
questions to be further explained, which allows the interviewer to identify any 
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problems with comprehension and to rephrase questions. This may be less feasible 
within the group setting (Bryman, 2004). 
An acknowledged weakness of the semi-structured interview approach is the risk of 
bias. Characteristics of the interviewer, such as gender, profession, socio-economic 
status and ethnicity can all affect a respondent’s replies (Bryman, 2004). Bias can 
also arise from the interviewer’s questioning style, if this leads and encourages 
respondents to answer in a particular way. 
The focus group technique was chosen for use with care home staff, as a 
means of obtaining information about a range of staff experiences and to highlight 
any variations in perspectives between the staff within each home and between care 
home types (Rabiee, 2004). Within the limited period of this MRes (2 years, part-
time), focus groups were considered a practical alternative to individual staff 
interviews, enabling the views of more people to be included (Ritchie and Lewis, 
2003) and for a relatively large amount of information to be collected in a short time. 
As the staff within a care home work closely together, it was also considered that the 
group environment would stimulate engagement and discussion. 
A 18.3 Sampling for the Qualitative phase 
 Once data collection was complete for the feasibility trial, those residents that 
indicated on the consent form that they would like to be considered for individual 
interviews formed the sampling frame for potential inclusion within the qualitative 
phase of the trial. A non-random method of purposive sampling involving care home 
staff discussions and consideration of the PROMs was used to identify potential 
participants per care home for individual semi structured interviews with the Primary 
researcher. The care home staff again made the initial approach to the potential 
participants to discuss their involvement. Those that remained interested in 
participation were introduced to the researcher, to provide further verbal and written 
information on this part of the trial. 
A focus group of staff (maximum of 8) was identified within each care home 
site that had management approval for staff participation (Gill et al., 2008). Care 
Home staff were selected on the basis that they had participated in the trial and 
would therefore have something to say. Separate information sheets for residents 
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and staff and consent forms were developed for the qualitative phase and were 
presented to eligible residents and staff prior to their inclusion. 
 
A 18.4 Qualitative Analysis 
 
The qualitative data will be analysed using the Krueger (Krueger, 1994) and 
Ritchie and Spencer (Ritchie and Spencer, 1994) framework analyses, assisted by 
the NVivo computer program as required. The process of data analysis will begin 
during data collection, through the effective facilitation of the interview and focus 
group discussions, complemented by observational notes. Following data collection, 
the dietitian researcher will transcribe the audio tapes and identify major themes.  
Concepts, ideas and short phrases identified within the text, will be used to develop 
categories and a thematic framework. Once a framework has been developed, the 
data will be indexed using a process of sorting, highlighting and arranging quotes to 
make comparisons between and within cases. Once indexed, the quotes will be re-
arranged under the appropriate thematic content. The final stage of analysis will be 
mapping and interpreting the data, identifying links between the quotes and exploring 
and explaining patterns of association. The qualitative analysis will be interpreted 
alongside the quantitative feasibility and acceptability findings, to inform the design 
of the future definitive trial. 
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Within each care home: 
 
 
 
 
 
 
 
Cluster randomisation of care homes: 
 
 
 
 
 
 
 
 
 
 
 
 
 
Six care homes selected and consented to participate. 
Two staff per home assigned for malnutrition and eligibility screening within each home 
 
‘MUST’ screening undertaken by assigned staff as per usual practice. 
Review of care home records by staff to ensure residents meet all eligibility criteria to 
receive a dietary intervention plan. Screening log initiated  
 
Written informed consent received for those residents that have capacity, to participate 
in the additional outcome measures  
 
Cluster randomisation of care homes into the 3 nutrition support interventions. 
Dietitian to inform each home of their allocated plan and provide a training session for staff 
1 Standard Care 
home diet for 
malnutrition 
 
2. Food-based 
dietetic Intervention:  
Addition of 600kcal and 
15-25g protein daily  
3. ONS dietetic 
Intervention:  
Addition of 600kcal and 
16-24g protein daily  
Dietitian visits to conduct and collect outcome measures at 3 months and 6 months. 
Incidence of mortality, retention, adverse events, compliance to be recorded  
 
Baseline assessments, collected by the Dietitian from each care home 
Standard outcome measures:  Anthropometry, average daily nutrient intake.  
Additional outcome measures: Quality of life, health state, appetite and dietary satisfaction 
 
 
 Collection of quantitative data finishes at 6 months, followed by Qualitative phase:  
Written informed consent received for residents and staff. 
Individual semi-structured resident interviews and staff focus groups conducted 
 
Senior care home staff assess the capacity of all identified residents. Those that have 
capacity are approached by care home staff to discuss possible involvement in 
participant-centric outcome measures. 
Care staff assign numbers to all eligible residents and provide baseline resident 
assessment data to the dietitian. 
 
6-month dietary plan commences 
APPENDIX 19:  
TRIAL SCHEMA 
Evaluate feasibility and use findings to inform future trial design 
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APPENDIX 20 
SUMMARY OF PARTICIPANT-REPORTED 
OUTCOME MEASURES DATA 
 
Table A20.1: Visual Analogue Scale (VAS) responses at 3-months 
(T1) and at 6-months (T2) 
VAS dimension SC FB ONS 
T1 
n =1  
T2 
n =1 
T1 
n =2 
T2 
n =1 
T1 
n =5 
T2 
n =5 
Rating  Rating Mean 
(SD) 
Rating Mean  
(SD) 
Mean  
(SD) 
Hunger 1 1 2.5 (4) 7 3.6 (5) 3.8 (3) 
Appetite 5 5 7 (3) 1 5 (5) 3.4 (3) 
Dietary satisfaction 8 8 7 (3) 7 4 (30 6.8 (3) 
Pleasantness of 
meals 
8 8 7 (3) 8 6 (4) 6.8 (3) 
Pleasantness of 
snacks 
7 6 7 (3) 8 3.2 (3) 7 (3) 
Pleasantness of 
drinks 
10 8 7 (3) 8 8.6 (0.5) 7.8 (2) 
SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements; VAS= Visual Analogue Scale, T1= Month-3; 
T2= Month-6 
Data are Means (SD) where n>1 and dimension rating where n=1 
 
Table A20.2: Other PROM responses at 3-months (T1) and at 6-
months (T2) 
PROM SC FB ONS 
T1 
n =1  
T2 
n =1 
T1 
n =2 
T2 
n =1 
T1 
n =5 
T2 
n =5 
COOP QoL Score* 6 6  4 (2 - 6) 6 2 (2 - 4) 4 (3- 6) 
EQ5D Overall VAS 
score 
45 45 70 (28) 50 60 (23) 56 (19) 
EQ5D Index 
Value** 
-0.112 0.011 0.16 
(0.3) 
-0.028 0.37 
(0.3) 
0.45 
(0.3) 
SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements; PROM= Participant Reported Outcome 
Measure; VAS= Visual Analogue Scale 
Data are Means (SD) for continuous data, or Median (IQR) for ordinal data (COOP)* where n >1. Data are PROM 
score where n=1 
**The EQ5D Index vale for health state was generated from the EQ5D-5L descriptive system, using an algorithm 
based on a sample from the adult UK population (Herdman et al, 2011). 
 200 | P a g e  
 
APPENDIX 21 
HOSPITAL ADMISSIONS 
 
Table A21.1: Hospital admissions as recorded by care home staff 
from baseline- 3-months (T1) and 3-months to 6-months (T2) 
Reason for 
admission 
T1 T2 
Number of visits 
recorded (n) 
Number of visits 
recorded (n) 
A&E 
Falls 5 4 
Suspected stroke 1  
Chest infection 1  
Outpatient appointments 
Biopsy 1  
Removal of growth on 
gum 
1  
Parkinson’s Disease 
Clinic 
1 1 
Dermatology 
appointment 
1 1 
Fracture to lower arm 1  
In growing eyelashes 1  
Diabetes check-up  1 
Inpatient admissions 
Unwell- GP requested 
admission 
1*  
Shingles  1* 
Worsening symptoms of 
Parkinson’s Disease 
 1* 
Aspiration Pneumonia  1** 
TOTAL: 14 10 
A&E= Accident and Emergency 
*Admitted for one-day only; **Led to an extended hospital stay and resident did not return to the care home (recorded 
on Figure 6) 
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APPENDIX 22 
HEALTHCARE PROFESSIONAL VISITS 
 
Table A22.1: GP call-outs as recorded by care home staff from 
baseline- 3-months (T1) and 3-months to 6-months (T2) 
Reason for call-
out 
T1 T2 
Number of visits 
recorded (n) 
Number of visits 
recorded (n) 
Medication review 7 15 
Cellulitis 7 3 
Wrist pain 1  
Sore mouth 1  
Infected hand 1  
Foot pain 1 2 
Chest examination 18 12 
Urinary tract infection 10 8 
Left-sided weakness 1  
Small growth abdomen 1  
Eye drops needed 1 2 
Diarrhoea and vomiting 5 1 
Constipation 1  
Bunion 2  
Blood test 1 3 
Following CPN  3 
Follow up after 
admission 
 2 
Shingles  1 
Bereavement  1 
Face rash  1 
Clinical deterioration  4 
Stool sample  1 
TOTAL: 58 59 
CPN= Community Psychiatric Nurse 
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Table A22.2 District Nurse visits as recorded by care home staff 
from baseline- 3-months (T1) and 3-months to 6-months (T2) 
 
Reason for visit T1 T2 
Number of visits 
recorded (n) 
Number of visits 
recorded (n) 
Catheter change 1  
Swollen legs 1  
Wound care 13 10 
Pressure area check 9 17 
Follow up after a fall 2  
Blood test 1  
Dementia review 1  
Leg ulcers 5  
Diabetes review  3 
TOTAL 33 30 
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APPENDIX 23 
PHYSICAL OUTCOME MEASURES AND NUTRIENT INTAKE 
Table A23.1: Physical outcome measures and nutrient intake: at 3-months (T1) and at 6-months (T2) 
Outcome measure SC FB ONS 
T1 
n =19  
T2 
n =19 
T1 
n =27 
T2 
n =23 
T1 
n =21 
T2 
n =21 
Weight (kg) n= 19 
48 (8) 
n= 19 
49 (7.2) 
n= 27 
56 (12) 
n= 23 
56 (13.3) 
n= 21 
50 (11) 
n= 21 
50 (11.5) 
BMI (kg/m
2
) n= 19 
18.6 (2.1) 
n= 19 
18.98 (1.9) 
n= 27 
21.7 (4.4) 
n= 23 
22.03 (4.8) 
n= 21 
19.7 (3.2) 
n= 21 
19.68 (3.4) 
MAC (cm) n= 13 
21 (2.1)  
n= 13 
21.2 (1.8) 
n= 24 
22 (3) 
n= 19 
22.2 (3.1) 
n= 18 
21 (2.9) 
n= 18 
21.7 (3.2) 
TSF (mm) n= 11 
10. 3 (4.4) 
n= 11 
9.2 (2.8) 
n= 19 
11.7 (5.4) 
n= 16 
12.95 (6.4) 
n= 15 
10.4 (3.4) 
n= 13 
10 (4.1) 
MAMC (cm) n= 10 
18.4 (2.1) 
n= 11 
18.28 (2.3) 
n= 19 
18.4 (2.4) 
n= 15 
18.14 (1.95) 
n= 16 
18.3 (2.4) 
n= 14 
18.44 (2.5) 
HGD (kg) n= 7 
9.1 (9.1) 
n= 6 
10.4 (9.4) 
n= 17 
8.3 (4.5) 
n= 11 
7.9 (5.6) 
n= 6 
8.1 (4.4) 
n= 6 
10 (3.4) 
Energy Intake (kcal) n= 18 
1578 (356) 
n= 17 
1652 (330) 
n= 27 
2169 (474)  
n= 23 
2059 (436) 
n= 21 
2014 (467) 
n= 21 
1987 (472) 
Protein Intake (g) n= 18 
48 (10) 
n= 17 
45 (39- 55.5) 
n= 27 
79 (15) 
n= 23 
78 (65- 92) 
n= 21 
72 (20) 
n= 21 
68 (52- 79) 
Fluid Intake (ml) n= 18 
1600 (1400- 1800) 
n= 17 
1318 (233) 
n= 27 
1600 (1400- 1600) 
n= 23 
1506 (204) 
n= 21 
1250 (1013- 1450) 
n= 21 
1312 (227) 
SC= Standard Care; FB= Food-Based; ONS= Oral Nutritional Supplements; BMI= Body Mass Index; MAC= Mid Upper Arm Circumference; TSF= Tricep Skinfold Thickness; MAMC= 
Mid Arm Muscle Circumference; HgD= Handgrip Dynamometer 
Normal data is presented as Mean change (SD), otherwise is Median change (IQR).  
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APPENDIX 24 
CALCULATION OF THE ICC AND SAMPLE SIZE  
 
A 24.1 The Intra cluster correlation coefficient (ICC) 
 
The ICC is a measure of the similarity of clustered data and is calculated using: 
 
ICC = Between cluster variability 
 (Within cluster variability + between cluster variability) 
 
For each desired outcome measure. When post-intervention data from all trial arms 
are used in the estimation of the ICC, a regression-based method is required 
(Eldridge et al., 2009). The value of the ICC ranges from zero to one. An ICC of zero 
suggests that the subjects within clusters are no more similar to each other than 
subjects from different clusters, whereas an ICC of one suggests that subjects within 
a cluster have identical outcomes (Hayes and Moulton, 2009).  
 
A 24.2 Design effect and effective sample size 
 
The ICC can be used to determine the increase in variance due to clustering, 
referred to as the Design Effect (DE), which varies for each outcome measure: 
DE = 1 + (m-1) x ICC 
Where, m is the average number of subjects in each cluster (Hayes and Bennett, 
1999).  
Further searching of the existing literature and further piloting within the older adult 
care home population is required to identify the most appropriate primary outcome 
measure for a definitive trial and to estimate the population variance of the outcome. 
The desired power and significance level can be used alongside the anticipated 
difference between means (effect size), estimated from the literature and pilot work, 
to calculate the size of the sample that would be required if no clustering was 
present.  
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The calculated DE can then be used to estimate the necessary inflation of the 
sample size (compared to that calculated for an individually randomised trial), to take 
account of the similarities in the clustered data: 
 
Effective Sample Size (ESS) = (m x k) 
DE 
 
Where, (m x k ) is the total number of subjects in a clustered trial 
m is the number of subjects in a cluster and 
k is the total number of clusters 
 
Generally, a greater ICC requires the enrolment of a greater number of trial 
participants (Donner, 1992). 
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